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 ABSTRACT 
The Impact of Brief Acceptance-Based Versus Control-Based Interventions on Distress 
Tolerance in Early Lapsing Nicotine Dependent Individuals 
Heather W. Murray, M.S. 
James D. Herbert, Ph.D. 
 
The prevalence of nicotine dependence continues to be a major public health concern.  
Despite advances in treatments, many smokers continue to be dependent on nicotine, and 
often relapse within hours or days of cessation attempts.  Preliminary investigations 
indicate that the level of tolerance for the distress of nicotine withdrawal is a key factor in 
early smoking lapse and subsequent relapse.  In this pilot study, the effect of brief 
interventions on early lapsing nicotine dependent individuals’ ability to tolerate 
psychological and physiological distress as imposed by laboratory challenges was 
examined.  Participants were early lapsing nicotine dependent individuals, a population 
of smokers that has elevated risk of maintaining smoking habits.  Participants were 
randomly assigned to one of three 30-minute interventions: 1) an acceptance-based brief 
intervention that promoted experiential acceptance, 2) a control-based brief intervention 
that encouraged attempts to alter or change thoughts, or 3) a health consequences 
comparison condition thought to increase awareness of health problems related to 
smoking. Participants’ distress tolerance significantly increased during the psychological 
and physiological stressors, but distress tolerance did not differ across groups.  In 
addition, differences between the groups in latency to smoking immediately following the 
termination of the stressors were not observed. 
 
  CHAPTER 1: INTRODUCTION 
The prevalence of nicotine dependence continues to be a major public health 
concern.  In the following section, the significant health consequences of smoking are 
reviewed, as well as the current modes of smoking cessation treatment.  Accumulating 
evidence indicating a relationship between early lapsing smokers and levels of distress 
tolerance is examined.  Potential treatment strategies targeting distress tolerance levels of 
early lapsing smokers are discussed and the need to further evaluate these strategies for 
this high-risk group of smokers is highlighted.   
Health consequences of smoking 
The health problems directly caused by smoking cigarettes are striking and 
profound.  In 1998, tobacco use, particularly cigarette smoking, killed four million people 
globally, which amounted to11,000 per day (World Health Organization, 1999).  Current 
smoking trends suggest that more than 500 million people worldwide living today will 
die from smoking (The Cancer Council, 2003).  Even in the United States (U.S.), where 
extensive educational efforts have taken place, smoking is the leading cause of 
preventable death, accounting for 440,000 deaths per year (CDC, 2002), which equates to 
one in every five deaths (CDC, 2001).  In the U.S., alcohol abuse, drug abuse, AIDS, 
motor vehicle accidents, homicide and suicide are six of the seven leading causes of 
death.  All six of these causes combined account for only half as many deaths each year 
as does cigarette smoking (CDC, 2000).  For most smokers, quitting smoking is the 
single most important thing that can be done to improve health (Edwards, 2004). 
Prevalence rates 
A Center for Disease Control report released in 2000 indicated that 23.3% of 
 adults reported currently smoking in the U.S. (CDC, 2000).  Yet, the number of smokers 
who want to quit is high:  Of the 42.2 million Americans who smoke, 70% want to quit 
(CDC 2002), and each year about 17 million adult smokers make a serious attempt do so 
(Swan et al., 2003).   
Quit rates 
Nevertheless, despite concerted efforts, smoking quit rates remain low:  The 
annual rate of sustained abstinence is just 2.5% (CDC, 1993).  Of those who attempted to 
quit smoking in the past year, only 4.7% were able to maintain abstinence for 3-12 
months (CDC, 2002).  In addition, the rates of successful smoking cessation declined 
throughout much of the 1990s with 60-98% of attempts to quit ending in relapse. 
The time frame in which individuals relapse merits further attention; it is 
becoming increasingly clear that a large portion of individuals have difficulty abstaining 
from nicotine for even short periods of time.  Among individuals whose quit attempt is 
unaided, the relapse rates are striking with approximately one-third to one-half returning 
to regular smoking patterns within the first few days (Brandon et al. 1990).  In addition, 
approximately 50-60% of unaided quit smoking attempts fail in the first two weeks 
(Ward et al., 1997; Brandon et al., 1990; Garvey et al., 1992).  Smoking relapse rates are 
correlated with the intensity of treatment interventions, though the smoking relapse rates 
continue to be high during the first week after the quit date.  Zhu and colleagues (1996) 
examined various intensity levels of smoking cessation interventions, which ranged from 
providing self help materials to 6 sessions of telephone counseling.  The researchers 
detected relapse rates of 59%, 54%, and 49% by the end of the first week for self-help, 
single and multiple phone contact groups.  Shiffman and colleagues (1996) examined 
 smokers enrolled in a cessation clinic that maintained abstinence for at least 24 hours and 
reported a 62% relapse rate within the first 26 days of quitting, with 5 days being the 
average length of time to relapse. 
When early relapse rates are examined in intensive treatment, a large percentage 
of quit attempters resume smoking within days of the target quit date (Schneider et al., 
1995).  In a study examining the effects of NRT on quit rates (Schneider et al., 1995), 6% 
of the individuals receiving nicotine replacement therapy (nasal spray), lapsed in the first 
24 hours and 24% lapsed by the second day.  Forty-three percent of the individuals in the 
placebo group lapsed by the second day.  In addition, Brown and colleagues (2001a) 
examined intensive behavioral smoking cessation interventions for smokers with a past 
major depressive episode, and found that 37% of participants lapsed on the planned quit 
date and 58.5% lapsed within the first week after quit date.  Interventions that combine 
nicotine replacement therapy and behavioral therapy fair better than NRT alone, though 
the percentage of individuals relapsing within the first week is almost one-third of the 
study population (Ussher et al., 2004) 
Shiffman et al. (1996) monitored lapses to smoking and determined that a vast 
majority (89%) of those who lapsed during the first four weeks after target quit date had 
an average second lapse within 3 to 4 days after the initial lapse (71% within 2 days and 
83% within one week).  Lapses in abstinence are common, and unfortunately more often 
than not lapses lead to relapses.  Brandon and colleagues (1990) reported that 88% of 
smokers that lapsed eventually relapsed. Ward and colleagues’ (1997) research findings 
suggest lapsing smokers resume regular smoking within 24 hours after their first smoking 
lapse.  In a study examining smokers with a history of MDD, only 10% of the smokers 
 who had relapsed during the first week of quitting demonstrated abstinence at the six-
month follow-up (Brown, 2004). 
The data regarding relapses have changed the conceptualization of nicotine 
dependence, and now it is perceived as a chronic disease, perhaps the most common in 
the developed world. Most smokers who try to quit smoking relapse within days, and 
many smokers who are able to maintain abstinence for longer periods of time such as 
weeks or months eventually relapse. The reality of nicotine addiction is that it is a 
chronic, relapsing, and in many cases lifelong problem that is likely to need repeated 
interventions to achieve long-term abstinence (Britton et al., 2001). 
Nicotine addiction 
The prevalence of smoking is remarkably high considering the increased 
awareness of health risks associated with smoking, the reported desire to quit smoking, 
and the motivation smokers demonstrate in a serious attempt to quit smoking.  The 
addictive property of tobacco, nicotine, contributes to the inability to maintain abstinence.  
When nicotine is administered in isolation it yields tolerance and physical dependence; 
acute doses produce elation and pleasure (Corrigall 1999; USDHHS, 1988).  When 
tobacco cigarettes are smoked the carcinogens are absorbed in the buccal mucosa, skin 
and lungs (Swan, Hudmon, & Khroyan, 2003).  The lungs absorb about 80% of inhaled 
nicotine, which then travels to the brain via the arterial blood, which has a direct passage 
to the brain without passing through any of the body filters including the liver (Swan, et 
al., 2003).  Concentrated bolos of nicotine reach the brain in 10-19 seconds after 
inhalation (Benowitz, Jacob, Fong & Gupta, 1994; Benowitz, Porchet, Sheiner & Jacobs, 
1988), and since brain tissue has a high affinity for nicotine the substance is quickly 
 absorbed (Maziere, Comar, Marazano & Berger, 1976).  As a result, nicotine quickly 
crosses the blood-brain barrier, a thin layer of tissue in the brain that typically blocks 
foreign substances from entering the brain.  Once nicotine enters the brain, it binds with 
acetylcholine neurotransmitters.  The brain reacts to the binding by releasing noradrenalin 
and dopamine, which both have widespread stimulating effects on the body. Nicotine has 
behaviorally reinforcing effects on the nervous system including stimulation of pleasure 
centers, increase in memory, mood modulation and skeletal muscle relaxation (Benowitz, 
1999). 
Not only is nicotine quickly absorbed, but also it is also quickly eliminated.  The 
half-life of nicotine is 2 hours for the body, yet only 10 minutes within the brain. When 
the level of nicotine decreases, withdrawal symptoms frequently occur including anger, 
irritability, anxiety, difficulty concentrating, drowsiness, fatigue, hunger, impatience, and 
restlessness (Hughes, Gust, Skoog, Keenan, & Fenwick, 1991). These withdrawal 
symptoms persist with intensity for 24 hours and peak in the first one to two weeks, and 
then typically resolve within 30 days after the last inhalation of tobacco smoke (Swan et 
al., 2003). Some individuals report cravings that last months or years after quitting 
(Swan, et al., 2003).  The addictive properties of nicotine are as potent as those of other 
addictive substances such as heroin or cocaine (Royal College of Physicians, 2000).  Like 
these other addictive drugs, nicotine withdrawal results in an increase in the threshold 
required for rewarding the brain (Epping-Joran, Watkins, Koob & Markou, 1998), which 
may account for the anhedonia that tends to accompany withdrawal (Baker et al., 2003).  
Moreover, withdrawal may be aversive not only because of the negative affect that results 
but also because withdrawal decreases the rewarding properties of nonpharmacologic 
 incentives such as social stimuli (Baker, Brandon, & Chassin, 2004). Individuals have 
reported withdrawal symptoms for months after quitting smoking (Piasecki, Fiore, & 
Baker, 1998; Piasecki et al., 2000). 
Conditioning  
 In addition to the development of a physical dependence to nicotine, smoking 
cigarettes becomes a learned behavior.  The paired behavioral rituals of smoking with the 
sensory aspects of nicotine uptake leads to secondary conditioning.  Cigarette smoking 
becomes part of a smoker’s daily routine, and is associated with certain times of the day, 
meals, events, people and locations, which come to function as triggers when the smoker 
attempts to quit smoking (Jarvis, 2004).  Environmental cues can elicit behaviors, 
depending on whether rewarding or aversive properties of nicotine have been conditioned 
(Swan et al., 2003).  Smokers’ reliance on cigarettes to cope with stress and negative 
emotions can be partially contributed to the conditioning response (Rigotti, 2002). 
Treatment 
 Four decades have passed since the surgeon general’s first report on smoking and 
health was published.  Since the 1964 report, a variety of treatments for nicotine 
dependence have been developed.  In the 1960s the advancement of smoking cessation 
programs proliferated with interventions including 5-day plans, rapid smoking, electric 
shock aversion, hypnosis, desensitization, conversant control, contingency management, 
and satiation (Shiffman, 1993).  This explosion of innovation in smoking cessation 
treatments slowed somewhat in the 1970s, with techniques such as self-management, 
stimulus control, nicotine gum, sensory deprivation, acupuncture, nicotine fading, and 
relapse prevention.  Innovation came to a near standstill in the 1980s, with cue exposure 
 emerging as the only novel intervention technique (Shiffman, 1993).  The 1990s was the 
era of pharmacological treatments. 
 The need for effective smoking cessation interventions is obvious and the desire 
to quit is common.  The following section reviews various treatments, along with the 
hypothesized theoretical mechanisms underlying the interventions and the available data 
on the efficacy of the treatments. 
Unaided smoking cessation. The majority of former smokers (91%) report 
quitting on their own (Fiore, Novotny, & Pierce, 1990) with stopping “cold turkey” the 
most commonly reported strategy (Skaar et al., 1997).  A meta-analysis that included 14 
studies from primary health care settings found that the rate of abstinence from smoking 
ranged from 8.5% to 13.5% for those attempting to quit, with an estimated rate of 
unaided smoking cessation (assessed over an average of 10 months) of 7.33% (Baillie, 
Mattick & Hall, 1995).  In community samples of smokers, only 2.5% have been able to 
maintain long-term abstinence (Morbidity and Mortality Weekly Report, 1993).  This 
percentage of individuals that can abstain from smoking without any intervention 
provides a rough baseline against which to judge the effects of smoking cessation 
treatments. 
Pharmacotherapy. Since the mid 1980s, when there were no pharmacological 
treatments approved by the Food and Drug Administration (FDA), there has been 
increased attention focused on developing pharmacological interventions.  The rational 
for developing pharmacotherapies for nicotine dependence is based on the nicotine 
properties of cigarettes that promote and maintain nicotine dependence.  Nicotine 
replacement therapy (NRT) and nonspecific pharmacotherapies such as anti-depressants 
 are used in an attempt to attenuate the nicotine withdrawal syndrome. 
Currently there are five FDA approved pharmacological interventions that are 
considered first-line agents for the treatment of nicotine addiction.  The Clinical Practice 
Guidelines (Fiore et al., 2000) have also recommended two pharmacological treatments 
as second-line approaches, particularly when clinicians consider first line treatments to be 
ineffective. 
  The FDA approved first-line treatments have been found to be safe and effective 
through rigorous clinical trials, which included randomized methodology comparing 
placebo with the active agent (Fiore et al., 2000).  Among the treatments approved for 
smoking cessation there are four forms of NRT, which provide nicotine in a variety of 
forms in order to ameliorate the withdrawal symptoms experienced during smoking 
cessation. 
Nicotine patch. The transdermal nicotine patch, a patch placed on the skin that 
releases nicotine into the body at a steady rate, has been found to be efficacious relative 
to placebo.  The PHS clinical practice guideline panel examined 27 studies in a meta-
analysis comparing the patch with placebo.  The results indicate that the nicotine patch 
approximately doubles long-term abstinence rates, both at 6-month and 1-year follow-up.  
Compared to placebo, the use of the nicotine patch resulted in a 22% abstinence rate at 1-
year follow-up, relative to 9% for placebo (Fiore, Smith, Jorenby, & Baker, 1994).    
Nicotine gum.  Like the nicotine patch, nicotine gum is available without 
prescription.  The nicotine in nicotine gum is absorbed through the buccal mucosa.  PHS 
meta-analysis of 13 studies examining the effectiveness of nicotine gum compared to 
placebo found that the 2 mg nicotine gum improves long-term abstinence rates by 
 approximately 30-80 percent compared to placebo (Fiore et al., 2000).  Abstinence rates 
at 1-year follow-up have been reported to be between 16.9 and 18.2% for nicotine gum 
and between 10.6 and 12.8% for the individuals receiving placebo (Cepeda-Bernito, 
1993; Silagy, Mant, Fowler, & Lodge, 1994; Teng, Law & Wald, 1994).  
Nicotine nasal spray.  Nicotine nasal spray has been shown to be an effective 
treatment for smoking cessation, and was shown to double long-term abstinence rates 
when compared to placebo spray (Fiore et al., 2000).  Twenty-four percent of smokers 
remained abstinent after 12 months (Silagy et al., 2004).  In 1996, the treatment was 
approved by the FDA. The nasal spray is introduced to the nasal passage and each spray 
delivers 0.5 mg of nicotine (with a recommendation of one spray each hour to control 
cravings).  Of the NRTs, the nasal spray reaches the brain the quickest, with peak levels 
of nicotine occurring within 10 minutes (American Psychiatric Association Work Group 
on Nicotine Dependence, 1996), and therefore is highly effective in reducing cravings. 
Nasal spray is only available with a prescription.  
 Nicotine inhaler. Like nicotine spray, the nicotine inhaler has been shown to be 
effective; it doubles long-term abstinence rates when compared to a placebo inhaler 
(Fiore et al., 2000). The Cochrane Review reports an average abstinence rate of 17% at 
12-month follow-up (Silagy et al., 2004). The use of the nicotine inhaler is designed to 
mimic smoking behaviors (including puffing and handling).   
Bupropion SR. Bupropion SR is the only FDA approved first line treatment for 
nicotine dependence that is not an NRT.  Bupropion SR is an anti-depressant that acts by 
inhibiting the synaptic reuptake of dopamine and norepinephrine (Dale et al., 2001; 
Hayford et al., 1999; Hurt et al., 1997).  This prescription medication does not address 
 specific cravings or act as a behavioral substitute for smoking.  Instead, its dopaminergic 
effects are thought to be relevant considering nicotine’s stimulating effects on the 
dopaminergic pathways in the mesolimbic system of the brain (Abrams et al., 2003).   
Randomized trials examining the efficacy of bupropion compared to placebo have 
shown significant effects, with those receiving active medication maintaining a higher 
abstinence rate at 1-year follow-up (24% for those taking 300 mg/d of bupropion 
compare to 10% for the placebo group; Hurt et al., 1997). However, Hall et al. (2002) did 
not find a significant difference between the placebo group and the bupropion group at 1-
year follow-up.  
 The Clinical Practice Guidelines (Fiore et al., 2000) have established the five 
treatments approved by the FDA (nicotine patch, nicotine gum, nicotine nasal spray, 
nicotine inhaler and Bupropion) to be efficacious.  When the odd ratios for these 
treatments relative to placebo are compared, the differences in confidence intervals 
among the active treatments are statistically indistinguishable.  In addition, Hajek and 
colleagues (1999) found no difference in efficacy when comparing nicotine patch, gum, 
inhaler and spray.   
Additive effects of multiple treatments.  Because no single treatment has led to 
high abstinence rates for smoking cessation, researchers have tried combining treatments.  
Various studies have combined pharmacological treatments in hopes of detecting additive 
effects. Kornitzer, Bojusten, Dramaix, Thijs, and Gustavvsson (1995) and Puska and 
colleagues (1995) compared the treatment of both nicotine gum and patch to nicotine 
gum alone and nicotine patch alone. Both studies found consistent results such that the 
combination of the gum and patch increased early abstinence rates compare to the NRT 
 alone; however, the significant differences were not maintained at 1-year follow-up. A 
study by Blondal, Gudmundsson, Olafsdottir, Gustavsson, and Westin (1999) provides 
evidence that the combination of nasal spray and the patch compared to the nicotine patch 
alone significantly increases abstinence rates at 1-year follow-up. Studies examining the 
combination of the nicotine patch and the nicotine inhaler indicate that this combination 
of treatments results in slightly increased abstinence rates relative to the patch alone, but 
these differences have not attained statistical significance (Bohadana, Nilsson, 
Rasmussen, & Martinet, 2000; Tonnesen & Mikkelsen, 2000).   
Jorenby and colleagues (1999) examined the additive effects of the antidepressant 
bupropion in a controlled trial with three groups: bupropion SR, nicotine patch, or both 
for smoking cessation.  The results indicated that bupropion with NRT was most 
effective, with 36% maintaining abstinence rates at one-year follow-up.  Bupropion alone 
evidenced a 33% abstinence rate, while the nicotine patch alone showed just a 16% 
abstinence rate.  The placebo group maintained a 15% abstinence rate after one year. 
 Evidence from numerous studies suggests that NRT and bupropion are effective 
treatments in achieving abstinence from cigarettes. NRT increases quit rates 1.5 to 2 fold 
and sustains long-term abstinence rates ranging from 14-24%.  Bupropion may be more 
effective than NRT for long-term abstinence rates, with Hurt et al. (1997) reporting 24% 
1-year abstinence rates.  In addition, studies suggest that combining pharmacological 
agents may increase abstinence rates.  The FDA approved pharmacotherapies have 
proven to be more effective in quitting when compared to unaided smoking cessation and 
placebo.  Rates of compliance, the side effect profile and the ease of administration 
should be considered when deciding if pharmacotherapy is a viable treatment option. 
 Alternative treatments, including behavioral treatments, have comparable abstinence rates 
and may be a more appropriate option for many persons for smoking cessation. These 
alternative treatments will now be discussed further. 
Brief clinical intervention. The proliferation of brief behavioral interventions 
arose in part from the demands of the health care system on clinicians’ time.  One of the 
benefits of brief intervention is that a wide range of clinicians can implement these 
treatments because the training is relatively minimal.  Also, the intervention can be 
effective with a diverse patient population.  Brief interventions, defined as those requiring 
less than 10 minutes to implement, have been primarily delivered in medical offices, 
community health centers, and outpatient and inpatient hospitals.  One strategy designed 
by the National Cancer Institute (NCI) for providing a brief intervention, the “5 A’s,” 
includes five steps.  The clinician addresses the 5 A’s when asking the patient if he or she 
uses tobacco, advises him or her to quit, assesses the patient’s willingness to make a quit 
attempt, assists him or her in making a quit attempt, and arranges for follow-up contacts 
to prevent relapse.  Brief interventions should not be undervalued, as a three minute 
intervention can produce quit rates of 13.4%, interventions between 3 and 10 minutes 
produce quit rates of 16%, and those greater than 10 minutes produce quit rates of 22.1% 
(Fiorre et al., 2000).  Findings suggest that a greater number of shorter visits are more 
effective than a small number of longer treatment sessions (Fiorre et al., 2000).  
 In addition to the 5 A’s, other techniques have been developed to aid in smoking 
cessation.  These include enhancing social support, providing coping skills training, and 
telephone hotlines and counseling.  These strategies range in intensity and time, and are 
often accompanied by other forms of treatment.  Psychoeducation regarding the 
 consequences of smoking and information about quitting by referring the patient to self-
help manuals, tapes or the internet is a cost-effective means of educating the patient.  
Unfortunately, when written manuals are used alone they have not been shown to be 
effective in helping smokers (Fiore et al., 2000), but when written materials are provided 
in combination with the 5 A’s, smoking abstinence may be further increased (Goldstein 
& Niaura, 1998). 
Intensive clinical intervention. It is not surprising that intensive clinical 
interventions are more effective in increasing abstinence when compared to brief clinical 
interventions. There is potential for every smoker to benefit from intensive interventions, 
not just those with severe nicotine dependence (Abrams et al., 2003). 
The Tobacco Use and Dependence Guideline Panel completed a meta-analysis 
examining the efficacy of intensity of clinical intervention including the variables of 
session length, total amount of contact time and the number of sessions (Fiore et al., 
2000).  Forty-three studies were included in the meta-analysis examining session length, 
which was defined as the amount of time the clinician spent with the patient addressing 
tobacco dependence in a single contact.  A strong relationship between contact time and 
abstinence was found; higher intensity counseling produced abstinent rates that were 
significantly higher than the rates produced by minimal or low intensity counseling. 
 Total amount of contact time was also examined with a meta-analysis including 
thirty-five studies that met the selection criteria (Fiore et al., 2000).  Total amount of 
contact time was defined as the total time accumulated across the number of sessions by 
session length.  A dose-response relationship was found, with any contact time 
significantly increasing abstinence rates over those produced by no contact.  There was 
 no evidence to support contact time above 90 minutes increasing abstinence above and 
beyond contact time of 31-90 minutes.  
 Finally, the relationship between number of sessions and abstinence rates was 
examined (Fiore et al., 2000).  Forty-five studies were included in the analysis, and five 
groups were compared. Again, the dose-response theory was supported with treatments 
lasting more than eight sessions being significantly more effective than interventions 
lasting either zero to one or two to three sessions. 
 These meta-analyses provide evidence of a dose-response relationship between 
amount of behavioral intervention and quit rates, with increase session length, contact 
time and number of session increasing abstinence rates.  The meta-analyses included a 
variety of treatments utilizing various techniques and intervention strategies.  It is not 
only crucial to understand relations between intensity and abstinence rates, but also 
between the types of interventions provided and intensity.  
 The techniques included in counseling and behavioral therapies vary with 
interventions, with some treatments focusing on a particular technique whereas others are 
more of a smorgasbord of techniques.  The various strategies reflect a variety of theories 
of smoking behavior and dependence, and consequently target different factors thought to 
be involved in smoking.  Common psychosocial approaches to smoking cessation therapy 
include coping skills, relapse prevention, social support, lifestyle changes, physical 
activity, relaxation training, stress management, problem solving, contingency 
contracting, weight gain prevention, and aversive smoking (Abrams et al., 2003).  
 The Clinical Practice Guidelines provide recommendations for the types of 
counseling and behavioral therapies.  The recommendations are a result of a meta-
 analysis comparing various therapies presented in 62 studies.  The analysis provides 
evidence that four specific types of therapies significantly increase abstinence rates when 
compared to untreated control conditions.  These therapy strategies included elements 
such as 1) providing practical counseling such as problem solving, skills training, relapse 
prevention, and stress management; 2) providing support during a smoker’s direct contact 
with a clinician (intra-treatment social support); 3) intervening to increase social support 
in the smoker’s environment (extra-treatment social support); and 4) using aversive 
smoking procedures (rapid smoking, rapid puffing, and other smoking exposures).  The 
limitations of this meta-analysis include confounds between treatment type with intensity 
and duration of treatment and limited generalizability with many of the treatments 
tailored to specific subpopulations.  Also, many of the techniques could have been 
provided within a wide range of theoretical orientations or explanations of nicotine 
dependence. 
Other interventions examined by the Tobacco Use and Dependence Guideline 
Panel (Fiore et al., 2000) include acupuncture, hypnosis, physiological feedback, and 
restricted environmental stimulation therapy.  The meta-analysis examining the 
effectiveness of acupuncture found no differences in efficacy between active acupuncture 
and control acupuncture (Fiore et al., 2000).  The hypnosis intervention lacked common 
or standard techniques making it difficult to make any conclusive statements (Fiore et al., 
2000).  The Cochrane group examined hypnosis for the treatment of smoking cessation 
and found insufficient evidence of effectiveness (Abbot, Stead, White, & Ernst, 1999). 
Insufficient studies examining the efficacy of physiological feedback and restrictive 
environmental stimulation have been conducted (Fiore et al., 2002). 
 Extinguishing conditioned response, Aversive Conditioning. The following 
techniques of extinguishing conditioned response and aversive conditioning are based on 
Pavlov’s paradigm.  Extinguishing a conditioned response requires that the individual be 
exposed to the conditioned stimulus without the unconditioned stimulus, i.e., encouraging 
the individual to systematically avoid smoking in response to the individual’s own 
dominant smoking cues (Lowe, Green, Kurtz, Ashenberg, & Fisher, 1980).  
 Aversive conditioning includes procedures that reduce the attractiveness of 
smoking or make smoking itself aversive; based on Pavlov’s conditioning paradigm this 
would include conditioning smoking with the unconditioned response of nausea or 
discomfort.  Rapid smoking is one of the techniques, in which an individual rapidly puffs 
on a cigarette every 6-8 seconds until he or she feels nausea (Fisher, Lichtenstein, Haire-
Josha, Morgan, & Rehberg, 1993).  Rapid smoking may constitute a health risk and 
should be conducted only after appropriate medical screening and supervision (Fiore et 
al., 2000).  Electric shock therapy has also been implemented under the same principle of 
aversive conditioning. Aversive conditioning is rarely used today because the procedures 
are unpleasant, are associated with risk and require close monitoring (Fisher et al., 1993; 
Fiore et al., 2000). 
Motivational Interviewing. Motivational interviewing (MI) is an approach 
developed by Miller and Rollnick (Miller & Rollnick, 1991; 2002) to help individuals 
build commitment and reach a decision to change, originally specifically targeting 
problem drinking.  The treatment approach incorporates a variety of strategies from 
client-centered counseling, cognitive therapy, systems theory, and the social psychology 
of persuasion.  MI has since been applied to other addictions including nicotine 
 dependence.  This intervention is based on the stages of change model and targets 
individuals according to their readiness to change. The fundamental aspect of this 
treatment is to motivate the individual to begin to change thoughts and behaviors as steps 
towards controlling the addiction.  This is accomplished through a directive, client-
centered counseling style geared to elicit exploration in order to resolve ambivalence.  
 Motivational interviewing has been examined in relation to smoking cessation. 
Colby and colleagues (1998) found no significant differences at the three-month follow-
up assessment between one session of motivational interviewing and a session of brief 
advise for adolescents in a hospital setting, with 20% of the participants in the MI group 
abstaining from smoking. 
 Another study, conducted by Butler and colleagues (1999), examined the 
effectiveness of motivational consulting compared to brief advice in reducing smoking.  
The results indicate that motivational consulting may impact abstinence rates, though 
duration of the interventions were not controlled for with the motivational consulting 
taking an average of 10 minutes compare to a 2 minute brief consulting intervention.  A 
trend favoring motivational consulting was detected for self-reported abstinence for one 
month.  Also, other significant differences between the two groups were found, with 
more people in the motivational consulting group reporting quitting for 24 hours at the 
six month follow-up, delaying the first cigarette of the day for more than five minutes, 
making an attempt to quit lasting longer than two weeks during the follow-up period, and 
being more likely to be in a more ready stage of change.  In addition, when the severity of 
smoking was examined in relation to readiness to change between the two groups, 
significant differences were found for the less ready subgroup and the more ready 
 subgroup for reduced smoking, self-reported no smoking in the previous 24 hours, quit 
attempts, and two or more quit attempts.  These findings support the stages of change 
model in that a subgroup (pre-contemplators) appears to derive particular advantage from 
motivational consulting relative to brief advice.  The results from this study also support 
the findings that intense treatment is more effective in reducing smoking when compared 
to brief interventions (Fiore et al., 2000). 
 Glasgow, Whitlock, Eakin and Lichtenstein (2000) examined the efficacy of a 
brief smoking cessation intervention for 1154 women attending Planned Parenthood 
clinics.  The participants were randomly assigned to either a condition that included 
advice and a stop smoking brochure or to a brief intervention that incorporated 
motivational interviewing and barrier-based counseling.  The analyses indicate that the 
brief intervention had significantly higher rates of 7-day abstinence at 6 weeks (10.2% vs. 
6.9%) yet the differences did not hold at the 6-month follow-up (18.3% vs. 14.9%).  
Based on the design of the study, it is impossible to determine the effects of the 
motivational components of the brief intervention on smoking cessation.  In addition, the 
staff providing the motivational interviewing had limited training, counselor competence 
ratings were not included with the findings, and a low rate of completion for the 
telephone follow-up dilute the validity of the reported findings (Resnicow et al., 2002). 
 Ershoff and colleagues (1999) completed a study evaluating cost-effective 
interventions for pregnant smokers attending their initial prenatal appointment.  The 
women were randomly assigned to one of three conditions: a self-help booklet, a booklet 
plus access to a computerized telephone cessation program, or the booklet plus proactive 
telephone counseling incorporating motivational interviewing techniques and strategies.  
 Treatment effects were not detected between groups at post-treatment as well as follow-
up. Cigarettes smoked per day decreased for women receiving the self-help booklet from 
8.6 cigarettes to 8.0 at follow-up, while women receiving the motivational interviewing 
had a self reported increase in cigarette smoking from 7.5 to 8.1 cigarettes per day. When 
self-reported rates of quitting for at least one week were evaluated at follow-up, 
participants receiving the motivational interviewing had the highest abstinence at 23.3%, 
followed by those receiving the booklet plus the computerized telephone intervention 
(18.2%), and those receiving only the booklet (16.4%), these differences did not reach 
significant levels.  
 Evidence supporting the effectiveness of long-term maintenance of abstinence for 
motivational interviewing is limited.  Studies by Colby et al. (1998), Glasgow et al. 
(2000) and Ershoff et al. (1999) examining motivational interviewing compared to 
minimal interventions did not find significant differences in the prevalence of smoking at 
6-month follow-ups.  In addition, Brown and colleagues’ (2003) study examining the 
impact of motivational interviewing compared to brief advice on smoking outcomes for 
adolescent smokers hospitalized for psychiatric and substance use disorders did not find 
significant differences.  However, adolescents in the MI condition had increased self-
efficacy for quitting smoking compared to the brief advice intervention. Adolescents with 
little or no intent to change their smoking faired better in the MI condition, though 
adolescents with pre-existing intent to cut-down smoking or to quit smoking did worse in 
the MI condition.  
Development of Cognitive Behavior Therapy (CBT) 
Parallels exist between the underlying theory of Cognitive Behavior Therapy 
 (CBT) and various ancient Greek philosophers such as Epictetus, Cicero, and Seneca 
(Ellis, 1989; Herbert, 2004).  A shift occurred in the prevailing theories of human 
behavior in the mid 1960s and early 1970s, fueled by reactions both to traditional 
psychodynamic theories and to strict behavioral theories that dominated the psychology 
field.  The formulation of this new approach incorporated affect as a subjective state 
resulting from the cognitive appraisal or evaluation of internal or external stimuli (Clark 
& Beck, 1999). 
 A.T. Beck originally developed cognitive therapy for patients with depression as a 
structured, short-term, present-oriented method.  Since the mid-1960s, the basic 
principals and techniques of CBT have been applied to an increasingly wide range of 
disorders and populations, in a variety of settings.  In 1976, Beck published Cognitive 
Therapy and Emotional Disorders, which pulled together the fundamental concepts of 
cognitive therapy, established principals and cognitive therapeutic techniques, and 
examined approaches for a variety of disorders.  Beck later published Cognitive Therapy 
of Substance Abuse (1993) as a clinicians’ guide in providing fundamental principles of 
cognitive therapy for individuals with substance abuse.  The cognitive approach to 
psychotherapy highlights the unique human capacity for abstract language as critical to 
both the development and amelioration of psychopathology.  Language allows for 
humans to think, think about thinking, speak, reason, remember, solve problems, invent 
and make choices (Werner, 1982).  Cognitive therapists focus on the interaction between 
thought, emotion and behavior.  The therapist helps the client to examine and correct 
errors in his or her thinking patterns that are held to be responsible for psychopathology.    
The cognitive model highlights three interrelated components: thoughts, 
 emotions, and behavior, which are viewed as interactive and multidirectionally 
determined.  Thoughts are considered the moment-to-moment mental content that is 
experienced by an individual.  Feelings are ongoing emotional experiences, and behavior 
is observable actions taken by an individual (White & Freeman, 2000).  Within the CBT 
model, a phenomenological approach is taken, one that increases the individual’s ability 
to track thoughts.  Underlying thoughts, feelings, and behaviors lay conditional beliefs 
that are considered the if-then statements by which a person makes sense of the cause and 
effect relations in the world (White & Freeman, 2000).  Core beliefs, the fundamental 
ways individuals view themselves in relation to the world, are in turn considered to be the 
causes of conditional beliefs.  CBT enhances the individual’s ability to identify thoughts, 
explore core beliefs, examine the relationship between beliefs and behavior though the 
use of various techniques such as cognitive restructuring.  Commonly utilized methods in 
CBT include automatic thought records, challenging thoughts, mood monitoring, arousal 
hierarchy, activity monitoring, problem solving, relaxation training, risk assessment, and 
relapse prevention. 
 In the early to mid 1990’s, the Division 12 (Clinical Psychology) of the American 
Psychological Association initiated a movement to promote and disseminate empirically 
validated psychological interventions.  Task forces were created to determine standards 
of evaluating treatments, to identify treatments meeting the established criteria, and to 
provide a list of empirically supported treatments (EST) to disseminate (Chambless & 
Hollon, 1998).  Treatments were categorized based on the level of support based on the 
number of supportive studies in the literature.  Treatments that meet the standards of 
category I (“well established”) must have at least two randomized trials showing their 
 superiority to placebo control conditions or another bona fide treatment (Chambless & 
Ollendick, 2001).  For a treatment to meet the standards of category II (“probably 
efficacious”), at least one RCT in which the treatment has been shown to be efficacious 
compared to a control group or an alternative bona fide treatment must be available.  
These criteria have been criticized on scientific grounds (Herbert, 2003; Herbert & 
Gaudiano, 2005).  Nevertheless, CBT meets the standards of the original task force for a 
variety of conditions for adults including: panic disorder with agoraphobia, generalized 
anxiety disorder, major depression, bulimia, and multicomponent CBT for rheumatic 
disease pain and multicomponent CBT with relapse prevention for smoking cessation.  
No ESTs meet the standards of the original task force for category I for chemical 
abuse and dependence.  However, CBT was determined an effective treatment for 
cocaine abuse based on the category II standards (Chambless & Ollendick, 2001).  In 
comparison, motivational interviewing did not meet the original task force standards for 
categories I or II for any chemical abuse or dependence including smoking cessation.  
However, MI treatment was found to be efficacious for alcohol abuse and dependence by 
Roth and Fonagy (1996).  
CBT for smoking cessation. A variety of CBT interventions for smoking cessation 
have been developed.  These CBT interventions typically include strategies for coping 
with urges and withdrawal symptoms by identifying behavioral changes as well as 
cognitive changes that can be implemented.  This section will examine studies focusing 
on CBT interventions as well as CBT interventions combined with NRT treatment.   
Researchers from the U.K. (Sykes & Marks, 2001) completed a randomized 
controlled trial examining the effectiveness of a self-help CBT program as part of the 
 “Quit for Life” program compared to a control treatment consisting of providing health 
education.  At follow-up, significant differences were detected between the two groups.  
In particular, approximately one in four of the individuals receiving the CBT self-help 
intervention were abstinent or had a significant reduction in cigarette consumption 
compare to one in 18 of the control patients.  The CBT protocol was found to be five 
times more efficacious than the health education program.  The authors attribute the 
significant differences between the two groups to the self-help intervention that included 
the CBT increasing smoker’s self-efficacy, in particular increasing the belief that the 
smokers could quit smoking.  The study has many limitations.  The amount of time, 
effort, believability, and practice of techniques were not assessed, and no efforts were 
made to equate the two groups on these factors.  In addition, it is unclear what factors of 
the active treatment group contributed to the difference in smoking rates.  Since the CBT 
was embedded in a program, other techniques included in the handbook could account for 
this difference (e.g., relaxation music, positive suggestions about quitting on the tape 
provided, using the help-line, meditation and increased activity).  
Patten, Martin, Myers, Calfas, and Williams (1998) studied CBT for smokers with 
a history of alcohol dependence and depression, a subpopulation of smokers that is 
associated with heavy smoking and treatment resistance.  Participants were randomized 
to behavioral counseling (BC) or to behavioral counseling with cognitive behavioral 
mood management (CBT).  Significantly more participants in the CBT group maintained 
abstinence at post-treatment than the BC group (69.2% vs. 31.3%), and maintained 
differences at 1-month follow-up and 12 month follow-up (46.2% vs. 12.5%).  These 
abstinence rates are impressive particularly when considering this “hardened target” of 
 smokers. 
Marcus et al. (1999) examined the efficacy of exercise as an aid for smoking 
cessation in 281 healthy, sedentary female smokers. Smokers were randomly assigned to 
either a 12-week cognitive-behavior group with an exercise component or a 12-week 
CBT group with contact control.  Significant differences between the two conditions 
were detected at the end of treatment with the CBT in combination with exercise 
consistently having higher continuous abstinence rates (19.4% vs. 10.2%, p = .03), at 3 
months (16.4% vs. 8.2%, p = .03), and at 12 months (11.9% vs. 5.4%, p = .05). The long-
term abstinence rates for the CBT group, however, are lower than those found in other 
studies. When the 7-day point prevalence abstinence rates, which represent a short time 
frame of abstinence compared to the continuous abstinence, are examined, there are no 
significant differences at the end of treatment (21.8% vs. 30.6%) and at the 12-month 
follow-up (19.4% vs. 13.6%).  The exercise component improves smoking cessation, 
delays weight gain and may modulate depression. 
There are few studies that examine CBT relative to a control group or to 
alternative behavioral interventions.  Studies combining CBT with pharmacological 
agents have been increasingly examined.  The methodology of these studies is limited, as 
few studies have examined CBT alone, but rather combine CBT with other treatments, 
especially pharmacological treatments.  The design of such studies precludes the 
determination of treatment effects due to specific treatment components.  It is likely that 
the absence of such studies is due largely to the resistance of pharmaceutical companies, 
who fund much of the smoking cessation research, and who are reluctant to evaluate the 
possibility that most or all of the effects in combined treatment conditions may be due to 
 CBT rather than pharmacotherapy.   
The intensity level of behavioral treatment provided in combination with Nicotine 
Replacement Therapy (NRT) was examined by Alterman, Gariti and Mulvaney (2001).  
Three groups of severe smokers, defined as smoking a pack or more per day with at least 
one prior failed attempt of nicotine abstinence, were compared.  The low-intensity group 
(LI) received NRT for 8 weeks, instructional videotapes, and one advice and education 
session provided by a nurse practitioner.  The moderate-intensity (MI) group received the 
treatment that LI received as well as three brief advice and education sessions, and the 
high intensity (HI) group consisted of the MI treatment in combination with 12 weeks of 
individualized, manualized CBT.  At all three follow-up time points, the HI group had the 
highest abstinence rates.  Surprisingly, the high intensity group showed significant 
differences when compared to the middle intensity group but not the low intensity group 
at both week 26 and week 52.  The combination of CBT with the NRT showed a 32.9% 
abstinence rate at one-year follow-up compared to the 5% abstinence rate that is typically 
reported for NRT intervention without additional treatment (Hughes, Goldstein, Hurt, & 
Shiffman, 1999).  
 Evidence from numerous studies suggests that NRT is more effective when 
combined with a psychosocial or intensive behavioral treatment than NRT alone 
(Fagerstrom, 1982; Fiore, Jorenby, Baker, & Kenford, 1992; Hall & Killen, 1985; 
Hughes et al., 1991; Killen, Maccoby, & Taylor, 1984).  Abstinence rates have been 
examined when brief or less intense treatments have been provided with NRT, and the 
findings are less robust compared to the intensive behavioral treatments combined with 
NRT (Hughes, Gust, Keenan, Fenwick, & Healey, 1989).  Regardless of the specific type 
 of behavioral treatment, abstinence rates increase when NRT is combined with a 
behavioral intervention (Lam, Sze, Sacks, & Chalmers, 1987; Hughes, 1995; Hughes et 
al. 1999). The combination of NRT with self-help has not been shown to be as effective.  
Fortmann and Killen (1995) examined nicotine gum with self-help behavioral treatment 
and found no significant differences between the group provided nicotine gum with the 
self-help treatment compared to the group receiving the nicotine gum only. 
 Recently, there has been an increase in the number of studies comparing 
antidepressants with behavioral treatment for smoking cessation.  The research group 
lead by Hall (2002) has examined numerous combinations of pharmacological and 
psychological treatments, including a recent investigation of two antidepressants with 
behavioral interventions.  The results suggest that the antidepressants nortripyline and 
bupropion, in combination with medical management, had similar abstinence rates as the 
psychological intervention (CBT) combined with placebo medication.  Also, it is 
important to note that in this study the antidepressants did not increase abstinence rates 
when the medication was provided with the psychological intervention.  For example, the 
abstinence rates for the psychological intervention alone did better at 24 weeks than both 
of the antidepressants in combination with the medical management, 31% abstinence for 
CBT, compared to 26% for bupropion and 23% for nortriptyline.  Thus, additive effects 
of the psychological intervention to the abstinence rates of participants receiving active 
medication were not detected. 
Recent findings from combination treatment research suggest that these 
approaches may be more effective for subpopulations within the nicotine dependent 
population.  Hitman and colleagues (1999) hypothesized that the addition of 
 antidepressant medication to CBT would blunt the negative impact of several personal 
attributes that have been shown to predict relapse.  Hitman and colleagues focused on 
gender, nicotine dependence, weight concerns and self-efficacy as possible moderators 
for adult smokers.  Fluoxetine failed to selectively benefit smokers with expressed weight 
concerns, low efficacy, and higher nicotine dependence.  Higher pretreatment scores on a 
depression inventory predicted lower likelihood of abstinence among unmedicated 
participants and a higher likelihood of abstinence rates among medicated participants. 
These results suggest that the combination treatment may in fact work better for 
depressed populations. 
In summary, few studies have compared the efficacy of CBT in isolation to 
alternative treatment approaches including other behavioral interventions and 
pharmacological interventions. CBT has been shown to be more effective than health 
education, and no studies provide consistent evidence that additional treatment 
components, such as exercise, increase long-term abstinence rates above those achieved 
with CBT alone.  In addition, few research designs include a condition of CBT alone 
relative to pharmacological agents.  The results from the small amount of research that 
does exist on this topic suggest that medication does not provide substantial additive 
benefits in maintaining long-term abstinence rates (e.g., Hall et al., 2002).  Moreover, 
when considering long-term abstinence rates, cost efficiency, and a larger population that 
could benefit from smoking cessation interventions, CBT appears to be an effective 
treatment option. 
Effective CBT Protocol. An efficacious CBT intervention program is detailed in 
the following section. Scientist-practioners affiliated with Brown University Medical 
 School have developed an intensive CBT intervention program that has emerged from 20 
years of clinical experience and research conducted across a wide range of smokers and 
settings.  In The Tobacco Dependence Treatment Handbook, published in 2003, Richard 
Brown devotes two chapters to the cognitive components of intensive behavioral 
interventions for smoking cessation.  The chapters explicate the cognitive model as it 
applies to smoking cessation, discuss the stages of the multicomponent treatment 
program, illustrate the objectives of each session, and provide detailed content for each 
session. The long-term abstinence rates for individuals receiving the intensive behavioral 
treatment developed by Brown and colleagues are comparable to the best outcomes 
reported in the PHS guidelines (Fiore et al., 2000).  The following section highlights the 
content of Brown’s intensive behavioral intervention program that consists of 8 sessions 
and is comprised of three interrelated phases: preparation, quitting, and maintenance of 
cessation or prevention relapse.  
 The first phase in Brown’s smoking cessation treatment is intended to prepare the 
smoker for abstinence, and includes increasing the smoker’s motivation to quit, 
strengthening the smoker’s commitment to the program, establishing a target quit date, 
and developing coping strategies needed to quit smoking.  Brown et al. (2001) identify 
two cognitive behavioral strategies used during the quitting phase.  The first approach is 
self-management, which teaches the smoker to systematically use coping skills to abstain 
from smoking, particularly when he or she is in situations that trigger the craving.  The 
second step in self-management is developing coping strategies to alleviate negative 
affect.  This is an important skill particularly because smokers often report smoking as a 
way to cope with stress. 
 Nicotine fading is the second approach to aid quitting.  Since many withdrawal 
symptoms are associated with quitting cold turkey, a gradual reduction of nicotine intake 
will decrease the intensity of the withdrawal symptoms, thereby making quitting less 
difficult.  The third phase of the Brown et al. (2001) smoking cessation intervention is the 
maintenance of abstinence.  Several strategies are employed to maintain abstinence, 
including relapse prevention, lifestyle modification, physical activity, and social support.  
These strategies are presented to the client from a CBT theoretical orientation with the 
focus on examining self-defeating attributes and negative emotional reactions.  This 
program can be provided to clients individually or within a group setting. 
The research indicates that about 25% of the individuals treated with this 
intervention maintained abstinence at one-year follow-up (Brown et al., 2001a).  Brown 
and colleagues (2001a) examined cognitive behavioral treatment for depression in 
smoking cessation.  Participants with a history of major depressive disorder were 
randomized to two cognitive behavioral treatments, a standard CBT and CBT for 
depression (CBT-D) that integrated CBT smoking cessation skills and CBT coping skills 
for depression. Each condition received eight 2-hour sessions over 6 weeks. Both 
treatments attained relatively high abstinence rates at one-year follow for a population of 
smokers that are considered a “hardened target,” with 24.7% maintaining abstinence in 
the standard CBT and 32.5% from the CBT-D condition.   
Reconceptualizing nicotine dependence 
 Despite its relative efficacy, it remains the case that CBT results in abstinence for 
only a minority of smokers.  Thus, new treatment innovations are needed.  One possible 
candidate for such an innovation is a novel form of CBT, which has already been shown 
 to be effective for a variety of disorders.  In fact, this intervention has been studied once 
for smoking cessation in comparison to NRT.  However, no study to date has examined 
this novel behavioral intervention relative to the present gold standard behavioral 
intervention.  In addition, there are minimal data on the moderating effects of variables in 
relation to each intervention. 
 Since the surgeon general’s first published report on the health consequences of 
smoking, numerous smoking cessation interventions have been developed.  The more 
effective and widely used interventions (NRT and CBT) attempt to attenuate withdrawal 
symptoms or increase the ability to cope with the withdrawal symptoms associated with 
smoking cessation, by providing levels of nicotine or developing coping strategies for the 
withdrawal symptoms.  In a majority of studies, both NRT and CBT interventions have 
been shown to double abstinence rates when compared to controls.  Yet a large majority 
of individuals, even when administered the gold standard intervention, are unable to 
maintain abstinence for even short periods of time.  
Studies have increasingly examined the role of the severity of withdrawal 
symptoms in relapse rates.  Given the temporal relationship between the rapid onset of 
withdrawal symptoms resulting from nicotine deprivation and the high rate of lapse to 
smoking occurring within hours of a quit attempt, the severity of withdrawal symptoms 
would be expected to play a major role in relapse.  Yet inconsistent findings indicate a 
weak relationship. Evidence that challenges the traditional model of drug dependence 
include the inconsistent relationship between the severity of withdrawal to be related with 
habitual use (Jaffe, 1980), infrequent reports of relapsers identifying withdrawal 
symptoms as a reason to relapse (Marlatt & Gordon, 1985), relapse occurring long after 
 the intense withdrawal symptoms have passed (Brandon, 1990), and the poor relationship 
between treatments that suppress withdrawal symptoms and abstinence (Jorenby et al., 
1995, Piasecki et al., 2000).  Shiffman and researchers (1996) examined temptations to 
smoke after quitting by comparing lapsers and individuals able to maintain abstinence.  
The lack of differences in reported frequency and severity of temptations between the 
groups provides further support that dismantles the idea that relapse is related to the 
severity of withdrawal.  Patten and Martin (1996) comprehensively reviewed 15 
prospective studies that examined the relationship between the severity of withdrawal 
symptoms and smoking cessation outcome, both short-term and long-term relapse rates.  
Overall, their findings were highly equivocal, with weak relationships between individual 
withdrawal symptoms, total frequency of withdrawal, and severity scores with smoking 
cessation and/or relapse.  Part of the difficulty understanding abstinence rates stem from 
inconsistent definitions of abstinence (Ockene et al. 2000).  In addition, there are 
methodological flaws in measuring situational aspects or emotional triggers of relapse.  
Most studies rely on long-term retrospective recall and do not make a distinction between 
early and late relapses.  Not surprisingly, little consistency has been reported in predictor 
variables for short- and long-term abstinence rates, which could be a result of 
methodologically limitations of existing studies.  Patten and Martin (1996) and Piasecki 
and colleagues (2000) propose that researchers may be measuring withdrawal 
inaccurately, both methodologically, including utilizing unproven reliable and valid 
measurement instruments and overlooking exclusion bias, as well as a lack of 
scrutinizing important dimensions of withdrawal.   
 Role of affect in smoking cessation. Psychological distress has been examined as a 
predictor of abstinence, with mixed results.  Hitsman and colleagues (2003) completed a 
meta-analysis examining 15 studies involving over 2,900 participants.  The analysis 
failed to detect a significant difference in abstinence rates for participants with and 
without a history of depression.  However, several studies indicate that recurrent episodes 
of depression may increase the risk for relapse.  Brown and colleagues (2001a) found that 
recurrent episodes of depression predicted relapse where as single episodes of depression 
did not.  Haas and colleagues (2004) replicated aspects of Brown et al. study. Haas 
examined differences in smoking cessation between participants with a single episode of 
MDD, recurrent MDD, and without a history of MDD in two treatment conditions, a 
cognitive-behavioral treatment (CBT) or a health education (HE) intervention.  The 
analysis indicated that participants with a history of MDD reported significantly higher 
levels of negative mood disturbances overall, with participants with recurrent MDD 
reporting the highest symptoms.  Moreover, participants with a history of recurrent MDD 
had higher rates of abstinence in the CBT intervention compared to the HE intervention.  
Despite increased levels of mood symptoms at pre-treatment and during the quit attempts 
among the participants with recurrent MDD relative to a single episode of MDD, the 
abstinence rates between the two groups were not significantly different.  It is important 
to note that the Haas et al. study examined affective disturbances and not symptoms of 
depression per se, which would have included cognitive and physiological symptoms 
related to depression.  The Brown and colleagues (2001) and Haas and colleagues (2004) 
studies bring to light the importance of distinguishing single episodes of MDD from 
recurrent episodes of MDD.  The inconsistencies in research findings connecting a 
 history of depression with smoking cessation could be related to the dichotomizing of 
depression into two groups with the first group consisting of participants with any and all 
episodes of depression and compared to a group without a history of MDD. 
Research investigating the relationship between participants in a current episode 
of MDD and abstinence rates from smoking cigarettes is limited, as most participants 
who meet diagnostic criteria for MDD are excluded from participating in the majority of 
studies. In a review paper by Patten and Martin (1996) on nicotine withdrawal, three 
studies examining clinically depressed smokers were highlighted.  The findings suggest 
that this population has more nicotine withdrawal symptoms when attempting to quit 
(Breslau, Kilbey & Andreski, 1992) and are less likely to abstain from smoking following 
smoking cessation treatment when compared to non-depressed smokers (Anda et al., 
1990; Hall, Munoz & Reus, 1991).  
Shiffman and colleagues (1996) compared the temptations of lapse to actual 
lapses using an ecological momentary assessment method to detect nearly real time 
changes in affect.  Shiffman and colleagues’ results suggest that negative affect does play 
a significant role in smoking relapse as well as alcohol consumption, urges and coping 
strategies.  Upon further examination, Shiffman and Waters (2004) recognized that lapses 
were related to precipitous increases in negative affect over a short period of time such as 
a few minutes where as day-to-day fluctuations in negative affect or stress did not lead to 
lapse.  This finding is consistent with Piasecki and colleagues’ (2000) results that 
temporal variability in negative affect best predicted smoking cessation outcomes, when 
compared to other withdrawal symptoms.  There is increasing evidence that 
psychological symptoms, such as negative affect, does contribute to relapse; though it 
 appears that the variability rather than the severity of the nicotine withdrawal syndrome is 
related to smoking cessation outcome (Baker, Brandon, & Chassin, 2004; Piasecki et al., 
2003)  
Shiffman (1993) remarked on the recent lack of progress in smoking cessation 
treatment innovations and stated “behavioral smoking cessation research is in a rut.  I 
believe that getting out of this rut will require a return to basics” [(Saul Shiffman, 1993); 
p. 720].  Returning to the basics may require re-examining the theoretical underpinnings 
of nicotine dependence.  The majority of treatments are based on the hypothesis that 
individuals have difficulty maintaining abstinence because of the severity of the 
withdrawal symptoms; which has led to treatments attempting to decrease the withdrawal 
symptoms or increase the ability to control the withdrawal symptoms.  Yet the abstinence 
rates have only increased for about one third of the population.  In addition, recent 
findings suggest that the severity of physiological and psychological withdrawal 
symptoms is not significantly related to smoking cessation outcome.  Brown and 
colleagues (2002) rose to the challenge and conceptualized nicotine dependence in a new 
light, taking into consideration the tolerance levels that nicotine dependent individuals 
have for distress related to withdrawal symptoms.   
Distress tolerance. Based on years of examining nicotine dependence in tightly 
controlled experiments, Brown and colleagues identified, what they refer to as “distress 
tolerance” as an underlining mechanism that significantly contributes to smoking 
cessation.  Brown and colleagues have defined the concept of distress tolerance as “a 
behavioral tendency to pursue a goal despite encountering various states of affective 
discomfort, which may be in response to perceived physical and/or psychological 
 distress” (Brown et al., 2005, p. 718).  The ability for smokers to tolerate distress requires 
overcoming powerful negative reinforcements of nicotine withdrawal and opting for the 
positive long-term reinforcements of smoking cessation.  Brandon and colleagues 
(Brandon et al., 2003; Quinn, Brandon, & Copeland, 1996) examined the behavioral 
aspects of distress tolerance, which they coined “task persistence.”  Task persistence, a 
hypothesized explanation of behavior derived from learned industriousness theory 
(Eisenberger, 1992) suggests that the amount of effort exerted towards goal-directed 
behavior is influenced by one’s reinforcement history for such effort (Brown et al., 2005).  
Task persistence may contribute to smoking behaviors, though previous research 
indicates that the ability to tolerate withdrawal symptoms and persist at a task (quit 
smoking) most likely involves several factors including self-efficacy (Bandura, 1997), 
motivation (Miller & Rollnick, 2002), and readiness (Prochaska & Velicer, 1997).  In 
addition, Brown and colleagues (2005) posit anxiety sensitivity and experiential 
avoidance, concepts that will be defined in the following sections, as contributing factors 
in individual differences in distress tolerance and persistence at the goal of quitting 
smoking.  In the review paper of distress tolerance with early smoking lapsers, Brown 
and colleagues (2005) cite the progression of accumulating evidence that supports the 
important role of these contributing factors.   The following section highlights the 
research that led to the current conceptualization of distress tolerance. 
Quinn et al. (1996) examined the differences in task persistence levels between 
smoking and non-smoking participants.  The researchers measured the average duration 
of time spent on two behavioral tasks known to induce psychological stress, the Anagram 
Persistence Task (APT) and the Mirror Tracing Persistence Task (MTPT).  The results 
 indicate higher levels of persistence on the APT and MPTP tasks for the non-smoking 
group when compared to the smoking group, even when controlling for demographic 
variables, vocabulary, negative affect, and problems associated with other substance use.  
The relationship between smoking and persistence could be confounded by withdrawal 
symptoms experienced by the smoking group, though this is unlikely since weak 
correlations were detected between self-reported urges to smoke and timing of 
participants’ last cigarette with persistence on the tasks.  When other substance use was 
investigated, a history of substance use in the non-smoking group was inversely related to 
task persistence, though no differences were detected in the smoking group.  The 
researchers concluded that an additive effect on task persistence was non-existent for the 
use of multiple substances; individuals with any history of problematic substance use 
display decreased persistence compare to individuals without a history of substance use.  
Since this investigation relied on correlational analysis, it is impossible to determine the 
causal direction, i.e. if decreased persistence contributes to substance use or if substance 
use decreases persistence. 
Further evidence (Brown et al., 2002) indicates differences in distress tolerance 
between individuals with a prior history of a sustained quit attempt (greater than three 
months) compared to individuals without a prior sustained quit attempt (immediately 
relapsing to smoking in less than 24 hours).  All participants were examined during 
physical stress challenges, both breath holding and exposure to CO2 enriched air, which 
induced many of the physical symptoms similar to those of nicotine withdrawal, 
including sweaty palms, difficulty concentrating, dizziness and cognitive disturbances.  
Participants also engaged in a psychological stress task, the Paced Auditory Serial 
 Addition Task (PASAT).  The results suggest that early smoking lapsers have higher 
levels of depressive symptoms and stress reactivity as well as less persistence on tasks 
requiring the ability to tolerate physical and psychological distress.   
Brown and colleagues’ (2002) findings support previous research conducted by 
Hajek and colleagues (1987).  Within a group motivated to quit smoking, Hajek et al. 
investigated the relationship between the individual’s capacity to endure the discomfort 
of breath-holding, a type of tolerance to discomfort that may reflect resisting nicotine 
withdrawal distress, and the individual’s success at quitting.  The research findings 
indicate that the duration of breath holding significantly predicted the outcome at the end 
of treatment. 
To further this line of research, Brown and colleagues (2004) designed a study to 
examine the influences of pre-cessation bio-behavioral variables on early smoking lapse 
in smokers making an unaided quit attempt.  Participants with low levels of persistence at 
baseline had a 2.94 times greater risk of lapse when compared to the high persistence 
group.  In addition, after 28 days, 32 % of the distress tolerant smoking group reported 
continuous abstinence compared to 5% of the distress intolerant smoking group.  This 
research demonstrates the importance of examining factors related to distress tolerance 
and task persistence in this high-risk group of early smoking lapsers.  These findings also 
suggest the need to develop a smoking cessation treatment for early smoking lapsers that 
focuses on the development of greater distress tolerance.  
Experiential Avoidance. Brown and colleagues (2005) discussed the role of 
anxiety sensitivity in the maintenance of smoking and reviewed a number of studies that 
contribute to our understanding of this relationship.  In this review paper, the authors 
 make the case that experiential avoidance may be used as a coping strategy when an 
individual has decreased levels of distress tolerance and increased levels of sensitivity to 
anxiety.  Smokers may attempt to escape the negative affect and physical symptoms 
associated with nicotine withdrawal by resuming smoking.  These efforts to control 
interoceptive sensations may exacerbate the cravings to smoke for a certain percentage of 
smokers.  Salkovskis and Reynolds (1994) examined the frequency of intrusive thoughts 
for individuals attempting to quit smoking.  The researchers detected an increase in 
frequency and intensity of smoking related thoughts when individuals were experiencing 
nicotine withdrawal.  Moreover, the results suggest that active attempts to suppress 
thoughts related to smoking induce intrusion of distressing thoughts.  The group that 
actively suppressed smoking related thoughts reported higher rates of unacceptability of 
intrusions.  Brown et al. (2001b) examined the relationship between anxiety sensitivity to 
negative smoking motives and the risk of relapse in a population of smokers with a past 
major depressive disorder. Higher levels of anxiety sensitivity were positively correlated 
with smoking to reduce negative affect and increased risk of lapsing during the first 7 
days after quit day.  The results from this study in conjunction with other cross-sectional 
investigations suggest that smokers with high levels of anxiety sensitivity are motivated 
to smoke to manage negative moods (Comeau, Steward & Loba, 2001; Novak, Burgess, 
Clark, Zvolensky & Brown, 2003; Stewart, Karp, Pihl & Peterson, 1997), are less able to 
tolerate early withdrawal symptoms, particularly negative affect during quitting (Brown, 
2001b), and report more affective problems during quitting (Zvolensky et al., 2004) 
As discussed above, despite its relative efficacy, it remains the case that CBT 
results in abstinence for a minority of smokers, particularly early lapsing smokers.  Given 
 the growing evidence that active attempts to suppress smoking related thoughts and 
experiential avoidance are ineffective coping strategies for early lapsers, the standard 
behavioral smoking cessation treatment that incorporates subtle control based strategies 
should be reconsidered for this population.  Thus, new treatment innovations are needed; 
treatment strategies that target distress tolerance and acceptance of interoceptive 
sensations and cognitions.   
One possible candidate for such an innovation is a novel form of CBT, which has 
already been shown to be effective for a variety of disorders.  Few studies implementing 
this intervention have been studied for smoking cessation.  Gifford and colleagues 
completed two studies examining the novel intervention.  Brown and colleagues are 
currently in the second phase of completing a NIDA Behavioral Therapies Development 
Program RO1 grant, and have developed a distress tolerance (DT) smoking cessation 
intervention for early lapsing smokers.  The DT intervention incorporates exposure to 
nicotine withdrawal and skills from this novel cognitive behavioral intervention, 
Acceptance and Commitment Therapy (ACT; Hayes, Strosahl & Wilson, 1999).  The 
researchers at Brown University are currently comparing the DT intervention to a 
standard CBT intervention.  Further investigation of the core components of this novel, 
exposure- and acceptance-based intervention is warranted.  Moreover, this novel 
intervention relative to the core components of the standard behavioral intervention merit 
research attention, particularly when applied to a population of smokers that has 
demonstrated difficulty quitting.  
Acceptance and Commitment Therapy 
 The present study examined a core component of a new behavioral treatment, 
 Acceptance and Commitment Therapy (ACT; Hayes et al., 1999). ACT is one of a 
number of novel CBT-oriented treatments that were developed in the 1990’s.  These 
treatments were spawned by a perception by some that traditional CBT, although 
reasonably effective for many problems, was nevertheless limited both in terms of the 
percentage of patients who were helped as well as the degree of therapeutic gains 
typically made.  As the field of psychology’s understanding of cognition and behavior 
advanced, several treatments incorporating an experiential approach to intervention 
within a broad CBT framework were developed, including ACT (Hayes, et al., 1999), 
Dialectical Behavior Therapy (DBT; Linehan, Armstrong, Suarez & Allmon, 1991), 
Functional Analytic Psychotherapy (FAP; Kohlenberg & Tsai, 1991), Integrative 
Behavioral Couple Therapy (IBCT; Jacobson, Christensen, Prince, Cordova & Eldridge, 
2000), and Mindfulness-Based Cognitive Therapy (MBCT; Teasdale et al., 2000).  These 
treatments all incorporate mindfulness and acceptance components derived in part from 
Buddhist principles, and have been referred to as reflecting a “third wave” of behavior 
therapy (Hayes, Mesuda, & De Mey, in press).  To date, ACT has received the most 
attention both by psychotherapy scholars and clinicians.  ACT has been applied to a wide 
range of conditions including depression, anxiety disorders, psychosis, substance use 
disorders and chronic pain. In addition, the number of randomized controlled trials 
comparing ACT to various standard treatments continues to provide evidence supporting 
the efficacy of ACT.  To date, the number of randomized controlled studies including 
ACT exceeds 17.  Many more studies are currently being conducted, several funded by 
NIDA, NIMH and the US Department of Justice.  
 ACT is based on a contextual theory of cognition and behavior known as 
 Relational Frame Theory (RFT; Hayes, Barnes-Holmes, & Roche, 2001), and highlights 
expanding the individual’s behavioral flexibility as a broad goal.  Unlike traditional CBT, 
in which the focus is largely on modifying the content of cognition and affect, ACT 
focuses on increasing acceptance of internal experiences, confronting experiential 
avoidance, recontextualizing problematic cognitions, and expanding behaviors consistent 
with one’s chosen life values (Hayes et al., 1999; Gifford et al., 2004a).  ACT and RCT 
are based on the philosophical system of functional contextualism, which adopts a 
pragmatic epistemology.  This epistemology is based on a pragmatic truth criterion in that 
“truth” is context specific, depending on what works to achieve specific goals in a 
particular context.  Functional contextualism is a philosophy with several underlying 
assumptions, many which stem from radical behaviorism.  This philosophy takes a 
holistic approach, in that the focus of psychological analysis is on the whole event, in 
particular the interaction between the organism and his or her environment.  Functional 
contextualism articulates specific scientific goals in that the focus is not only on 
predicting behavior but also having the ability to impact the behavior in question. 
 RFT is a functional contextualistic approach to natural language, and represents 
the basic theory underling ACT.  According to RFT, verbal rules that begin developing 
very early in life tend to dominate behavior.  Language allows individuals to experience 
events that they have never experienced as well as to re-experience previous experiences. 
Based in evolution, language is extremely adaptive in that information can be readily 
passed from one individual to another, and even from one generation to future 
generations.  In addition, language is adaptive in that it tends to be biased towards danger, 
and is useful for problem solving.  However, there are also negative consequences to 
 language.  Language also affords humans with increased contact with painful 
experiences.  Since humans cannot regulate pain that is not the result of immediate 
aversive stimulation, humans often try to cope with pain through experiential avoidance, 
which “occurs when a person is unwilling to remain in contact with particular private 
experiences (e.g. bodily sensations, emotions, thoughts, memories, behavioral 
predispositions) and takes steps to alter the form or frequency of these events and the 
contexts that occasion them” (Hayes et al., 1999).  
The strategies that humans use to maintain experiential avoidance include 
cognitive fusion, evaluation, avoidance, and reason giving (Hayes et al., 1999). These 
strategies lead to a variety of problems such as negative self-evaluation, knowledge of 
death, comparison to an ideal, worry about the future and existential crises.  According to 
ACT, people tend to expend considerable effort attempting to escape aversive private 
experiences including thoughts, feelings, memories, and physiological reactions (Hayes 
et al., in press). The general aim of ACT is to undermine the verbal content of cognitions 
that result in this avoidant behavior, and to develop an alternative context in which 
behavior is in alignment with one’s chosen values.  ACT is an experiential form of 
behavior therapy, in which metaphors, paradoxes, and experiential exercises are used as 
tools to achieve defusion from and acceptance of aversive cognitive and affective 
content, in the context of moving forward toward chosen values and goals.  Core 
concepts of ACT include creative hopelessness (i.e., demonstration through experiential 
exercises the futility of past change attempts, especially those focused on controlling 
private experiences), the unworkability of the control agenda (i.e., the idea that 
controlling aversive private experiences is necessary to effective functioning), 
 experiential acceptance as an alternative agenda, fostering a transcendent sense of self, 
defusing language and cognition, exploration of personal values and associated goals, and 
fostering commitment to moving forward in the direction of one’s values.  An open, 
consultative, egalitarian relationship is stressed throughout therapy (Hayes et al., in 
press). 
As applied to smoking, ACT helps the patient identify external and internal 
triggers of their smoking.  The treatment focuses on accepting the internal stimuli and 
conceptualizing attempts to control or avoid the stimuli as part of the problem.  In 
addition to increasing mindfulness, the target of the intervention is to help the patient 
become committed to valued action.  Although still relatively novel, ACT has been 
successfully applied to a variety of populations, and several scholars have suggested that 
ACT may be especially helpful for severe or treatment refractory cases.  Studies 
examining the efficacy of ACT and an ACT protocol specifically for smoking cessation 
will be described in the following sections.  
Empirical Evidence for ACT 
 There has been a recent proliferation of studies examining the efficacy of ACT for 
a variety of psychological disorders and problems.  Most of these studies provide 
empirical evidence that ACT appears to be as beneficial as the current gold standard 
treatment or better. The pathology examined ranges from mood disorders and pain 
tolerance to psychosis and substance abuse. 
Depression. Two randomized controlled studies have examined the effectiveness 
of ACT for individuals with depression.  Zettle and Hayes (1986) conducted the first 
randomized ACT study comparing ACT to two variations of Beck’s Cognitive Therapy 
 (CT, Beck et al., 1979).  The first variation included cognitive restructuring with 
cognitive distancing, whereas the second included just cognitive restructuring.  The 
results indicate that both the ACT and CT treatments significantly decreased depressive 
symptoms, as measured by the Hamilton Rating Scale for Depression (HAM-D) at post-
treatment.  Moreover, the treatments were significantly different, with ACT reducing 
more of the depressive symptoms at the two-month follow-up.  Zettle and Rains (1989) 
completed a similar study, again examining CT with ACT in a depressed population.  
ACT was again compared with two versions of CT in 31 depressed women, a complete 
package and a partial package that lacked the cognitive distancing component.  The three 
conditions all demonstrated significant decreases in depressive symptoms at post-test and 
two-month follow-up, with no differences detected between groups. These studies 
provide evidence that ACT is as effective, if not more effective, as the current gold 
standard psychotherapeutic treatment for depression.  Also, the studies suggest that the 
process of change is different between the two treatments.  For instance, ACT reduces the 
believability of depressogenic thoughts more quickly, but the frequency decreases more 
slowly, whereas the opposite pattern was found in the CT group (Hayes et al., in press).  
Chronic pain and pain tolerance. ACT has been applied to populations 
experiencing chronic pain.  Geiser (1992) completed a quasi-experiment in which 
participants were assigned to either an ACT-based treatment to CBT.  Both conditions 
showed clinical improvements at the end of treatment and at three-month follow-up with 
no differences between the groups.  Also, ACT has been studied in a non-clinical 
population subjected to a task with induced pain to examine pain tolerance (Hayes et al., 
1999b).  In this study, 32 college students were randomly assigned to receive an ACT-
 based intervention, a control-oriented intervention, or an attention placebo.  Participants 
were instructed to submerge the non-dominant hand in ice cold water at two time points, 
pre and post intervention.  Participants who received the ACT-based rationale sustained 
the cold presser for a significantly longer period of time compared to those who received 
the control rationale and to those in the placebo group.  
Psychotic disorder. Two studies have been conducted implementing ACT for 
psychosis.  Bach and Hayes (2002) randomized 80 psychotic inpatients to treatment as 
usual (TAU) or to 4 sessions of ACT plus TAU.  The primary outcome measure was 
rehospitalization within a four month time period; 20% of the ACT participants and 40% 
of the TAU participants were rehospitalized.  The ACT participants reported lower 
believability of symptoms compared to the TUA group.   
Gaudiano and Herbert (2006) replicated the Bach and Hayes study, with results 
supporting the efficacy of ACT for psychotic inpatients.  Those who received an average 
of only three sessions of ACT demonstrated 28% readmission at 4-month follow-up, 
relative to a rate of 45% for patients who received enhanced treatment-as-usual.  
Mediational analyses supported the theorized mechanism of action of ACT (Gaudiano & 
Herbert, in press).  Pre-treatment believability in hallucinations mediated the relationship 
between retrospectively reported frequency of hallucinations and post-treatment distress 
about hallucinations.  Also, in the ACT condition, the changes in hallucination 
believability predicted change in distress when controlling for change in frequency.  Both 
the Bach and Hayes and the Gaudiano and Herbert studies provide evidence that an ACT 
intervention significantly decreases rehospitalization among patients with chronic 
psychotic disorders compared to treatment as usual.  
 Substance abuse. ACT has also been applied to the treatment of substance use.  A 
large randomized clinical trial examined the effectiveness of treatment interventions for 
polysubstance abusing opiate addicted individuals maintained on methadone (Hayes et 
al., 2002).  Participants (n = 114) were randomly assigned to 16 weeks (48 sessions) of 
either methadone maintenance alone, a combination of methadone and ACT, or a 
combination of methadone with Intensive Twelve Step Facilitation.  No significant 
differences were detected during the active treatment phase or at the initial post-treatment 
assessment.  However, at the 6-month follow-up assessment, ACT patients decreased 
opiate use, as measured by urinalysis, more than those who received methadone 
maintenance alone (Hayes et al., 2002).  Both groups receiving the ACT and Intensive 
Twelve Step Program showed a decrease in total drug use compare to the methadone 
maintenance alone group.   
Food Cravings. Acceptance-based strategies have also been applied to food 
cravings. Forman and colleagues (2007) compared acceptance and control-based 
strategies for coping with food in an analog study. Ninety-eight college students were 
randomized to receive either no intervention, acceptance-based strategies, or control-
based strategies and then all the participants were given transparent boxes of chocolate 
and told to keep the chocolates with them without eating them for 48 hours. Both of the 
active strategies were found to somewhat effective in helping participants cope with their 
cravings and maintain their abstinence from chocolate. In particular, participants that 
endorsed low levels of psychological sensitivity to food at baseline randomized to the 
control-base strategy, this strategy appeared to be helpful. Participants randomized to 
receive the acceptance-based strategies faired better for participants with high levels of 
 psychological sensitivity. 
Additional Pathology. ACT has also been examined within other populations. 
Case studies have been reported for Obsessive-Compulsive disorder (Hayes, 1987), 
Generalized Anxiety Disorder (Huerta Romero et al., 1998), Agoraphobia with and 
without panic attacks (Hayes 1987), exhibitionism (Paul, Marx & Orsillo, 1999), and 
anorexia nervosa (Heffner, Sperry, Eifert & Detweiler, 2002).  Dalrymple and Herbert (in 
press) found strong effects of an ACT-based intervention for generalized social anxiety 
disorder in an uncontrolled pilot investigation.  Small-randomized controlled trials have 
also been conducted in populations including generalized anxiety disorder (Roemer & 
Orsillio, 2002; Borkovec & Roemer, 1994; Borkovec, Alcaine, & Behar, in press; 
Crasket, Barlow, & O’Leary, 1992), trichotillomania (Twonig & Wood, in press), 
mathematical anxiety (Zettle, 2003), and work place stress (Bond & Bunce, 2000).  All of 
these studies found significant reductions in symptoms, in the studies that compared ACT 
with EST, ACT consistently was as effective if not more effective in reducing symptoms.  
These results are promising and suggest the need for continued research on ACT.  
Replication of these studies is essential, as are attempts to increase the clinical 
applicability of ACT. Of particular interest is the possibility of identifying subpopulations 
that may be especially responsive to ACT.  Possibilities along these lines include 
treatment resistant patients or those with especially severe pathology.   
ACT for smoking cessation 
An intervention based on the ACT model may be especially relevant for smoking 
cessation because of the focus on acceptance of negative internal experiences including 
thoughts and physiological sensations, which are invariably associated with cessation of 
 smoking, as well as the emphasis on behaving in a way that is consistent with one’s 
chosen values.  ACT may have the potential to improve upon established psychotherapies 
for substance abuse, including both motivational interviewing and CBT.  Although 
motivational interviewing interventions encourage smokers to begin to change thoughts 
and behaviors as steps towards controlling the addiction, the intervention does not 
include strategies of how the smoker should actually implement change.  CBT is a more 
advanced treatment approach in that specific techniques and strategies are utilized.  CBT 
helps the smoker identify the problem by focusing on the interactions between thoughts, 
emotions, and behavior as well as eliciting change by teaching the smoker specific 
strategies including cognitive restructuring and coping strategies.  The underlying 
assumption of CBT is that smokers can learn to control their behavior by changing 
thoughts.  Although this approach is shown to be efficacious for many smokers, an 
alternative approach that focuses less on controlling internal experiences and more on 
increasing awareness and acceptance may prove to be especially efficacious for 
subpopulations in which control-oriented interventions have failed. 
Gifford, Hayes and Kohlenberg (2004a) developed a comprehensive ACT 
intervention targeting smoking cessation.  The protocol focuses on the following: helping 
smokers notice their internal triggers as they occur; change what they can and accept 
what they cannot; make public commitments to behaving in alignment with chosen 
values (especially regarding smoking); and practice a variety of constructive actions in 
response to these triggers (Gifford et al., 2004a).  The Gifford et al. protocol includes 
several components aimed at shaping the behavioral repertoires and therapist help the 
client with the following: (1) identify their internal triggers, i.e., thoughts, feelings and 
 physiological sensations associated with smoking and distinguish internal triggers from 
external triggers; (2) identify that efforts to control or avoid internal experiences are 
linked to smoking and to problems with quitting; (3) provide smoking schedules 
according to algorithms based on current client smoking and hours of wakefulness; (4) 
clarify their values, define goals related to their values, and identify barriers to achieving 
their goals; (5) provide the rationale for approaching/accepting previously avoided 
internal stimuli, and for the skills training format; (6) encourage clients to participate in 
experiential exercises designed to develop a safe and consistent perspective from which 
to observe and accept all changing inner experiences; (7) establish individualized 
exposure hierarchies; (8) encourage clients to participate in a series of exercises designed 
to identify and defuse cognitive triggers, with particular emphasis on rationalizations for 
smoking; and (9) encourage clients to practice a range of adaptive responses in the 
presence of negative affect.  The goal is to shape flexibility as an overarching response, 
and to develop repertoires that provide realistic behavioral alternatives to the negatively 
reinforced smoking behavior. 
Empirical evidence for ACT with smoking cessation 
Gifford and colleagues (2004b) completed the only two randomized trials to date 
examining the efficacy of ACT for smoking cessation.  In the first study, 76 dependent 
smokers, recruited from a community sample, were randomized to either ACT or NRT.  
The ACT group received seven 50-minute individual sessions and seven 90-minute group 
sessions. The intervention was provided by advanced doctoral psychology students and a 
psychologist trained in ACT.  The individual and group sessions were provided within a 
seven-week time frame.   
 The participants randomized to the NRT condition received an initial 1 1/2 hour 
group education meeting conducted by a board licensed psychiatrist, which included 
information and basic advice on quitting smoking, as well as the rationale as to why NRT 
is an effective treatment based on the physical dependence model.  The participants in the 
NRT condition were provided each week with the nicotine replacement patch at a 
scheduled regiment of 22 mg per patch/day for the first four weeks followed by 11 mg 
per patch/day for three weeks. Each participant was provided with clear instructions on 
the proper use of the nicotine patch.  
 The participants were assessed at baseline, then weekly during the active phase of 
treatment, and then at follow-up time points, six month and one year time points. The 
severity of nicotine dependence, withdrawal symptoms and smoking behaviors as well as 
mood and client satisfaction were incorporated in a multimodal assessment. 
 The Gifford et al. (2004b) results indicate an equal distribution of demographic 
variables, smoking severity and support between the two groups at baseline.  Also, no 
significant difference in treatment attendance was reported for the seven-week active 
treatment phase, as well as no difference in attrition from assessment at both post 
treatment phases.  Although no significant difference was detected between conditions on 
treatment satisfaction, it is important to note that participants in the ACT condition 
reported better relationships with the treatment provider that could be a reflection of the 
one psychiatrist providing the initial educational meeting.  
 Analyses focusing on the efficacy of smoking outcome variables indicate no 
significant difference in quit rates between groups at post or at the six month follow-up, 
despite the numerically higher quit rates reported for ACT at both assessment points 
 (35% vs. 33% at post and 23% vs. 11% at 6-month follow up for ACT and NRT, 
respectively). At one-year follow-up, significant differences in smoking status were 
detected, with a 35% quit rate for the ACT participants as compared to 15% in the NRT 
condition. 
 Gifford and colleagues examined withdrawal symptoms, negative affect, 
avoidance and inflexibility as mediators of smoking status, while controlling for baseline 
levels of cigarettes smoked.  The results suggest that avoidance and inflexibility mediate 
the effect of acceptance-based smoking treatment on smoking status at outcome. Upon 
further analysis of avoidance and inflexibility, a large effect size for condition was found 
with participants receiving ACT significantly less likely to endorse the importance of 
reducing or eliminating emotions associated with smoking.   
 Gifford and colleagues (2002) conducted a larger randomized controlled trial of 
306 nicotine dependent individuals after the ACT versus NRT study.  Participants were 
randomized to receive ACT in conjunction with bupropion SR or bupropion SR alone.  
The combination ACT/bupropion SR treatment yielded significantly higher quit rates 
than did treatment with bupropion SR alone with 60% compare to 22% at post treatment 
and 22% verse 9% at one year follow up.   
 These initial investigations, despite the limited power and small sample size, 
provide promising results for the efficacy of ACT.  Replication of the Gifford et al. study 
is clearly needed.  In addition, the moderators and underlying mechanism of action for 
this relatively new treatment merit further investigation.  
 Empirical evidence for distress tolerance treatment. Given Brown and colleagues’ 
accumulating evidence indicating an important role of distress tolerance in smoking 
 cessation and the promising results from Gifford’s smoking cessation study, Brown and 
colleagues have focused their attention on applying strategies consistent with ACT to a 
population that they have identified as high risk, smokers have been unable to maintain 
abstinence for more than 72 hours.  Brown recently received an RO1 grant to meet the 
objectives of the NIDA Behavioral Therapies Development Program.  The project aims 
to develop a specialized protocol for nicotine dependence in early smoking lapsers, which 
incorporates behavioral exposure to nicotine withdrawal and training in ACT skills to 
facilitate tolerance of distress and persistence in the face of discomfort associated with 
quitting smoking.  The second phase of the study will include a randomized trial 
comparing the distress tolerance (DT) treatment to a standard smoking cessation (ST) 
comparison intervention for early lapsing smokers. 
 The initial phase of the program, which has been completed, involved the 
development of a standardized protocol incorporating the strategies of ACT.  The 
treatment manual was devised using the expertise of Brown and colleagues at Brown 
University and consultation with ACT researchers at the University of Nevada at Reno, 
both Elizabeth Gifford and Steven Hayes.  The treatment has been piloted on 16 nicotine 
dependent participants, with a prior history of failed abstinence within 72 hours of the 
quit attempt, seeking smoking cessation treatment.  Preliminary findings from the 
treatment development phase are promising. In particular, for these participants that had 
never been able to quit smoking for more that 72 hours, follow-up data found that the 
majority (81.2%) were able to remain quit for longer than 72 hours. Moreover, 75% of 
the participants were able to stay quit for longer than one week, 68.8% for longer than 
two weeks, and 43% for longer than one month.  In addition, participants continued to 
 persist at maintaining smoking abstinence even after lapses. Since previous research has 
indicated that a greater number of and greater duration of past quit attempts predicts 
smoking cessation at 6-month follow-up, the findings in Brown and colleague’s pilot data 
are particularly meaningful (Brown et al., in press).    
 The second phase of the NIDA grant is currently underway.  Participants are 
being recruited for a preliminary randomized trial to examine the efficacy of the distress 
tolerance (DT) treatment relative to the standard smoking cessation (ST) treatment in 
early lapsing smokers.  All eligible participants will receive 8 weeks of transdermal 
nicotine patch in addition to the assigned behavioral treatment condition.  Participants 
randomized to the DT condition will receive the developed DT intervention, which 
includes a combination of 6 60-min individual sessions and 9 2-hour group sessions for a 
total of 10 weeks.  The treatment strategies involve exposure to nicotine withdrawal 
through nicotine fading and scheduled abstinence as well as the development of ACT 
skills utilized to enhance the smokers’ tolerance to the discomfort associated with 
quitting smoking.  Participants randomized to the ST will receive 6 60-min group 
sessions and one individual brief telephone contact (during quit week) over an eight week 
time period.  The ST is based on Brown and colleagues’ behavioral smoking cessation 
treatment previously discussed as an empirically supported CBT intervention. 
 The secondary aim of Brown and colleague’s study involves testing the 
hypothesis that early smoking lapsers who are randomized to the DT condition will show 
greater improvement in mechanisms hypothesized to mediate the relationship between 
DT treatment and improved smoking outcomes.  Brown and colleagues hypothesize task 
persistence and emotional avoidance as mediating mechanisms to quit smoking. 
  The researchers intend to measure smoking history and nicotine dependence, 
depressive symptoms, mood and affective vulnerability, task persistence and emotional 
avoidance, and post-cessation smoking outcomes. Task persistence and emotional 
avoidance will be assessed by administering the Pace Auditory Serial Attention Task 
(PASAT; described below), as well as evaluating persistence on physical challenges 
including a breath holding duration task and inhalation of carbon dioxide-enriched air.  
Also, the Acceptance and Action Questionnaire (AAQ) and Avoidance and Inflexibility 
Scale (AIS) will be administered.  Post-cessation smoking outcome variables include 
self-reported smoking status, expired carbon monoxide readings, and saliva cotinine and 
will be collected up to 26 weeks post-cessation. 
Summary and study rational 
 Nicotine dependence is one of the most serious public health concerns in the 
United States.  Behavioral interventions have demonstrated increased abstinence compare 
to self-help or “cold turkey” quitting strategies.  Yet, only one third of individuals 
receiving intensive behavioral therapy remain abstinent at one-year follow-up.  
Pharmacological treatments have been shown to increase smoking cessation to 1.5 to 2 
fold compared to placebo, with long-term abstinence rates ranging from 14-24%.  
Additive effects of combining the behavioral treatments with pharmacological treatments 
have been examined, with minimal benefits.  A significant proportion of individuals 
attempting to quit smoking are unable to maintain abstinence for more than 72 hours.   
 Emerging evidence, opposing the tradition model of drug dependence, suggests 
that the severity of withdrawal symptoms is less related to abstinence rates than once 
believed.  Instead, there is growing support that an individual’s reaction to the discomfort 
 of nicotine withdrawal is directly related to the individual’s ability to abstain from 
cigarettes.  Smokers have unique reactions to withdrawal, which may, in part, be related 
to the individuals’ distress tolerance, with anxiety sensitivity and experiential avoidance 
contributing to a smoker’s level of distress tolerance. 
 Based on principles derived from Relational Frame Theory (RFT), Hayes and 
colleagues created an intervention using the technology of Acceptance and Commitment 
Therapy (ACT) targeting experiential avoidance.  A recent proliferation of studies 
examining the efficacy of ACT for a variety of disorders has provided empirical evidence 
that ACT is a beneficial treatment.  In particular, Gifford and colleagues’ (2002, 2004) 
studies yielded promising results, with the ACT intervention proving to be effective for 
long-term abstinence (1 year follow-up) and more effective that NRT for smoking 
cessation, and the combination of ACT plus bupropion was more effective than 
bupropion alone.  Moreover, the results from this study found similar effect sizes to the 
most effective state-of-the-art cognitive behavioral treatments.  In many of the clinical 
trials examining ACT interventions, the hypothesized mechanism of change for the 
increase in functioning is directly related to the ACT strategies that decrease experiential 
avoidance.  Yet, few studies have examined the impact that the core components of ACT 
have on experiential avoidance in a tightly controlled environment.  Brown and 
colleagues are currently developing and investigating a distress tolerance treatment that 
incorporates ACT strategies for early lapsing smokers.  Brown’s study has been designed 
to compare a distress tolerance treatment to standard CBT treatment for smoking 
cessation and post-cessation outcome.  
 Since early lapsers constitute a large proportion of smokers unable to quit 
 smoking, further investigation of primary factors leading to relapse is essential in 
developing treatment strategies for this population.  Given the emerging evidence 
regarding the constructs of distress tolerance, in particular individual differences in 
response to nicotine withdrawal, the present study further examined early lapsing 
smokers’ distress tolerance levels when exposed to psychological and physiological 
stressors.  This study paralleled the pioneering research of Brown and colleagues by 
providing brief interventions that target the smokers’ ability to tolerate the distress related 
to the psychological and physiological stressors.  One advantage of the present study is 
the ability to isolate what is believed to be factors responsible for change in both the ACT 
and CBT brief interventions and to measure these factors in analog laboratory challenges.  
The challenges have two purposes: 1) the time to task completion and task persistence on 
the challenges serves as dependent variables that measure distress tolerance; and 2) the 
challenges were chosen because of the associated psychological and physiological 
discomfort that mirrors psychological and physiological discomfort that nicotine 
dependent individuals experience during withdrawal. 
The present study compares the differences in performance and persistence on the 
analog laboratory challenges between three conditions, participants randomized to an 
acceptance-based intervention, a control based intervention, and a third comparison 
group, the health consequence comparison group, which has been designed as an 
attention placebo control group. The 30-min health consequence intervention provided 
psychoeducation regarding the health consequences of smoking and did not include any 
strategies to reduce stress or cravings for cigarettes.  The goal of including the health 
consequence comparison group was to ensure construct validity in the study by 
 controlling for factors common to receiving a 30-min intervention.  To standardize the 
interventions, each of the three conditions was delivered to the participant by videotape.  
In addition, the reinforcements the participants received during the stressors were 
standardized. The computerized tasks provided standard feedback to the participant.  In 
addition, the participants were told that they could earn a gift certificate worth $5 if their 
scores on the tasks, described in the methods section below, were greater than the average 
score of the other participants. This compensation procedure was intended to produce 
some incentive for continuing the task while being weak enough not to create a ceiling 
effect in persistence. 
In designing this study, internal validity was a priority and factors such as 
exposure time to the intervention, reinforcements for persisting at psychological and 
physiological tasks, and the environments in which the study occurred were all tightly 
controlled to ensure consistency between the treatment conditions.  Evidence from 
Gifford and colleagues smoking cessation studies suggests that strategies developed to 
enhance a smoker’s acceptance of the psychologically aversive withdrawal symptoms 
and to encourage behavior that is consistent with one’s chosen values are effective 
interventions, and in fact appear to be as effective as the gold standard treatment.  The 
core components from ACT were applied to a treatment resistant smoking population, 
and compared to the core components of standard behavioral smoking intervention and to 
an attention placebo control group in a controlled environment.   
Research Hypotheses 
 This study tested the effects of three brief analog interventions designed to 
increase distress tolerance in early lapsing smokers abstaining from cigarette use, and 
 examined the effects of these interventions in an analog laboratory paradigm.  One 
intervention focused on increasing awareness of thoughts and feelings and increasing 
acceptance of distressing internal experiences.  Another intervention focused on control 
strategies typical of standard CBT programs, including controlling behavior by changing 
thoughts as well as distraction techniques.  The health consequence comparison 
intervention focused on increasing awareness of the health consequences of stress and 
smoking cigarettes.  
 The specific hypotheses of the study included: 
1. It was hypothesized that participants in the acceptance-based condition would 
demonstrate increased distress tolerance when exposed to psychological and 
physiological challenges compared to a control-based condition and a health 
consequence comparison condition.  It was further hypothesized that the 
control-based condition would demonstrate increased distress tolerance when 
compared to the health consequence comparison condition. 
2. It was hypothesized that participants in the acceptance-based condition would 
show a longer latency to smoke during a break in the experimental procedures 
relative to participants in the control-based condition and to those in the health 
consequence comparison condition.  Participants in the control-based 
condition were hypothesized to show a longer latency to smoke during a break 
in the experimental procedures than the participants in the health consequence 
comparison condition. 
3. It was hypothesized that participants in the acceptance-based condition would 
identify the intervention as more valuable and more useful relative to the 
 participants in the control-based condition and the health consequence 
comparison condition.  
  
CHAPTER 2: METHODS 
Participants 
 Recruitment.  Participants were recruited through local community media, in 
Boston, Massachusetts, including newspaper advertisements, local postings of flyers and 
postings on local websites (e.g., Craig’s List).   
Inclusion and exclusion criteria.  Given that this study examined characteristics of 
early lapsing nicotine dependent individuals, nicotine dependent individuals, as defined 
by having a score of six or higher on the Fagerstrom Test for Nicotine Dependence 
(FTND) questionnaire (see description below), having attempted to quit smoking at least 
once in their life and having been unable to maintain abstinence for more than one week 
in the past ten years, were included in the study.   
The inclusion criteria for the study included: 
1. Adults ages of 18-60 
2. Currently smoking an average of 20 or more cigarettes every day 
3. High levels of nicotine dependence as measured by a score of 6 or greater on the 
FTND 
4. At least one previous failed attempt at quitting, with no quit attempt lasting for more 
than one week in the past ten years 
5. Fluency in English 
6. Voluntary consent to participate 
The exclusion criteria were: 
1. Currently using treatment for smoking cessation (e.g. psychotherapy, nicotine 
replacement therapy) 
 2. Significant depressive symptoms as measured by a score of 16 or higher on the CES-
D (see description below) 
3. Currently taking psychotropic medication 
4.   Taken opiate based pain medication in the previous week 
5.   Unstable acute or chronic medical condition or pain disorder 
Design 
 The design of this study was a randomized between group design with three 
conditions: acceptance-based intervention, control-based intervention, and health 
consequence comparison condition. Initially, the participants’ eligibility, nicotine 
dependence and smoking history were assessed.  Participants then received one of the 
three intervention conditions, which were randomly assigned, and then given both the 
psychological and physiological challenges.  After the completion of the challenges, the 
participants were asked to wait an hour in which they were provided an opportunity to 
smoke.   
The dependent measures for the challenges included self-reported anxiety, 
irritability, concentration, discomfort, and urge to smoke as well as latency to task 
termination.  Another dependent variable was the latency in time to smoking after the 
challenges had been completed.  The latency in time to resume smoking was expected to 
be less than one hour.  The independent variable was the 30-minute intervention; the 
acceptance-based intervention, the control-based intervention, and the health 
consequence comparison condition. 
Measures 
The following is a list of the measures used in the initial assessment, during the 
 psychological and physiological challenges, at the completion of the study, and as part of 
the manipulation check: 
Fagerstrom Test for Nicotine Dependence (FTND, Appendix A). The FTND 
(Heatherton, Kozlowski, Frecker & Fagerstrom, 1991) is a 6-item self-report measure of 
severity of smoking. The measure includes items such as “do you find it difficult to 
refrain from smoking in places where it is forbidden such as church, the library, or the 
movie theatres?”  The assessment is widely used and has a Cronbach alpha equal to .56 
(Payne, Smith, McCracken, McSherry & Antony, 1994).   It is a revised version of the 
Fagerstrom Tolerance Questionnaire (FTQ, Fagerstrom, 1978).   
Demographics Questionnaire (Appendix B).  The Demographics Questionnaire is 
a self-report measure created by the researchers for the current study to collect 
information regarding age, gender, ethnicity, smoking history, and current smoking 
patterns.  
Medical History Questionnaire (Appendix C). The Medical History Questionnaire 
is a self-report measure created by the researchers for the current study to collect 
information regarding past medical injuries, surgeries, or conditions as well as any 
current medical problems and prescription medication. 
Center for Epidemiological Studies Depression Scale (CES-D, Appendix D).  The 
CES-D (Radloff, 1977) is a 20-items self-rating scale assessing depressive symptoms.  
The CES-D shows excellent internal consistency (coefficient alpha >0.85) and test-retest 
reliability (r >.5) (Radloff, 1977). 
Anxiety Sensitivity Index (ASI, Appendix E).  The ASI (Peterson & Reiss, 1992) 
is a 16-item self-report measure assessing concern for possible negative consequences of 
 anxiety symptoms.  Respondents are requested to rank their concern on a 5-point Likert-
type scale.  High scores indicate greater anxiety sensitivity. The ASI has high levels of 
internal consistency in nonclinical populations (alpha coefficient = 0.90) and good test-
retest reliability (r = 0.75 for a two week time period). 
State Trait Anxiety Inventory (STAI, Appendix F).  The STAI (Spielberger, 1983), 
is a 40-item self-report measure that assesses both state anxiety and trait anxiety.  High 
scores on the respective scales mean more trait or state anxiety and low scores mean less. 
The test-retest reliability, which varied in length of time from one hour to 104 days, for 
the Trait-anxiety scale ranged in coefficients from .65 to .86, whereas the range for the 
State-anxiety scale was .16 to .62. This low level of stability for the State-anxiety scale is 
expected since responses to the items on this scale are thought to reflect the influence of 
whatever transient situational factors exist at the time of testing. 
The Avoidance and Inflexibility Scale (AIS, Appendix G). The AIS (Gifford, 
Kohlenberg, Hayes, Anonuccio, Piasecki & Palm, 2002) is a 13-item measure that 
assesses smokers’ uses of avoidance strategies related to smoking and smoking cessation.  
High scores represent an avoidant strategy toward internal experiences and an inflexible 
link between these experiences and smoking. The measure’s reliability was established in 
a recent study of 306 participants (Gifford et al., 2002) and has a Cronbach alpha of .93. 
The Acceptance and Action Questionnaire (AAQ, Appendix H).  The AAQ 
(Hayes et al., 2004) is a 9-item self-report measure that assesses emotional avoidance and 
emotion-focused inaction.  Respondents are instructed to rank statement, such as “anxiety 
is bad” on a 7-point Likert scale.  High scores indicate emotional avoidance and low 
scores correspond with acceptance and commitment to action.  The internal consistency 
 (Cronbach alpha = 0.70) is adequate (Hayes et al., under review). Additionally, Bruce and 
Bond (2000) found very good internal consistency, with alphas ranging from .89 to .92.   
Difficulties in Emotional Regulation Scale (DERS, Appendix I).  The DERS 
(Gratz & Roemer, 2004) is a 36-item scale designed to assess the degree of emotional 
avoidance. Higher scores indicated greater difficulties in emotion regulation. Preliminary 
findings from a recent study (Gratz & Roemor, 2004) suggest that the DERS has high 
internal consistency, good test-retest reliability, and adequate construct and predictive 
validity. In particular, results indicate that the DERS had high internal consistency (α = 
.93). Also, results indicate that the overall DERS score had good test-retest reliability 
over a period ranging from 4 to 8 weeks (r  = .88, p < .01). 
Philadelphia Mindfulness Scale (PHLMS, Appendix J). The PHLMS (Cardaciotto 
et al., under review) is a 20-item self-report measure with items rated on a 5-point Likert 
scale. This assessment mindfulness assesses two key components: present-moment 
awareness and acceptance. Good internal validity was demonstrated in non-clinical 
populations and clinical populations (Cardaciotto et al., in press). 
Wisconsin Inventory of Smoking Dependence Motives (WISDM-68, Appendix K). 
The WISDM-68 (Piper et al., 2004) is a 68-item self-report measure with items rated on a 
7-point Likert scale. This assessment of dependence measures motives for smoking.  
Psychometric analysis of the WISDM-68 indicates acceptable internal consistency (Piper, 
et al., 2004). 
Timeline Followback Assessment(TLFB, Appendix L).  The TLFB (Sobell & 
Sobell, 2000) is a self-report method that assesses daily patterns of frequency of drinking 
and drug use behavior over a 72 hour time period. Participants are instructed to indicate 
 on a calendar any drinking or drug use for the past 72 hours. The psychometric properties 
of this strategy have been examined and reports indicate that the assessment tool has high 
retest reliability, convergent and discriminant validity with other measures, agreement 
with collateral informants’ reports of patients’ substance use and agreement with results 
from patients’ urine assays (Fals-Steward, O’Farrell, Freitas, McFarlin & Rutigliano, 
2000). 
Expired carbon monoxide (CO).  Air samples to measure carbon monoxide (CO) 
were obtained by the breath-holding procedure described by Irving, Clark, Crombie and 
Smith (1988).  Concentrations of CO are used to corroborate 24-hour point prevalence 
reports of smoking status at baseline and again before the intervention.  Readings of 11 
parts per million or less are generally accepted as reflecting the non-smoking range 
(Irving et al, 1988).  The CO monitor used in this study measures carbon monoxide in the 
breath by having the participant blow into the monitor, using hygienic disposable 
mouthpieces. A reading of CO, in ppm and blood %COHB, was shown within seconds 
and indicated the level of CO in the participant’s lungs which represents the amount of 
cigarettes the person had been smoking within the last 12 hours (Bedfont Scientific, 
2006). 
Physiological reactivity.  A Coulbourn Lablinc V, Human Measurement System 
was used to record physiologic analog signals, including skin conductance and heart rate.  
Skin conductance was measured by a Coulbourn Isolated Skin Conductance coupler 
(V71-23) using a constant 0.5 V through 9-mm (sensor diameter) Invivo Metric Ag/AgCl 
electrodes placed on the hypothenar surface of the subject's non-dominant hand in 
accordance with published guidelines. The SC electrodes were separated by 14 mm, as 
 determined by the width of the adhesive collar.  Interbeat interval were recorded via 
standard limb electrocardiogram leads connected to a High Gain Bioamplifier (V75-04) 
and converted to heart rate. Physiologic analog signals were digitized by a Coulbourn 
analog to digital converter (V19-16). An IBM-compatible computer system was used to 
sample and store the digitized physiologic signals.  To ensure that the sensors had a good 
connection to the skin, the areas to which the electrodes were attached were rubbed with 
a mildly abrasive pad.   
Assessment of (a) anxiety, (b) irritability, (c) concentration, (d) discomfort (e) 
urge to smoke (as used by Brown et al., 2002; Appendix M). These single-item self-report 
questions are rate on a Likert-type scale ranging from 0 (none) to 100 (extreme).  The 
participants were asked to draw a vertical line indicating “how much anxiety do you feel 
right now”. Participants were instructed to use this rating for irritability, concentration, 
discomfort and urge to smoke. These items were selected on the basis of their relevance 
for sensitivity to psychological and physical distress.  Composite scores were created for 
the anxiety, irritability, difficulty concentrating, and discomfort items to form a dysphoria 
scale, given their very high intercorrelations. In the Brown et al. (2002) study, a 
dysphoria scale was created for anxiety, irritability and difficulty concentrating based on 
the intercorrelations between those scales. 
 Values and usefulness assessment (as used by Hayes et al., 1999; Appendix N).  
The values and usefulness assessment is a 2-question measure that assesses the 
participant’s perception of the value and usefulness of the intervention in enduring the 
psychological and physiological stressors.  Subjects are asked to respond to the two 
questions by drawing a vertical line through a 10 centimeter horizontal line (visual analog 
 scale), scaled from “not at all” (“0”) at the left to “very much” (“10”) at the right.  The 
first question is “How valuable was the training to you in handling the tolerance test after 
training?” and the second is “When you had gone through the training, but before you 
had done the tolerance test, how useful did you think the training would be?”  The 
assessment was measured on a continuous scale, with a ruler. 
 Perceived efficacy (Appendix O) is a one-item self-report measure that assessed 
the degree of the perceived efficacy in regulating emotional response during the 
challenge.  The participant was asked to indicate on a 100-mm visual analog scale the 
degree of his or her perceived efficacy at the end of the challenges. 
 Manipulation check (Appendix P) is a self-report measure created by the authors 
to measure how the participants attempted to regulate their emotional responses during 
the challenges.  This assessment strategy serves as a check to identify the extent to which 
the participants actually relied on the strategies provided in each intervention. 
Procedures 
 Individuals interested in participating in the study were instructed to respond to 
community advertisements by telephone, and upon responding the interested individual 
underwent a 20-minute telephone screening interview.  During the telephone screening, 
the individual was informed of the study procedures, time obligations and compensations.  
In addition, individuals were assessed to determine eligibility based on the study 
inclusion and exclusion criteria.  Those individuals that were interested in the study and 
were appropriate were invited to the clinic, where informed consent was obtained before 
any procedures begun.  At the time of the phone interview, the individuals were 
instructed to maintain their usual smoking patterns. 
  At the clinic, the participants were asked to complete a questionnaire packet that 
included self-report measures assessing demographic information, smoking history, 
current nicotine dependence, psychological distress, and current coping strategies.  
Participants also completed a self-report questionnaire assessing their medical history and 
current medical condition.  A CO reading was taken at this time. Participants who met the 
study criteria were randomized to one of the three conditions, with gender, high or low 
levels of nicotine dependence (as measured by the FTND), and high or low psychological 
distress (as measured by the CES-D) counterbalanced across the three conditions.  
The participants’ cigarettes were collected by a staff member and the participants 
were informed that their cigarettes would be returned to them at the end of the challenges.  
Participants were then provided with one of the three interventions.  Each intervention 
was delivered by computer and lasted approximately 30 minutes.  Also, a workbook that 
highlighted the strategies discussed in the video was provided to each participant before 
the intervention began.  The workbook also included practice exercises and a short quiz 
at the end to ensure that the participant understood the material covered in the video and 
workbook.  The descriptions of each pre-recorded videotape intervention are as follows 
(see Appendix Q for the comparison of the functional goals of the interventions). 
 Acceptance-based brief intervention. The acceptance-based brief intervention (see 
Appendix R) incorporated core components of Acceptance and Commitment Therapy as 
it applied to a smoking population.  The general aim of the acceptance-based brief 
intervention was to enhance experiential acceptance by promoting defusion from 
thoughts and feelings, i.e. recognizing private events as distinct from a core sense of self.  
This was accomplished by increasing the individuals’ awareness of internal and external 
 experiences related to craving cigarettes, smoking and withdrawal.  Through metaphors, 
the individuals begin to recognize that the control strategies that were often applied to 
external triggers were not effective when applied to internal triggers, and can actually 
increase the distress (urges).  The alternative to struggling/controlling internal 
experiences was acceptance.  The individual was encouraged to be willing to experience 
something different from what he or she automatically did and to practice awareness, to 
become aware of the internal experiences and to accept the experience without attempting 
to control the thoughts and feelings.  The second goal of the intervention was to enhance 
the individuals’ ability to distinguish thoughts and feelings from behavior.  Individuals 
were informed that we have less control over our feelings and thoughts than our behavior.  
Metaphors were used as a tool to achieve diffusion from and acceptance of aversive 
cognitive and affective content.  
 Control-based brief intervention. The control-based brief intervention (see 
Appendix S) incorporated core components of Cognitive Behavioral Therapy as it relates 
to smoking.  The general aim of the control-based brief intervention was to increase 
awareness of automatic thoughts and to actively alter or change the thought in order to 
change behavior (i.e., engage in stressful activities longer, abstain from smoking).  This 
was accomplished by encouraging the individual to begin to identify his or her automatic 
thoughts.  Individuals were taught strategies to evaluate automatic thoughts and 
determine if they were realistic and/or helpful.  Then the individual was taught to replace 
his or her automatic thoughts with more positive thoughts.  For example; the individual 
was encouraged to replace the thought “I need a cigarette to handle this stress” with a 
more positive thought such as, “I can do it, I have been through worse.”  Also, a 
 traditional behavioral strategy was implemented, the Benson Relaxation Breathing 
Technique.  The general aim of the deep breathing was to control the urges through 
relaxation techniques.  The specific techniques of the deep breathing were discussed in 
detail and the participant was encouraged to use the strategy. 
 Health Consequences Comparison Condition.  The general focus of the health 
consequences comparison condition (see Appendix T) was to provide psychoeducation 
regarding the physical health consequences of smoking cigarettes.  The individuals was 
provided with detailed facts regarding the morbidity and mortality associated with 
smoking cigarettes such as “smoking is the leading cause of preventable death, 
accounting for 440,000 deaths per year (CDC, 2002), which equates to one in every five 
deaths (CDC, 2001)”, and “in the United States, alcohol abuse, drug abuse, AIDS, motor 
vehicle accidents, homicide and suicide are six of the seven leading causes of death.  All 
six of these causes combined account for only half as many deaths each year as does 
cigarette smoking (CDC, 2000).” In addition, information on the effects of second hand 
smoke was provided.  Also, the benefits of quitting smoking was provided including, 
“abstinence of 10 years or more decreases the risk of lung cancer 30-50% compare to 
active smokers” (Edwards, 2004) and “quitting before the age of thirty decreases the 
lifelong risk for lung cancer by 90%” (Edwards, 2004).  Individuals were instructed to 
think about the health consequences of smoking the next time that he or she was having 
cravings to smoke a cigarette. 
 Participants were instructed to apply the strategies discussed in the 30-minute 
videotape when exposed to the challenges.   
 Procedures for the challenges 
 All eligible participants were exposed to both psychological and physiological 
challenges.  The order in which the participant were exposed to the stressors was 
counterbalanced by stressor (psychological and physiological) and gender according to a 
Latin square.  Regardless of which stressor the participant received first, the session 
began and ended with an assessment of self-reported anxiety, irritability, difficulty 
concentrating, bodily discomfort and urge to smoke as assessed by a single-item Likert-
type scale.   
The sessions took place in an 8’X 8’ experimental room with a desk supporting a 
computer, a color monitor, and a mouse.  The experimenters sat in an adjacent room and 
viewed the participant through a video monitoring system.  All the data from the 
psychological stressors was automatically organized into a computer system.  The data 
from the physiological challenges were collected by the experimenter and entered into a 
data system.  During the laboratory challenges, the participants’ heart rate and skin 
conductance were used as measures of physiological reactivity to the distress tolerance 
laboratory challenges.  
Psychological stressor 
 Pace Auditory Serial Addition Task (PASAT):  A modified computer version of 
the PASAT was used in this study.  In this task, numbers were sequentially flashed on the 
screen.  Participants were asked to sum the most recent number with the previous number 
and used the computer’s mouse to click on the correct answer using a keyboard provided 
on the computer screen.  After the participant provided each sum, the participant was 
required to then ignore that sum and add the following numbers to the most recent 
 number provided (e.g., 4 + 3 [correct response = 7] + 6 [=9] + 11 [=17].  When the 
participant answered correctly, a point was obtained.  Points were continuously updated 
in the upper-right-hand portion of the computer screen.  If the participant answered 
incorrectly or no answer was provided before the next presentation of the next number, 
an “explosion” sound effect was played.   
The PASAT was comprised of levels 1-3, lasting 3, 5, 10 minutes, respectively.  
The latency between the number presentations was 3 seconds for Level 1, 1.5 seconds for 
Level 2, and 1 second for Level 3.  Because an answer needed to be provided before the 
presentation of the next number to obtain a point, the difficulty increased as latencies 
decreased.  After the participant progressed through Levels 1 and 2, participants were 
given a 2 minute period to provide an additional set of responses to the same single-item 
self report questions that were completed at the start of the session, to examine the stress-
related effects of the PASAT.  Although Level 3 will be set to 10 minutes, participants 
were given an “escape” button to click if they want to terminate exposure to the task.  
Before the participants started the PASAT, the task was thoroughly explained, including 
the presence of the quit option in the final level.   
 The Computerized Mirror-Tracing Persistence Task (MTPT-C; Strong, Lejuez, 
Daughters, Marinello, Kahler, & Brown, 2003). A computerized version of the Mirror 
Tracing Persistence Task (MTPT; Quinn, Brandon, & Copeland, 1996) was used in this 
study. Participants were instructed to trace a red dot along a star using the computer’s 
mouse, with the mouse programmed to move the red dot in the reverse direction. If the 
participant moved the red dot outside of the star or if the participant stalled for more than 
2 seconds, a loud buzz sounded and the red dot returned to the starting position.  
 Participants were told that they could end the task at any time by pressing any key on the 
computer, but also that how well they did on the task would affect how much money they 
made. The participants were not told that the task will terminate after 5 minutes.  
Physical challenges 
 Breath-Holding Endurance Task:  Participants were informed that the duration of 
his or her breath holding would be timed.  The participants were instructed to stand up 
during the task and to take a deep breath and hold it for as long as possible.  No pretest 
hyperventilation was suggested or encouragement given.  A stopwatch measured the 
duration of the breath holding. 
  After the completion of the psychological and physiological challenges, all the 
participants were told “There is good news and bad news. The good news is that you are 
all done with the challenges.  The bad news is that since you are done early, I don’t have 
your money available or the last part of the study ready so you’ll have to wait about an 
hour before you can finish up. Here is your pack of cigarettes. There is no smoking in the 
building, though you can go outside to smoke if you need to.  It maybe helpful to use the 
strategies discussed in the video to help cope with the cravings to smoke. Let me know if 
you need to have a cigarette so that I can unhook the equipment.” 
Latency to smoking was measured by a stopwatch.  After the participant finished 
the cigarette or after an hour had passed, the participant met with a staff member.  The 
participant was asked to complete the assessment of anxiety, irritability, concentration, 
discomfort, and urge to smoke as well as the Values and Usefulness Assessment, the 
Perceived Efficacy and the manipulation check.  The participant was then debriefed and 
compensated for his or her time.  Also, participants were provided with a referral to local 
 quit smoking programs if they expressed interest in quitting. 
 Compensation.  The procedures for compensation were explained to all 
participants at the beginning of the session.  Participants were financially reimbursed for 
their participation with cash.  Participants were told that they would receive $50 for the 
completion of the study.  Also, the participants were told that they could earn an 
additional five dollars if they had good accuracy on the quiz following the 30-minute 
intervention. Also, they were told that they could earn five dollars if their scores on the 
tasks were greater than the average score of the other participants. This compensation 
procedure was intended to produce some incentive for staying engaged in the video 
intervention as well as continuing the task while being weak enough not to create a 
ceiling effect in persistence.  All participants were compensated the full amount, $60 
regardless of their accuracy or performance on the quiz and tasks. 
Statistical Analysis 
 Preliminary analysis. To determine if the groups significantly differed in 
demographic information, baseline severity of nicotine dependence, psychological 
distress, and baseline coping strategies, one-way ANOVAs and chi-square tests were 
conducted to ensure equality between the groups. Post-hoc analysis (t-test) were 
conducted when significant differences were detected from the one-way ANOVAs. 
Frequencies and scatter plots were calculated for the groups to assess for outliers and data 
entry error.   
 Manipulation checks. Two manipulation checks were embedded in the study. 
Correct responses on the quiz specific to the assigned intervention were examined 
between the groups using a one-way ANOVA. To test whether participants utilized the 
 strategies specific to the intervention they had received to a greater extent than the 
interventions they did not receive, a 2 (Scores: on assigned intervention, on non-assigned 
intervention) X 3 (Condition: ACT, CBT, HCCC) mixed model ANOVA was conducted. 
T-tests were then conducted to determine differences between the conditions in 
intervention specific responses to interventions not viewed.  
 Primary analysis.  To test the hypothesis that self-reported ratings were 
significantly different between the conditions, a composite score was constructed for 
several of the self-reported ratings. A mixed model 2 (Phase: pre-challenge, post-
challenge) X 3 (Challenge: breath holding, mirror tracing task, PASAT) X 3 (Condition: 
ACT, CBT, HCCC) ANOVA was conducted, with Phase and Challenge as repeated 
measures factors and Condition as a between-participants factor.  A similar mixed model 
2 (Phase: pre-challenge, post-challenge) X 3 (Challenge: breath holding, mirror task, 
PASAT) X 3 (Condition: ACT, CBT, HCCC) ANOVA was conducted for the “urge to 
smoke” variable.  
To examine the effect of condition on participants’ ability to tolerate frustration 
and persistence of the tasks, participants’ time to terminate on the three frustration 
inducing tasks (breath holding, PASAT, Mirror Tracing task) were standardized (to 
account for different scales of time measurement) and a 3 (Condition: ACT, CBT, 
HCCC) X 3 (Task: breath holding, PASAT, Mirror Tracing task) mixed model ANOVA, 
with Condition as a between-subjects factor and Task as a within subject factor, was run 
on these standardized scores.  Since the distribution of time to terminate on the 
psychological challenges was significantly truncated, time to termination was coded 
dichotomously.  Chi-square analyses were run to determine differences between groups 
 in termination of challenges. To test whether participants’ accuracy on the psychological 
tasks differed between groups, two independent one-way ANOVAs were run.    
To ensure that the baseline physiological response was equal between the three 
groups, two separate one-way ANOVAs were conducted, one examining heart rate and 
other examining skin conductance.   ANOVAs were conducted to test the hypothesis that 
there would be group difference in changes in physiological reactivity.  A 3 (Phase: 
baseline, PASAT, Mirror task) X 3 (Condition: ACT, CBT, HCCC) mixed model 
ANOVA was conducted on heart rate data.  A separate 3 (Phase: baseline, PASAT, 
Mirror task) X 3 (Condition: ACT, CBT, HCCC) mixed model ANOVA was conducted 
on skin conductance data.  Post hoc analyses were run accordingly. 
 Secondary hypothesis.  To test the hypothesis that between group differences 
would be detected for participants’ rating on how valuable the training was in handling 
the challenges, how useful they thought the training would be in tolerating the challenges, 
and how well they thought they were able to regulate their emotional response to the 
challenges, three separate one-way ANOVAs were conducted.  
 Power analysis.  To determine the number of participants needed for initial 
enrollment in the study, a power analysis and attrition estimates were completed.  As no 
studies to date have examined the interventions’ impact on distress tolerance to 
physiological and psychological stressors in a laboratory environment for early lapsing 
smokers, the expected effect sizes of the interventions had not been determined at the 
initiation of the study.  The power analysis was calculated based on the Hayes and 
colleagues’ study examining the impact of acceptance versus control rationales on pain 
tolerance, the cold pressor challenge, with college students.  With a power of .80, an 
 alpha of .05, and an effect size of .60, the number of subjects needed for each condition 
was calculated to be 20. During the data collection, preliminary analysis were conducted 
to calculate the effect size using Cohen’s d (Cohen, 1992), and due to small effect sizes 
between the conditions (d ranging from .10-.25) recruitment efforts were discontinue. 
 CHAPTER 3: RESULTS 
Participants 
 Response rate. Over three hundred and fifty adults responded to local internet and 
newspaper advertisements and were phone screened. The majority of people that were 
phone screened were not eligible for the study, primarily because reported quit attempts 
exceeded one week in duration. Of the 60 participants who provided initial informed 
consent to participate in the study, 44 met the study inclusion criteria and were randomly 
assigned to one of three conditions (ACT n = 15, CBT n = 15, and HCCC n = 14).  Of the 
sixteen participants who were ineligible for inclusion in the study, 14 evidenced elevated 
CES-D scores, 1 had quit smoking for six months in the previous decade, and 1 requested 
participating at a later date and never returned to the laboratory.  Chi-square tests 
indicated that participants in the three study conditions did not differ according to gender, 
race, education attainment, or average income. However, a significant difference between 
the groups was detected for employment status (χ2(2) = 8.23, p < .05), with fewer 
participants in the ACT condition reporting current employment. Separate one-way 
ANOVAs were conducted between the eligible and non-eligible participants on smoking 
variables including number of years of smoking, number of quit attempts, longest 
reported quit attempt in the past 10 years, and FTND scores. No significant differences 
were found. However, a one-way ANOVA comparing eligible and non-eligible 
participants on the number of cigarettes smoked each day indicated significant 
differences (F(1,57)=10.57, p <.05), with eligible participants smoking less (M = 22.66, 
SD = 7.92) than non-eligible participants (M = 35.14, SD = 21.59). 
 Demographic information.  As shown in Table 1, of the 44 participants 
 randomized to study conditions, 34% were female and 61% identified their race as 
Caucasian. For 32% of the sample, the highest grade completed was high school. More 
than half of the study population (57%) had never been married.  Fifty-five percent of the 
sample was currently employed, though the average yearly income was relatively low 
with half of the sample making an average income of less than $19,999 per year.  
Smoking information. Smoking characteristics of the sample are shown in Table 
2. Participants, on average, reported that they smoked 23 cigarettes per day (SD = 7.93), 
for an average of 22 years (SD = 10.72).  On average, participants tried to quit smoking 5 
times (SD = 15.76) in their lives and reported their longest quit attempt to last on average 
3 days (SD = 2.79).  The mean Fagerstrom score was 8.48 (SD = 1.8) which indicates that 
the study population had a very high addiction to nicotine. The average CO reading was 
12.89 (SD= 7.73), a level that is consistent with “regular smokers”. In addition to 
collecting data about smoking habits, general health information was collected. In this 
sample, 13 participants (30%) reported exercising on a regular basis and three 
participants (6.8%) reported following a special diet. Thirty-four participants (77.2%) 
endorsed drinking at least 1-3 servings of coffee per day, and two reported drinking 
alcohol daily (4.5%). Of those participants who reported drinking alcohol in the past year, 
24 (66.7%) reported that they always smoke more while they are drinking.  Twelve 
participants (27.3%) reported drinking alcohol in the 72 hours prior to participating in the 
study and one participant (2.3%) reported using illicit drugs in the 72 hours prior to the 
study. 
Preliminary Analysis 
Equality of groups.  Participants were counterbalanced to the condition groups by 
 FTND score, CES-D score and gender. For counterbalancing, the FTND scores were 
dichotomized, by high scores (a score of 9 or above) and low scores. The CES-D scale 
was also dichotomized into high and low variables, with high CES-D equaling scores 
greater than eight. Based on this counterbalancing method, no females with low CES-D 
scores and high FTND scores were randomized to a condition. Separate one-way 
ANOVAs were conducted to determine if the groups were equivalent with respect to their 
nicotine dependence and depression. Chi-square analysis was run to determine if the 
gender was equally distributed between the groups. Results indicated that random 
assignment to condition was successful in producing groups that did not differ on these 
three variables.   
Chi-square analyses were performed to investigate potential differences across the 
three study conditions on demographic variables.  Results indicated that no group 
differences emerged for representation of gender, race, education attainment, marital 
status, or household income, but significant differences did emerge for employment 
status (χ2 (2) = 14.64, p < .05), with more employed participants assigned to the CBT and 
HCCC condition in comparison to the ACT condition.  Separate analyses were conducted 
using a covariate of employment status. No differences in the results from these analyses 
and those conducted without the covariate were detected. All analyses reported are the 
results of the analyses that did not include the covariate. 
To determine whether the conditions differed with respect to variables related to 
the severity of participants’ smoking habits, one-way ANOVAs were conducted on 
number of cigarettes smoked per day, FTND scores, CO reading, number of failed quit 
attempts, and longest quit attempt in the past 10 years. The three groups did not 
 significantly differ on the majority of indicators of smoking severity. However, a one-
way ANOVA indicated that the groups differed with respect to the number of years that 
participants had smoked (F (2, 41) = 3.90, p <. 05).  Tukey post-hoc tests indicated that 
the participants in the HCCC condition (M = 27.36, SD = 11.96) reported having smoked 
a significantly higher number of years than the participants in the CBT condition (M = 
16.93, SD = 9.15, p < .05). The difference between the participants in the HCCC 
condition and those in the CBT condition on length of smoking was taken into 
consideration when performing the primary analyses, length of smoking was covaried 
when ANOVAs were conducted. No differences between the analyses that covaried for 
length of time smoking and the analysis that did not covary for this variable were 
detected. Therefore, all the following analyses reported do not include the covariance. 
Pre-intervention self report measures. Participants completed a battery of self 
report measures prior to receiving the brief intervention. The battery of measures was 
designed to assess mood symptoms, anxiety symptoms (including anxiety sensitivity), 
emotional avoidance, and avoidance toward internal experiences related to smoking. 
These measures included the CES-D, PHLMS, DERS, WISDM tolerance subscale, ASI, 
AIS and AAQ. The means and standard deviations of each measure are presented in 
Table 3.  A series of one-way ANOVAs were conducted on these measures to evaluate 
potential between-group differences.  Results indicated no significant differences on any 
of the self-report measures.  
Descriptive analyses. The scores on the pre-intervention self-reported measures 
were correlated with the main outcome measures. The dysphoria scores after the 
completion of the mirror task were significantly correlated positively with the ASI and 
 DERs, and negatively correlated with the PHLMS awareness scale (r = .350, .321, -.335, 
p< .05 respectively). The PHLMS acceptance subscale was significantly positively 
correlated with dysphoria at pre and post breath holding challenge ( r = .433, .466, 
p<.05). The PHLMS awareness scale was significantly negatively correlated with latency 
to smoke (r = -.340, p <. 05). There was also a significant relationship between the scores 
on the CES-D and the time to termination on the mirror task (r = .356, p < .05). 
Manipulation checks. 
 Primary manipulation checks.  In order to investigate the effectiveness of 
manipulations, two manipulation checks were conducted.  First, data from participants’ 
quiz responses at the completion of the 30-minute interventions were examined.  Half of 
the participants in the study answered all of the 6 questions correctly and only one 
participant answered less than half of the questions correctly. A one-way ANOVA 
comparing the number of correct responses for each condition revealed significant 
differences across conditions (F(2,41) = 4.16, p < .05). Tukey’s post-hoc tests indicated 
that participants in the HCCC condition (M = 5.79, SD = 0.43) scored significantly higher 
on the quiz relative to participants in the ACT condition (M = 4.93, SD = 1.1, p  <  .05). 
No significant differences were detected between the CBT condition (M = 5.27, SD = 
0.70) and either of the two other conditions. 
A second manipulation check was performed to assess whether during the 
challenges participants utilized the strategies specific to the intervention to which they 
had been assigned, and refrained from using strategies specific to the interventions to 
which they were not assigned.  At the conclusion of the experiment, participants were 
asked to rate the extent to which they had used such strategies. There were 12 question in 
 which the participants were asked to rate the extent to which they used these strategies on 
a scale from 0 (very little) to 4 (very much). Two scores were derived from this 
questionnaire in order to perform the manipulation check: (a) a mean score reflecting the 
use of strategies specific to the assigned intervention, and (b) a mean score reflecting the 
use of strategies specific to the interventions to which a participant had not been 
assigned.  Over half (52.3%) of participants reported, on average, having used at least 
“some” of the strategies discussed in the intervention to which they had been assigned, 
whereas 27% of the participants reported, on average, using at least “some” of the 
strategies discussed in the interventions they did not receive.  
 To test whether participants utilized the strategies specific to the intervention they 
had received to a greater extent than the interventions they did not receive, a 2 (Scores: 
on assigned intervention, on non-assigned intervention) X 3 (Condition: ACT, CBT, 
HCCC) mixed model ANOVA was conducted. Results indicated a main effect of score 
(F (1, 41) = 4.25, p < .05).  Participants endorsed using the strategies specific to their 
intervention significantly more than they used strategies specific to the other intervention 
(p < .05). A t-test was conducted to determine whether participants in the ACT condition 
reported significantly higher scores in rating the use of the strategies specific to the ACT 
intervention compared to the interventions that were not viewed. A significant difference 
was detected; participants in the ACT condition reported using strategies specific to the 
ACT condition significantly more than using strategies from the other conditions (t (14) = 
2.91, p < .01). For participants in the CBT condition, a t-test likewise revealed significant 
findings for the ratings of strategies specific to the CBT intervention compared to the 
other interventions not viewed (t (14) = 2.14, p < .05). No differences were detected for 
 the HCCC condition. These results indicate that, as expected, participants were actively 
using the strategies discussed in the active conditions, though not in the control 
comparison condition.  
In order to address whether participants in the active conditions (ACT and CBT) 
elicited equivalent ratings in the use of strategies specific to the assigned intervention, 
two independent sample t-tests were conducted. The first t-test was run to determine if 
the participants in the active conditions (ACT and CBT) elicited equivalent ratings in the 
use of the strategies discussed in the viewed intervention. No significant differences were 
detected between the groups. The second t-test was conducted to compare ACT to CBT 
for rating the strategies discussed in the interventions that were not viewed. Again, there 
were no significant differences between the active conditions.  This suggests that the 
active conditions were equally effective in fostering use of their prescribed strategies, 
since there was no difference between the conditions in the rating of use. 
Primary Analyses. 
Several analyses were conducted to test participants’ reactivity to experimental 
procedures.  Reactivity was measured with self reported anxiety, irritability, difficulty 
concentrating, bodily discomfort and urge to smoke. Participants’ ability to engage in 
activities that produced distress was measured by the length of time the participants were 
able to remain engaged in the breath holding, PASAT and mirror tracing task before 
terminating these procedures. Participants’ accuracy on the tasks (PASAT and mirror 
tracing task) were also measured and compared between conditions. In addition, 
reactivity to the challenges was measured by changes in heart rate and skin conductance. 
Further analyses were conducted to examine differences between the active conditions 
 (ACT and CBT) and the comparison condition (HCCC) 1.  
Self-reported measures: Composite scores were constructed for several of the 
self-reported ratings including anxiety, irritability, difficulty concentrating, and bodily 
discomfort in order to reduce data in situations in which the shared variance between the 
measures approached very high levels of intercorrelations (i.e., r = .48 or greater). The 
ratings on these scales were combined to form a Dysphoria Scale, which was shown to be 
reliable (e.g., the four subscale ratings pre and post the PASAT challenge had a 
Cronbach’s alpha of .87 and .84 respectively). Due to the fact that the levels of 
intercorrelations between the ratings of “urge to smoke” and the other ratings included in 
the Dysphoria Scale were not high (r ranges from .06 -.33 ), the scores on the urge to 
smoke scale were independently evaluated. A mixed model 2 (Phase: pre-challenge, post-
challenge) X 3 (Challenge: breath holding, mirror tracing task, PASAT) X 3 (Condition: 
ACT, CBT, HCCC) ANOVA was conducted, with Phase and Challenge as repeated 
measures factors and Condition as a between-participants factor.  Results indicated a 
main effect of Phase, such that dysphoria decreased significantly from pre-challenge (M= 
34.57, SD = 24.07) to post-challenge (M = 28.80, SD = 20.54), F(1,30) = 6.62, p <.05, 
though the levels of dysphoria increased for both the psychological challenges. The 
inconsistency between the levels of dysphoria for the psychological and physiological 
challenges may reflect the psychological nature of the ratings included in the dysphoria  
________________________________________________________________________ 
1All of the analysis mentioned below examining the reactivity to the experimental 
procedures were also conducted between the active conditions (ACT and CBT) and 
compared to the comparison condition (HCCC). No significant differences between the 
two groups were detected for any of the measurements of reactivity to the experimental 
procedures.  
 
 scale. In addition, it is hypothesized that the dysphoria levels may have decreased after 
the breath holding task because there were no lingering physical distress after the 
discontinuing the breath holding. There was also a main effect of Challenge, (F (2, 29)= 
7.24, p < .01). Specifically, Tukey’s post hoc analyses indicated that the PASAT induced 
significantly more dysphoria (see Figure 1) than did the Mirror Tracing Task (F (2,29) = 
7.24, p < .01; as shown in Figure 2) and the Breath Holding Task (F (2,29) = 7.24, p < 
.01; as shown in Figure 3). The reactivity, as measured by the self report measures are 
shown in Table 4. A similar mixed model 2 (Phase: pre-challenge, post-challenge) X 3 
(Challenge: breath holding, mirror task, PASAT) X 3 (Condition: ACT, CBT, HCCC) 
ANOVA was conducted for the “urge to smoke” variable.  No significant main effects or 
interaction terms emerged.   
Performance and persistence: Analyses were also conducted to examine the effect 
of condition on participants’ ability to tolerate frustration and to persist despite 
discomfort. Participants’ time to terminate on the three frustration inducing tasks (breath 
holding, PASAT, Mirror Tracing task) were standardized (to account for different scales 
of time measurement) and a 3 (Condition: ACT, CBT, HCCC) X 3 (Task: breath holding, 
PASAT, Mirror Tracing task) mixed model ANOVA, with condition as a between-
subjects factor and Task as a within subject factor, was run on these standardized scores. 
As shown in Table 5, no significant differences between conditions were detected among 
the three challenges.  
Since the distribution of time to termination on the PASAT and mirror tracing 
task was significantly truncated with 48% of the participants not terminating the PASAT 
during the 10-minute experimental period and 25% not terminating the mirror tracing 
 task before the 5-minute experimental period, the time to termination on the two tasks 
were coded dichotomously. The PASAT and mirror tracing task variables were recoded 
as early termination and completers.  Based on chi-square results, no differences emerged 
between conditions on ability to persist at the PASAT task until task termination. 
Similarly, no differences between the conditions were detected for the ability to persist at 
the mirror tracing task. Results of these chi-square tests are consistent with the results for 
the 3 x 3 mixed model ANOVA examining the time to termination for the PASAT and 
mirror tracing task.   
In addition to examining participants’ persistence on the challenges, accuracy of 
performance on the psychological tasks was calculated. Specifically, the effect of 
Condition (ACT, CBT, HCCC) on (a) the number of errors committed on the mirror 
tracing task and (b) the total score on the PASAT were examined using two independent 
one-way ANOVAs. No significant differences between conditions emerged on either 
performance accuracy measurement. 
Physiology reactivity analysis:  Participants’ heart rate and skin conductance were 
measured at baseline, during the PASAT challenge, during the mirror task, and during the 
breath holding task (see Table 6). For each period in which heart rate and skin 
conductance data were measured, a mean response was calculated.  Physiological data 
were collected for only a portion of the sample due to equipment difficulties. 2 The order  
______________________________________________________________________  
2 The baseline reading of heart rate and skin conductance was collected for 26 and 17 
participants, respectively. During the PASAT challenge, heart rate and skin conductance 
was measured for 25 and 14 participants, respectively. For the mirror task, heart rate and 
skin conductance was collected for 25 and 13 participants, respectively and during the 
breath holding task heart rate and skin conductance was measured for one and two 
participants respectively. 
  
in which the challenges were presented to the participants was counterbalanced; 15 
participants were counterbalanced to receive the challenges in the order of the PASAT 
first, the Mirror task second and Breath holding task last. Of these 15 participants, the 
physiological data was collected on 10 participants. Thirteen participants were 
counterbalanced to receive the order of Mirror task first, Breath holding task second and 
the PASAT third. Of those randomized to that order, physiological data was collected on 
10 of them. Sixteen participants completed the tasks in the order of Breath holding task 
first, PASAT second and Mirror task third and physiological data was collected on 11 of 
the participants.   
To ensure that the baseline physiological response was equal between the three 
groups, two separate one-way ANOVAs were conducted.  No significant findings were 
detected between the three conditions for neither heart rate nor skin conductance. To 
determine physiological reactivity to the challenges, the mean baseline physiological 
response was compared to the mean physiological response for the PASAT task and the 
Mirror task. Changes in physiological response from baseline to the breath holding task 
were not calculated due to the insufficient data for the breath holding task (n = 2). 
ANOVAs were conducted to test the hypothesis that there would be group difference in 
changes in physiological reactivity.  A 3 (Phase: baseline, PASAT, Mirror task) X 3 
(Condition: ACT, CBT, HCCC) mixed model ANOVA was conducted on heart rate data.  
As shown in Figure 4, results indicated that no effects of Phase or Condition emerged.  A 
separate 3 (Phase: baseline, PASAT, Mirror task) X 3 (Condition: ACT, CBT, HCCC) 
mixed model ANOVA was conducted on skin conductance data.  Similarly, no effects 
involving Phase or Condition emerged (see Figure 5). Because a significant trend in 
 Phase was detected, post-hoc analyses were run.  Significant differences were detected in 
the skin conductance between baseline (M = 4.40, SD = 3.97) and the PASAT (M = 10. 
56, SD = 9.97) challenge (t (12) = -3.04, p <.05) and between baseline (M = 4.40, SD = 
3.97) and the mirror task (M = 9.05, SD = 9.71) (t (12) = -3.03, p <.05). The response in 
heart rate did not significantly differ between baseline measurements and the challenges.  
Latency to smoke. Given that the distribution of latency to smoke was 
significantly truncated because the majority of participants (85%) opted to smoke 
immediately, the latency to smoke was coded dichotomously, smoking immediately 
versus waiting until later.  To test the hypotheses that participants in the ACT condition 
would abstain from cigarette smoking until the end of the study relative to the other two 
conditions, a chi-square test was conducted. No significant differences between the 
conditions on smoking immediately were detected. 
In summary, the challenges significantly induced distress in the sample as shown 
by the increase in baseline-to-task in the self-reported Dysphoria Scale and the skin 
conductance. However, no significant differences were detected between the conditions 
on reactivity to the experimental conditions as measured by self-report, performance on 
the challenges, and physiological response to the challenges. In addition, a chi-square 
analysis failed to detect a significant difference between the conditions and latency to 
smoke.  
Usefulness of Training. Participants rated how valuable the training was in 
handling the challenges, how useful they thought the training would be in tolerating the 
challenges, and how well they thought they were able to regulate their emotional 
response to the challenges. Three separate one-way ANOVAs were conducted to 
 determine if significant differences existed between the three groups for each of these 
ratings. No differences were detected. 
 CHAPTER 4: DISCUSSION 
 The current study was an experimental analog trial that investigated the 
effectiveness of brief video interventions on distress tolerance levels for early lapsing 
smokers. The study recruited individuals with high levels of nicotine dependence and an 
inability to maintain abstinence from nicotine for more than one week in the past decade, 
a population of smokers that has been identified as having lower levels of tolerance to 
distress. The brief video interventions consisted of strategies derived from Acceptance 
and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT). These 
interventions were compared to a health consequence comparison condition (HCCC) that 
included facts regarding the health consequences of smoking. After completion of the 
brief interventions, participants were exposed to challenges known to induce distress that 
mimicked some of the psychological nicotine withdrawal symptoms. The participants’ 
ability to tolerate the distress and continue with the challenges was measured with 
multimodal dependent variables including self-report, physiological response, and 
persistence and accuracy on the challenges. Results suggested that the participants 
experienced a significant increase in distress during the challenges, though the three brief 
interventions demonstrated an equal impact on the participants’ ability to tolerate the 
distress and persist with the challenges. Few studies have examined the distress tolerance 
levels of early lapsing smokers, and even fewer studies have examined the impact that an 
intervention targeting distress tolerance has on this populations’ tolerance levels and 
behavior. Therefore, the results of this study should be examined in relation to the other 
studies of distress tolerance in early lapsing smokers. 
 
 Distress Tolerance. 
It was hypothesized that participants randomized to the acceptance-based 
condition (ACT) would demonstrate increased distress tolerance when exposed to 
psychological and physiological challenges compared to a control-based condition (CBT) 
and the health consequence comparison condition (HCCC). It was further hypothesized 
that the control-based condition would demonstrate increased distress tolerance when 
compared to the health consequence comparison condition.  In general, these hypotheses 
were not supported by the findings from this study. In addition, no differences were 
detected on any of the reactivity measures to the experimental procedures between the 
active interventions (ACT and CBT) when compared to the comparison condition 
(HCCC).  
Based on the participants’ accuracy on the quiz following the assigned 
intervention, there was reason to believe that participants received and understood the 
strategies embedded in each of the interventions. The scores on the quiz for participants 
that viewed the CBT intervention were not significantly different from the ACT or 
HCCC scores.  However, the heightened scores on the quiz for the HCCC condition 
compared to the ACT condition suggested that there were differences in the material of 
the given intervention. The HCCC was created as an attention placebo condition and 
included simple, straight-forward material whereas the ACT intervention introduced 
strategies to the participants that were very unfamiliar. In addition, the concepts discussed 
in the ACT intervention may have required the participant to be more flexible in their 
thinking and practice strategies that they were less comfortable with, which may have 
impacted their understanding of the material and the retention of the strategies. If this was 
 the case, this would actually support the idea that the strategies of early lapsing smokers 
were familiar with this material (i.e., reminding themselves the health consequences of 
smoking prior to lighting up a cigarette) and were not useful in changing smoking 
behavior.  The strategies derived from ACT may have been very novel and not 
intrinsically applied without specific training.  
In addition to participants grasping the material discussed in the interventions, 
there was evidence that supported that “cross pollination” did not occur.  The responses 
on the manipulation checks indicated that the participants were not using strategies that 
were in the interventions that they did not view.   
Furthermore, the participants’ experienced increased distress during the 
challenges. Therefore the lack of significant findings can not be attributed to a lack of 
distress. In particular, changes in participants’ self-reported dysphoria, during the 
psychological challenges and physiological reactive, as measured by skin conductance, 
were detected for the study sample. The consistency in the lack of significant findings 
across multi-modal assessments suggests that a type II statistical error did not occur.  
Moreover, the small effect-sizes which were calculated for the primary analysis indicated 
that the interventions had an equal impact on the distress tolerance levels.  
The results indicated no differences in the three interventions in terms of 
participants’ distress tolerance and ability to abstain from smoking during the break in the 
experimental procedures. In addition, when the active treatments were compared to the 
control treatment, no differences were detected. Since differences between the active 
interventions (ACT and CBT) and the attention placebo condition (HCCC) were 
anticipated, a no treatment condition was not included in the design of the study. 
 Unfortunately, the absence of a no treatment condition precluded determination of 
whether all three interventions impacted the distress tolerance levels equally, or if none of 
them did at all. 
A number of correlations were run to examine the relationship between the 
outcome measures and the baseline self reported psychological distress, emotional 
avoidance and avoidance toward internal experiences. No meaningful pattern emerged 
from the analyses, though one finding was worth noting. Participants’ scores on the 
PHLMS awareness scale were significantly negatively correlated with latency to smoke, 
which suggests that individuals with increased awareness were more likely to have 
difficulty abstaining from smoking.   
Even though the findings from the current study were not expected to have as 
robust results as the Gifford smoking cessation treatment outcome study on smoking 
behavior, it was expected that even a small dose of the distress tolerance intervention 
derived from the acceptance and commitment therapy would impact smokers’ distress 
tolerance for nicotine like withdrawal symptoms. In addition to the differences in the 
“dose” of intervention, there are several other significant differences among the study 
populations that may account for the inconsistent findings.  Gifford recruited smokers 
who were motivated to quit smoking whereas the current study recruited early lapsing 
smokers, a population recognized for having lower distress tolerance levels (Brown et al., 
2002). In addition, the smokers included in the current study did not have specific 
interests to quit smoking. Last, the current study recruited participants who may not have 
had intrinsic motivation to apply the strategies discussed in the intervention or 
willingness to change their behavior. 
 Brown and colleagues (in press) examined a multicomponent distress tolerance 
smoking cessation treatment for early lapsing smokers in a pilot study. This study 
supported the effectiveness of acceptance-based interventions targeting distress tolerance 
on the impact of early lapsing smokers’ ability to tolerate the distress associated with 
quitting smoking, as evidence of prolonged quit attempts.  Because the distress tolerance 
treatment was in the stages of development, this pilot study did not include a comparison 
condition, though when participants’ abstinence rates were compared to their past history, 
participants achieved longer days of continuous abstinence and non-continuous days of 
abstinence (3 days as compared to 24 days, and 40.5 days respectively).  Brown and 
colleagues attributed greater length of abstinence from cigarettes, in part, to an increase 
in distress tolerance (Brown et al., in press).  In addition to the differences noted between 
the current study and Gifford’s study, there were also parallel differences between 
Brown’s study and the current study, mainly the dose of treatment and the motivation to 
change behavior. Interestingly enough, Brown and colleagues’ distress tolerance study 
included participants with elevated levels of depression, with the average score on the 
CES-D indicting mild to moderate depressive symptoms, which the current study 
excluded.  Brown and colleagues could argue that the intervention not only increased 
levels of tolerance for the psychological aspects of withdrawal symptoms (i.e., irritability, 
agitations etc.), but, in addition, the distress tolerance was generalized to psychological 
distress, including symptoms of depression or anxiety. However, it remains unclear how 
symptoms of depression interact with smoking outcomes. It could be possible that 
distress tolerance impacts tolerance of depressive symptoms which effects outcome 
measures across time which were not measured in this study sample, since participants 
 with elevated CES-D scores were excluded from the study.  
The inconsistencies between Gifford’s study and Brown’s study with the current 
study could also be attributed to the efficacy of the particular strategies selected to be 
included in the 30-minute intervention. The differences could also be related to the 
delivery of the treatment. The developers of both CBT and ACT and the clinicians that 
practice these interventions emphasize the importance of the relationship between the 
provider and the treatment participant (which was likely lost in the video presentation). 
The therapeutic relationship is generally considered to be an essential part of these 
intervention programs.  In developing the pilot study for distress tolerance for early 
lapsing smokers, Brown and colleagues incorporated individual sessions for the 
participants in the early stages of treatment, in part to develop a relationship with the 
participant which was then proved to enhance treatment engagement (Brown et al., in 
press). 
 Hayes and colleagues (Hayes et al., 1999) examined the effects of acceptance-
based versus control-based rationales on pain tolerance, as measured by the cold pressor 
task. In this study participants that were randomized to receive 90-minute individual 
acceptance-based intervention demonstrated greater tolerance of pain when compared to 
participants randomized to the 90-minute control-based intervention. The findings from 
the current study did not support the results from the Hayes and colleague study, though 
notable differences in the study population could contribute to the inconsistent results. 
Hayes and colleagues study population included university students, arguably a 
population that has a wider variability in distress tolerance levels when compared to early 
lapsing smokers’ distress tolerance levels, a population that has been identified as having 
 particularly low levels of baseline distress tolerance.  In addition, the interventions in the 
Hayes and colleague study were administered in person for 90-minutes, three times the 
length of the interventions in the current study.  As with the previous research mentioned 
conducted by Gifford and Brown and colleagues, the delivery of the acceptance-based 
interventions by a clinician may make a substantial difference in the receiving and 
experiencing concepts within the interventions.  
It was also hypothesized that participants in the acceptance-based condition would 
abstain from cigarette smoking for a longer period of time relative to the participants in 
the control-based condition and to the participants in the health consequence comparison 
condition. In addition, it was hypothesized that participants in the control-based condition 
would abstain from smoking longer than the participants in the health consequence 
comparison condition. No support was found for either of these hypotheses.  
With 85% of the study population opting to immediately terminate latency to 
smoke, there was limited variability in this outcome measure. Prior to the data collection, 
concerns regarding truncation of this outcome variable were discussed. In particular, it 
was thought that the majority of participants would stay the entire hour due to character 
demands of the staff. In part, the limited latency to smoke in the study sample provided 
more evidence that the distress tolerance levels were very low for this population and the 
ability to abstain from smoking for short periods of time was difficult.  
Brown and colleagues’ previous work (Brown et al. 2001) examined quit rates for 
smokers with a history of early lapse receiving distress tolerance treatment. This study 
found that 37% lapsed on quit day. The study population in the current study had no 
intention of quitting smoking and received a very small dose of intervention in 
 comparison to participants enrolled in the Brown and colleague behavioral smoking 
cessation treatment.  When the lack of significant findings from the current study were 
considered in this context, it was not surprising to see the results that the majority of early 
lapsing smokers, with no intention of quitting, were unable to abstain from smoking after 
the completion of the three challenges.  
 Finally, it was hypothesized that participants in the acceptance-based condition 
would identify the intervention as more valuable and useful when compared to the 
participants in the control-based condition and the attention-placebo condition.  No 
support for this hypothesis was found.  
 The results on the participant ratings of value and usefulness of the ACT 
treatment in the current study were inconsistent with previous studies examining 
acceptance-based treatment for smoking cessation as well as acceptance-based treatment 
for other psychological disorders. For example, Gifford and colleagues measured 
participants’ level of satisfaction for the treatment and quality of relationship with the 
treatment provider. These findings supported that participants who experienced 
successful outcomes were significantly more satisfied with treatment in the ACT 
condition compared to the NRT condition on the Client Satisfaction Questionnaire. Also, 
participants randomized to the ACT condition reported better relationships with their 
treatment provider when compared to the participants randomized to the NRT condition, 
as measured by the Working Alliance Inventory.  
 In addition, preliminary findings from the treatment development phase for 
Brown and colleagues’ novel distress tolerance treatment for early lapsing smokers 
indicated participant satisfaction for this treatment. In particular, of the participants that 
 completed the treatment rated high levels of usefulness for the treatment, 82% indicated 
that the specific skills learned in the programs were “very” or “extremely useful” in 
helping them quit smoking.  
 In the study conducted by Hayes and colleagues examining the impact of 
acceptance versus control rationales on pain tolerance, participants were asked to rate 
how valuable the training was in handling the pain associated with the cold pressor task 
and usefulness the participant believed the training would be in completing the cold 
pressor task. No significant differences were noted between the group of participants that 
received the 90-minute individual acceptance-based rationale compared to the control-
based rationale or the attention placebo rationale.  The lack of differences between groups 
on ratings assessing value and usefulness in the Hayes et al. study was consistent with the 
findings in the current study, though inconsistent with the previous research of Gifford 
and colleagues and Brown and colleagues. One plausible explanation to consider is that 
when individuals apply strategies to meaningful behaviors (i.e., quitting smoking) as 
opposed to experimenter applied behaviors (i.e., persisting at a computer task or 
submerging a hand in cold water); the participants may conceptualize the value or 
usefulness of the strategies very differently.  
Limitations. 
 The current study possesses several strengths, including examination of an 
understudied population in a controlled environment, randomization to the conditions, 
use of multimodal measures, use of standardized assessment measures and diversity of 
sample demographics. However, the study has several limitations which should be noted 
when interpreting the results. The limitations include the following: small sample size, 
 technical difficulties with the physiological equipment, reliance on self reported drug use, 
varying experience with computers, and non-blind study personnel.   
 Despite extensive recruiting efforts and a large response rate, less than 8 % of the 
participants interested in the study met the study criteria. Only 44 participants were 
randomized to the study conditions which limited the statistical power. A priori power 
analysis was based on an assumed moderate effect size between the intervention 
conditions and when the effect sizes were calculated for the primary hypothesis, very 
small effect sizes were detected. Therefore, it was decided to terminate the study 
prematurely since clinical significance was limited. 
 Furthermore, numerous technical difficulties occurred in measuring the 
physiological reactivity of the participants which limited the power to detect differences 
between the conditions. As of recent, significant difficulties reading the skin conductance 
of African-American participants has been noted, with African-American participants 
demonstrating significantly lower response by exhibiting an average skin conductance 
score below 3.0 μ which is believed to be related to differences in physiology between 
the participant’s race, potentially including sweat gland activity, skin thickness, and skin 
pigmentation (Basden et al.,2007). In addition, few readings of the physiological 
reactivity during the breath holding task were collected, in part due to the location of the 
physiology equipment and short duration of the breath holding task. Regardless of the 
limited power, differences in physiological reactivity were detected across the phase 
(time) and between challenges.  
 Another potential limitation was relying on self-reported illicit drug use for 72 
hours prior to participation and one week prior to participation of opiate-based pain 
 medication.  Due to the lack of biological markers of drug use, the participant’s accuracy 
in reporting drug use was unknown.  However it is important to note that since the study 
did include random assignment to the conditions, participants that reported not using but 
were actually using illicit drugs or opiate pain medication in the week prior to 
participation, should have been equally distributed between the conditions.   
 Participants varied drastically in their abilities to use a computer mouse. Two 
participants had such difficulties using a mouse that they were unable to accurately report 
their dysphoria or urge to smoke at the beginning of the psychological challenges on the 
computer. Both participants did not terminate the challenge, and since they were not 
engaged in the challenge their physiological reactivity may not have been capturing their 
“distress tolerance”. Therefore the data for these participants were removed for the 
primary analyses. Although these two participants were identified because their computer 
abilities were so limited, other participants with limited computer skills may have been 
included in the main analyses. Therefore the conceptualization of the participant 
persisting at the challenge despite distress may not have been occurring if the participant 
was not engaged in the activity enough to experience distress. The nature of random 
assignment would have equally distributed these participants between the conditions. 
 Finally, another limitation of this study was the lack of blind study personnel.  
The study personnel’s knowledge of the treatment condition may have influenced the 
participants’ self-reported ratings, performance on the challenges, latency to smoke and 
reported valued and usefulness of the intervention received. Since a multi-modal 
assessment approach was taken, (i.e. utilizing self-report measures, physiological 
reactivity, and behavioral measures in the form of accuracy and persistence) the impact of 
 the study personnel on the outcome variables was limited. Regardless, no significant 
findings were detected between groups so if study personnel did influence performance, 
it did not have a significant impact.  
Directions for Future Research. 
Given the health consequences of continued smoking and the more recent slowing 
of reduction in quit rates, continuing research to further identify underlying factors that 
maintain smoking behaviors is more important than ever. Brown and colleagues’ 
examination of early lapsing smokers has led to a comprehensive conceptualization of 
this high risk population. In particular, Brown has identified distress tolerance as a core 
factor and hence refined treatment interventions targeting distress tolerance. Though, 
relatively few studies have examined intervention that attempt to directly alter smokers’ 
ability to increase distress tolerance.  
 The majority of research to date indicates that people believe that the treatments 
targeting distress tolerance, including acceptance-based interventions like ACT, in 
general, are useful and valuable. In addition, evidence supports that a wide range of 
individuals grasp the concepts of acceptance-based treatments and are able to apply the 
core concepts of acceptance to their smoking behaviors. Even though the current study 
did not support an impact of acceptance-based intervention on distress tolerance levels or 
smoking behaviors, the studies that have examined distress tolerance treatments for 
smoking cessation suggest that acceptance-based treatments are effective in increasing 
distress tolerance which therefore increases smokers’ ability to abstain from smoking.
 Although both Gifford and colleagues and Brown and colleagues smoking 
cessations studies have significantly contributed to the conceptualization of smoking and 
 treatment options, the combination of the individual and group smoking cessation 
treatment is limiting. This line of research could be advanced by continuing to examine 
distress tolerance in an analog laboratory setting delivering the strategies to the early 
lapsing smokers in person for a longer session. Also since it is speculated that the 
participants enrolled in the current study had little intrinsic incentive to apply the 
strategies to their behaviors, recruiting participants that are interested in quitting smoking 
may increase the motivation to apply the strategies discussed in the interventions. Within 
each of the interventions, the participants were instructed how to specifically apply the 
strategies discussed in the intervention during psychological and physiological 
challenges. In future studies examining similar strategies, including time to practice 
applying the strategies in the intervention with the provider while experiencing 
psychological or physiological discomfort may strengthen the participants understanding 
of the application of the strategies. 
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  Table 1  
Demographic Characteristics of the Sample 
________________________________________________________________________ 
 
Characteristic   Total Sample ACT  CBT  HCCC 
                                       (n = 44) (n = 15) (n = 15) (n = 14) 
________________________________________________________________________ 
Sex 
   Male    66 % (29) 67 % (10) 67 % (10) 64.% (9) 
   Female   34 % (15) 33 % (5) 33 % (5) 36 % (5) 
 
Race 
  Caucasian   61 % (27) 67 % (10) 47 % (7) 71 % (10) 
   African-American  32 % (14) 20 % (3) 47 % (7) 29 % (4) 
   Hispanic   5 % (2) 7 % (1) 7 % (1) 0 % 
   Other   2 % (1) 7 % (1) 0 %  0 %  
 
Education 
   Some H.S.   14 % (6) 20 % (3) 7 % (1) 14 % (2) 
   H.S. diploma/GED  32 % (14) 33 % (5) 40 % (6) 21 % (3) 
   Some college  36 % (16) 33 % (5) 40 % (6) 36 % (5) 
   College Degree  16 % (7) 13 % (I2) 14 % (2) 21 % (3) 
   Master’s Degree  2 % (1) 0 %  0 %  7 % (1) 
 
Marital Status 
   Never married  57 % (25) 53 % (8) 53 % (8) 64 % (9) 
   Married   5 % (2) 7 % (1) 7 % (1) 0 % 
   Divorced   18 % (8) 13 % (2) 13 % (2) 29 % (4) 
   Separated   2 % (1) 7 % (1) 0 %  0 % 
   Widowed   2 % (1) 0 %  7 % (1)  0 % 
   Engaged   5 % (2) 7 % (1) 7 % (1) 0 % 
   Living together  11 % (5) 13 % (2) 13 % (2) 7 % (1) 
 
Employment 
   Employed   55 % (24) 27 % (4) 67 % (10) 71 % (10) 
   Unemployed   43 % (19) 73 % (11) 33 % (5) 21 % (3) 
   Missing   2 % (1) 0 %  0 %  7 % (1) 
 
Family Income 
   0-9,999/yr   14 % (7) 13 % (2) 13 % (2) 21 % (3) 
   10-19,999   32% (14) 27 % (4) 33% (5) 36 % (5) 
   20-29,999   14 % (6) 13 % (2) 27 % (4) 0 % 
   30-39,999   12 % (5) 13 % (2) 7 % (1) 14 % (2) 
   40-49,999   11 % (5) 7 % (1) 7 % (1) 21 % (3) 
   >50,000   11% (5) 20% (3) 7% (1)  7% (1) 
   Missing   5 % (2) 7 % (1) 7 % (1) 0%  
 Table 2 
Smoking Characteristics of the Sample: Means (Standard Deviations) 
________________________________________________________________________ 
 
Characteristic   Total Sample ACT  CBT  HCCC 
                                       (n = 44) (n = 15) (n = 15) (n = 14) 
________________________________________________________________________ 
 
Number of Cigarette  22.7 (7.9) 23.6 (7.6) 21.2 (5.3) 23.2 (10.6) 
    
Years of Smoking  21.8 (10.7) 21.4 (12.0) 16.9 (9.2) 27.4 (8.7) 
 
Number of Quit Attempts 5.0 (15.8) 10.4 (25.9) 1.6 (1.5) 2.4 (1.7) 
 
Fagerstrom Score  8.5 (1.8) 8.7 (2.2) 8.6 (1.6) 8.1 (1.7) 
 
CO Reading   12.9 (7.7) 11.5 (7.3) 13.2 (7.4) 14.0 (8.8) 
 
 
 Table 3 
Baseline Means (Standard Deviations) for Self Report Measures 
________________________________________________________________________ 
 
Characteristic   Total Sample ACT  CBT  HCCC 
                                       (n = 44) (n = 15) (n = 15) (n = 14) 
________________________________________________________________________ 
 
CES-D       8.38 (5.75)        7.13 (4.60)         9.79 (6.60)         8.31 (6.06) 
 
ASI      18.84 (11.29)      22.40 (13.02)     14.27 (8.80)       19.93 (10.75) 
 
STAI 
     Trait     32.31 (8.04)       31.60 (6.87) 32.13 (8.75) 33.42 (9.02) 
      State     30.19 (6.22)       30.67 (6.08) 30.00 (6.39) 29.85 (6.63) 
 
AIS      42.89 (10.62)     40.07 (10.18)       44.07 (11.65)    44.64 (10.07) 
 
AAQ      34.14 (7.83)        34.73 (8.27)        33.07 (9.18)      34.64 (6.05) 
 
PHLMS 
      Acceptance    30.64 (7.99)         33.85 (8.16)       30.46 (8.92)        27.62 (5.90) 
      Awareness     37.13 (6.77)         38.08 (8.26)        35.54 (5.32)       37.77 (6.72) 
 
DERS      70.95 (18.74)       71.67 (22.83)      68.27 (17.28)     73.07 (16.29) 
________________________________________________________________________ 
 
Note.  CES-D=Center for Epidemiological Studies Depression Scale; ASI=Anxiety 
Sensitivity Index; STAI=State Trait Anxiety Inventory; AIS= The Avoidance and 
Inflexibility Scale; AAQ=The Acceptance and Action Questionnaire; PHLMS=The 
Philadelphia Mindfulness Scale Acceptance and Awareness Subscales; 
DERS=Difficulties in Emotional Regulation Scale.  
 
 
 
 Table 4 
Reactivity to Experimental Procedures Self Report Measures: Means (Standard 
Deviations 
________________________________________________________________________ 
 
Source     ACT       CBT  HCCC 
     (n = 14)      (n = 14)  (n = 14) 
________________________________________________________________________ 
 
Self-report Dysphoria 
 Pre Breath Holding  49 (27.17)      32.76 (20.91) 25.82 (25.17) 
 Post Breath Holding  33.43 (23.27)      28.45 (19.87) 17.65 (13.77) 
 Pre PASAT   19.28 (19.95)      14.00 (13.31) 17.23 (18.92) 
 Post PASAT   44.64 (20.16)      30.98 (19.90) 39.46 (33.68) 
 Pre Mirror Task  30.98 (20.32)      27.03 (19.75) 26.94 (28.48) 
 Post Mirror Task  55.65 (21.88)      35.23 (20.96) 34.22 (30.85) 
 
Self-report Urge to Smoke 
Pre Breath Holding  75.20 (24.72)      67.64 (30.96) 60.07 (30.66) 
 Post Breath Holding  64.14 (31.86)      56.30 (34.90) 50.45 (26.73) 
 Pre Mirror Task  64.69 (33.12)      53.87 (32.54) 60.08 (36.18) 
 Post Mirror Task  73.23 (25.88)      59.40 (34.80) 64.75 (29.39) 
 
  
 
 Table 5 
Reactivity to Experimental Procedures:  Time to Termination Means (Standard 
Deviations) 
________________________________________________________________________ 
 
Source      ACT   CBT   HCCC 
________________________________________________________________________ 
   
   
Breath Holding (sec)    51.60 (24.35) 46.00 (18.77)  49.05 (23.39)  
 
PASAT (sec)     400.36 (238.89) 380.60 (255.03) 334.23 (296.77) 
  
Mirror Task (sec)    213.54 (131.99) 231.60 (151.25) 269.77 (144.97) 
  
Latency to Smoke (sec)   8.57 (21.78) 8.13 (21.06)  4.62 (16.64) 
 
 
 Table 6 
Reactivity to Experimental Procedures: Physiological Response Means (Standard 
Deviations) 
________________________________________________________________________ 
 
Source   ACT   CBT   HCCC 
________________________________________________________________________ 
 
PASAT 
  Heart rate  104.01 (36.74) 95.76 (31.85)  110.84 (27.82) 
  Skin conductance 7.31 (8.71)  8.08 (2.12)  5.75 (4.74) 
 
Mirror task 
  Heart rate  109.08 (37.52) 96.41 (37.84)  100.91 (25.14) 
  Skin conductance 6.55 (5.92)  7.79 (2.42)  5.39 (3.89) 
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Figure 1. Dysphoria change during the PASAT challenge by condition. 
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Figure 2. Change in dysphoria during the mirror task by condition. 
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Figure 3. Dysphoria change during the breath holding task by condition.  
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Figure 4. Change in heart rate by condition. 
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Figure 5. Change in skin conductance by condition.  
 
 
 
 
 
 
 
 
             Appendix A 
FAGERSTROM SCALE 
 
1.  How soon after you wake up do you smoke your first cigarette?  
 Within 5 minutes          
 6 – 30 minutes 
 31- 60 minutes 
 After 60 minutes         
            
2.  Do you find it difficult to refrain from smoking in places where it is forbidden e.g. in 
church, at the library, in cinema, etc.? 
      
 Yes 
 No           
           
3.  Which cigarette would you hate most to give up? 
      
 The first one in the morning  
 All others           
 
4.  How many cigarettes per day do you smoke? 
  
 10 or less  
 11-20 
 21-30 
 31 or more          
  
5.  Do smoke more frequently during the first hours after waking than during the rest of 
the day? 
   
 Yes 
 No            
 
6.  Do you smoke if you are so ill that you are in bed most of the day? 
      
 Yes 
 No            
 
7.  a. What is your usual brand of cigarettes? 
   Brand:           
b. Check off all the following that apply to your brand: 
   
Type: Size: Flavor: Packaging: Filter: 
___Regular ___Kings ___Menthol ___Hard Pack ___Filter 
___Lights ___100’s ___Non-Menthol ___Soft Pack ___Non-Filter 
___Ultra-Lights ___120’s    
               
           Appendix B 
ID#_______                    Date ___/___/____ 
 
SMOKING DEMOGRAPHICS QUESTIONNAIRE 
 
 
For each question below, please circle the number of your answer. 
 
1. Sex:                1 = Male          2 = Female  
2. Date of birth:  _____/_____/_____ 
3. What is your race / ethnic group? 
 
          1 = White 4 = Asian 
          2 = African-American 5 = Other: (please specify below) 
          3 = Hispanic       _______________________ 
  
4. Highest grade completed:  
 
1 = Less than High School 4 = Some College 7 = Master’s Degree 
2 = Some High School 5 = Associate’s Degree 8 = Doctorate Degree 
3 = Graduated High School 6 = Bachelor’s Degree 9 = More than Doctorate 
 
Household Information 
 
5. How many people live in your household altogether? (include yourself, infants, etc.) (Circle One) 
 
                               1       2       3        4       5       6       7       8       More than 8 
 
 
6. How many people living in your household currently smoke? (include yourself) (Circle One) 
  
                               1       2       3        4       5       6       7       8       More than 8 
 
7. Marital Status: (CIRCLE ONE)  
 
1 = Never Married 4 = Widowed 7 = Living Together 
2 = Married 5 = Separated  
3 = Divorced 6 = Engaged  
 
         7a.  If married or living together, does your spouse / partner smoke?        1 = YES          0 = NO  
     
 
 
 8. What is your present total household income range? (Circle One)       
 
1 = 0-$9,999/yr 4 = 30-$39,999/yr 7 = Over $60,000 
2 = 10-19,900/yr 5 = 40-49,900/yr  
3 = 20-29,999/yr 6 = 50-59,999/yr  
 
Employment Information 
 
9. Are you employed?  1 = YES 0 = NO   
a. If No, skip to question 13. 
10. What is your present occupation?  (select number that best describes what you do) 
 
1  =  Official or Manager  6  =   Craft Worker (skilled) 
2  =   Professional 7  =   Operator (semi-skilled) 
3  =   Technician 8  =   Laborer (unskilled) 
4  =   Sales 9  =   Service Worker 
5  =   Office and Clerical  0  =  Other ______________________________ 
  
11. How many colleagues at work do you interact with (come in contact with) every day? (Circle One) 
 
               1       2       3        4       5       6       7       8       More than 8 
 
12. How many of these people at work smoke? (Circle One) 
 
                     1       2       3        4       5       6       7       8       More than 8 
 
 
General Health Information 
 
13. Other than at work, do you exercise on a regular basis?    1 = YES   0 = NO  
 
14.  Do you follow a special diet?   1 = YES          0 = NO 
 
15. How much caffeinated coffee do you drink?      
    0 = 0 servings per day 2 = 3-5 servings per day 
    1 = 1-3 servings per day 3 = 5+ servings per day 
     
16. How much caffeinated tea do you drink?       
    0 = 0 servings per day 2 = 3-5 servings per day  
    1 = 1-3 servings per day 3 = 5+ servings per day 
     
17. How much other caffeinated beverages (e.g., soda, cocoa) do you drink?   
    0 = 0 servings per day 2 = 3-5 servings per day 
    1 = 1-3 servings per day 3 = 5+ servings per day 
 
 
 18. How often do you drink alcohol? 
    0 = Never             3 = Less than Weekly 
    1 = Less than monthly           4 = Weekly   
    2 = Monthly             5 = Daily 
Smoking and Drinking Patterns 
If you have not drunk alcohol in the past year, check here and skip the following questions. ______ 
 
Please use the following scale to indicate how often items #19 - 23 occur… 
 0=Never      1=Almost Never        2=Sometimes         3=Fairly Often         4=Always 
 
19.  I smoke more while I am having a drink. 0        1        2        3        4 
20.  Drinking results in my wanting a cigarette more.  0        1        2        3        4 
21.  It is second nature for me to pick up a cigarette while I am drinking. 0        1        2        3        4 
22.  I enjoy cigarettes more after I have a drink. 0        1        2        3        4 
23.  I need a cigarette while I am drinking. 0        1        2        3        4 
  
General Information 
 
Now, we would like to ask you a few questions about how things have been, in general, for you  
in the past month.  Use the scale below for questions # 24 - 27. 
 
0=Never       1=Almost Never        2=Sometimes         3=Fairly Often         4=Always  
 
24.  In the last month, how often have you felt that you were unable to  
       control the important things in your life. 
 
0        1        2        3        4 
25.  In the last month, how often have you felt confident about your  
       ability to handle your personal problems? 
 
0        1        2        3        4 
26.  In the last month, how often have you felt that things were going  
       your way? 
 
0        1        2        3        4 
27. In the last month, how often have you felt that difficulties were piling 
      up so high that you could not overcome them? 
 
0        1        2        3        4 
 
  
Smoking Information 
 
28. How important do you feel your stopping smoking is to the person(s) who are most important to you? 
    1 = Not important to them 4 = Important to them 
    2 = Somewhat important to them 5 = Very important to them 
    3 = Neutral 
      
29. Do you have a spouse or close friend that is interested and concerned about your smoking?   
    1 = YES 0 = NO  
 
30. How long have you been thinking seriously about quitting smoking?             
    1=Less than one month 3=Less than one year 
    2=Less than six months 4=More than one year 
    
31. At this time, what is your goal with regard to smoking?     
   1 = To quit and stay off forever 4 = To quit someday but not now 
   2 = To not smoke for a limited time 5 = To continue to smoke 
   3 = To be able to control how much I smoke 
 
32. How confident are you that you will be able to quit smoking at this time? 
    1 = Not at all confident 4 = Very confident 
    2 = Somewhat confident 5 = Extremely confident 
    3 = Moderately confident 
 
33. How much of a problem do you feel weight gain will be for you after you quit smoking? 
 
    1 = Not a problem 4 = Major Problem 
    2 = Very minor problem 5 = Very major problem 
    3 = Minor problem 
 
34. After you quit, how confident are you that you will be able to resist the urge altogether in the  
 future, regardless of the situation? 
 
      1 = Not at all confident 4 = Very confident 
    2 = Somewhat confident 5 = Extremely confident 
    3 = Moderately confident 
   
After reading statements 35 - 41, please use the following scale to rate yourself. 
   1 = Not at all         2 = Slightly        3 = Very Much        4 = Extremely 
 
35. How addicted do you think you are to smoking? 1        2        3        4 
36. I resent other people telling me I shouldn't smoke. 1        2        3        4 
37. If I really wanted to, I could quit smoking. 1        2        3        4 
38. I'm not going to give up smoking unless someone helps me. 1        2        3        4 
39. I think of smoking as a sickness which needs to be cured. 1        2        3        4 
40. What I really need is a pill or medicine that will stop me wanting to smoke. 1        2        3        4 
41. I don't think I'm really prepared to quit smoking if it proves too difficult or    
      distressing. 
1        2        3        4 
 Appendix C 
Medical History 
 
I. Has a doctor or health professional ever told you that you have any of the following? 
1. ___ Heart disease 
2. ___  Family history of heart disease 
3. ___  High Blood Pressure (hypertension) 
4. ___ High Cholesterol 
5. ___ Obesity 
6. ___ Lack of physical activity 
7. ___ Diabetes 
8. ___ Heart Attack (myocardial infarction) 
9. ___ Stroke 
10. ___ Anemia 
11. ___ Asthma 
12. ___ Thyroid problem or disease 
13. ___ Epilepsy or seizures 
14. ___ Pregnant 
15. ___ Eating Disorder 
16. ___ Mental Illness (please specify) ________________________ 
17. ___ Other major disease and/or surgery (please specify) ________________ 
 
II. Are you currently taking any of the following medications? 
1. ___ Blood Pressure Medication 
2. ___ Cholesterol Medication 
3. ___ Blood Sugar Medication 
4. ___ Heart Medication 
5. ___ Please list all other medication you are currently taking 
______________________________________________________________________________________
______________________________________________________________________  
 
III. How would you rate you overall state of health? 
1   2   3    4  
Poor   Fair   Good       Excellent 
 
IV.  Do you follow a special diet? ___ Yes ___ No 
 ID#__________ 
Date____________           
        Appendix D 
CES- D 
Rate the following items using the scale below. Choose one number for each question. 
 
 0 = Rarely or none of the time (less than 1 day) 
         1 = Some or a little of the time (1-2 days) 
                       2 = Occasionally or a moderate amount of the time (3-4 days) 
                                                3 = Most or all of the time (5-7 days) 
During the past week: 
  
1. I was bothered by things that usually don’t bother me.  ______ 
2. I did not feel like eating; my appetite was poor.  ______ 
3. I felt that I could not shake off the blues even with help from my family and friends. ______ 
4. I felt that I was just as good as other people. ______ 
5. I had trouble keeping my mind on what I was doing. ______ 
6. I felt depressed. ______ 
7. I felt that everything I did was an effort. ______ 
8. I felt hopeful about the future. ______ 
9. I thought my life had been a failure. ______ 
10. I felt fearful. ______ 
11. My sleep was restless. ______ 
12. I was happy. ______ 
13. I talked less than usual. ______ 
14. I felt lonely. ______ 
15. People were unfriendly.   ______ 
16. I enjoyed life. ______ 
17. I had crying spells. ______ 
18. I felt sad.  ______ 
19. I felt that people disliked me. ______ 
20. I could not get going. ______ 
 Appendix E 
      
ASI 
Please rate each item by selecting one of the five answers for each question.  
Please answer each statement by circling the number that best applies to you. 
 
 
 Very A   Very 
 little little Some Much Muc
h 
1.  It is important to me not to appear nervous. 0 1 2 3 4 
2.  When I cannot keep my mind on a task, I worry that I 
     might be going crazy. 
0 1 2 3 4 
3.  It scares me when I feel “shaky” (trembling). 0 1 2 3 4 
4.  It scares me when I feel faint. 0 1 2 3 4 
5.  It is important for me to stay in control of my emotions. 0 1 2 3 4 
6.  It scares me when my heart beats rapidly. 0 1 2 3 4 
7.  It embarrasses me when my stomach growls. 0 1 2 3 4 
8.  It scares me when I am nauseous. 0 1 2 3 4 
9.  When I notice that my heart is beating rapidly, I worry      
      that I might have a heart attack. 
0 1 2 3 4 
10. It scares me when I am short of breath. 0 1 2 3 4 
11. When my stomach is upset, I worry that I might be 
       seriously ill. 
0 1 2 3 4 
12. It scares me when I am unable to keep my mind on a 
      task. 
0 1 2 3 4 
13. Other people notice me when I am shaky. 0 1 2 3 4 
14. Unusual body sensations scare me. 0 1 2 3 4 
15. When I am nervous, I worry that I might be mentally ill. 0 1 2 3 4 
16. It scares me when I am nervous. 0 1 2 3 4 
 
 ID # _______________            
            Appendix F 
Date ______________ 
 
STAI 
 
Directions: A number of statements which people have used to describe themselves are given 
below. Read each statement and then check the appropriate circle to the right of the statement to 
indicate how you feel RIGHT NOW, that is, AT THIS MOMENT. There are no right or wrong 
answers. Do not spend too much time on any one statement, but give the answer which seems to 
describe your present feeling best. 
 
  
 
Not at All 
 
 
Somewhat 
 
Moderately 
So 
 
Very Much 
So 
1. I feel calm. ο 1 ο 2 ο 3 ο 4 
2. I feel secure. ο 1 ο 2 ο 3 ο 4 
3. I am tense. ο 1 ο 2 ο 3 ο 4 
4. I am regretful. ο 1 ο 2 ο 3 ο 4 
5. I feel at ease. ο 1 ο 2 ο 3 ο 4 
6. I feel upset. ο 1 ο 2 ο 3 ο 4 
7. I am presently worrying over possible 
misfortune. 
ο 1 ο 2 ο 3 ο 4 
8. I feel rested. ο 1 ο 2 ο 3 ο 4 
9. I feel anxious. ο 1 ο 2 ο 3 ο 4 
10. I feel comfortable. ο 1 ο 2 ο 3 ο 4 
11. I feel self-confident. ο 1 ο 2 ο 3 ο 4 
12. I feel nervous. ο 1 ο 2 ο 3 ο 4 
13. I am jittery. ο 1 ο 2 ο 3 ο 4 
14. I feel “high strung.” ο 1 ο 2 ο 3 ο 4 
15. I am relaxed. ο 1 ο 2 ο 3 ο 4 
16. I feel content. ο 1 ο 2 ο 3 ο 4 
17. I am worried. ο 1 ο 2 ο 3 ο 4 
18. I feel over-excited and “rattled.” ο 1 ο 2 ο 3 ο 4 
19. I feel joyful. ο 1 ο 2 ο 3 ο 4 
 20. I feel pleasant. ο 1 ο 2 ο 3 ο 4 
  
  
Directions: A number of statements which people have used to describe themselves are given 
below. Read each statement and check the appropriate box to the right of the statement to indicate 
how you GENERALLY FEEL. There are no right or wrong answers. Do not spend too much time 
on any one statement but give the answer which seems to describe how you generally feel. 
  
 
Almost 
Never 
 
 
 
Sometimes 
 
 
 
Often 
 
 
Almost 
Always 
21. I feel pleasant. ο 1 ο 2 ο 3 ο 4 
22. I tire quickly. ο 1 ο 2 ο 3 ο 4 
23. I feel like crying. ο 1 ο 2 ο 3 ο 4 
24. I wish I could be as happy as others seem to be. ο 1 ο 2 ο 3 ο 4 
25. I am losing out on things because I can’t make up my 
mind. 
ο 1 ο 2 ο 3 ο 4 
26. I feel rested. ο 1 ο 2 ο 3 ο 4 
27. I am “calm, cool, and collected.” ο 1 ο 2 ο 3 ο 4 
28. I feel that difficulties are pilling up so that I cannot 
overcome them. 
ο 1 ο 2 ο 3 ο 4 
29. I worry too much over something that really doesn’t 
matter. 
ο 1 ο 2 ο 3 ο 4 
30. I am happy. ο 1 ο 2 ο 3 ο 4 
31. I am inclined to take things hard. ο 1 ο 2 ο 3 ο 4 
32. I lack self-confidence. ο 1 ο 2 ο 3 ο 4 
33. I feel secure. ο 1 ο 2 ο 3 ο 4 
34. I try to avoid facing a crisis or difficulty. ο 1 ο 2 ο 3 ο 4 
35. I feel blue. ο 1 ο 2 ο 3 ο 4 
36. I am content. ο 1 ο 2 ο 3 ο 4 
37. Some unimportant thought runs through my mind and 
bothers me. 
ο 1 ο 2 ο 3 ο 4 
38. I take disappointments so keenly that I can’t put them 
out of my mind. 
ο 1 ο 2 ο 3 ο 4 
39. I am a steady person. ο 1 ο 2 ο 3 ο 4 
40. I get in a state of tension or turmoil as I think over my 
recent concerns and interests. 
ο 1 ο 2 ο 3 ο 4 
 
             
         Appendix G 
 
AIS 
 
Below are three sections.  In each section you will find a statement followed by a 
list of questions.  Please rate your response to each question by circling the appropriate 
number on the scale beneath the question.  There are no right or wrong answers. 
 
 
Section One 
 
Sometimes people have thoughts that encourage them to smoke, for example, “I need 
a cigarette!” or “I wish I could have a cigarette now!”   
 
 
1. How likely is it that these thoughts will lead you to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very likely 
 
 
2. How much are you struggling to control these thoughts? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very much 
 
 
3. To what degree must you reduce how often you have these thoughts in order not 
to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
4. To what degree must you reduce the intensity of these thoughts in order not to 
smoke? 
 
1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
 
 
 
  
Section Two 
 
Sometimes people have feelings that encourage them to smoke, for example, they may 
really feel like having a cigarette, and/or they may have feelings such as stress, 
enjoyment, fatigue, boredom, satisfaction, etc. that encourage them to smoke.   
 
 
 
5. How likely is it that these feelings will lead you to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very likely 
 
 
6. How important is getting rid of these feelings? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very important 
 
 
7. How much are you struggling to control these feelings? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very much 
 
 
8. To what degree must you reduce how often you have these feelings in order not to 
smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
9. To what degree must you reduce the intensity of these feelings in order not to 
smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
 
 
 
 
 
 Section Three 
 
 
Sometimes people have bodily sensations that encourage them to smoke.  For example, 
physical cravings or withdrawal symptoms may encourage people to smoke. 
 
 
 
10. How likely is it that these bodily sensations will lead you to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very likely 
 
 
11. How much are you struggling to get rid of these bodily sensations? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         very much 
 
 
12. To what degree must you reduce how often you have these bodily sensations in 
order not to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
13. To what degree must you reduce the intensity of these bodily sensations in order 
not to smoke? 
 
 1------------------2-------------------3-------------------4--------------------5 
not at all              a little               somewhat         considerably         extensively 
 
 
 
 
             
           Appendix H 
 AAQ 
 
Below you will find a list of statements.  Please rate the truth of each 
statement as it applies to you.  Use the following scale to make your choice.   
 
 1----------------2-----------------3------------------4-----------------5----------------6----------------7     
 never           very seldom seldom  sometimes frequently       almost always      always 
true    true     true      true     true   true    true 
 
_______ 1.  I am able to take action on a problem even if I am uncertain what is the  
    right thing to do.  
_______ 2.  When I feel depressed or anxious, I am unable to take care of my responsibilities.  
_______ 3.  I try to suppress thoughts and feelings that I don’t like by just not thinking about them.  
_______ 4.  It’s OK to feel depressed or anxious.  
_______ 5.  I rarely worry about getting my anxieties, worries, and feelings under control.  
_______ 6.  In order for me to do something important, I have to have all my doubts worked out.  
_______ 7.  I’m not afraid of my feelings.  
_______ 8.   I try hard to avoid feeling depressed or anxious.  
_______ 9.   Anxiety is bad.  
_______  10.  Despite doubts, I feel as though I can set a course in my life and then stick to it.  
_______  11.  If I could magically remove all the painful experiences I’ve had in my life, I would do so.  
_______  12.  I am in control of my life.  
_______  13.  If I get bored of a task, I can still complete it.  
_______  14.  Worries can get in the way of my success.  
_______  15.  I should act according to my feelings at the time.  
_______  16.  If I promised to do something, I’ll do it, even if I later don’t feel like it.  
_______  17.  I often catch myself daydreaming about things I’ve done and what I would do differently 
next time.  
_______  18.  When I evaluate something negatively, I usually recognize that this is just a reaction, not an 
objective fact.  
_______  19.  When I compare myself to other people, it seems that most of them are handling their lives 
better than I do. 
  
            Appendix I 
DERS 
 
Please indicate how often the following statements apply to you by filling in the appropriate numbered 
bubble from the scale below: 
1=almost never (0-10%); 2=sometimes (11-35%); 3=about half the time (36-65%); 4=most of the time (66-
90%); 5=almost always (91-100%). 
 A
lm
ost never 
Som
etim
es 
A
bout half the 
tim
e 
M
ost of the 
tim
e 
A
lm
ost alw
ays 
1. I am clear about my feelings. 
 
1 2 3 4 5 
2. I pay attention to how I feel. 
 
1 2 3 4 5 
3. I experience my emotions as overwhelming and out of control. 
 
1 2 3 4 5 
4. I have no idea how I am feeling. 
 
1 2 3 4 5 
5. I have difficulty making sense out of my feelings. 
 
1 2 3 4 5 
6. I am attentive to my feelings. 
 
1 2 3 4 5 
7. I know exactly how I am feeling. 
 
1 2 3 4 5 
8. I care about what I am feeling. 
 
1 2 3 4 5 
9. I am confused about how I feel. 
 
1 2 3 4 5 
10. When I’m upset, I acknowledge my emotions. 
 
1 2 3 4 5 
11. When I’m upset, I become angry with myself for feeling that 
way. 
 
1 2 3 4 5 
12. When I’m upset, I become embarrassed for feeling that way. 
 
1 2 3 4 5 
13. When I’m upset, I have difficulty getting work done. 
 
1 2 3 4 5 
14. When I’m upset, I become out of control. 
 
1 2 3 4 5 
15. When I’m upset, I believe that I will remain that way for a long 
time. 
 
1 2 3 4 5 
  A
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16. When I’m upset, I believe that I’ll end up feeling very 
depressed. 
 
1 2 3 4 5 
17. When I’m upset, I believe that my feelings are valid and 
important. 
 
1 2 3 4 5 
18. When I’m upset, I have difficulty focusing on other things. 
 
1 2 3 4 5 
19. When I’m upset, I feel out of control. 
 
1 2 3 4 5 
20. When I’m upset, I can still get things done. 
 
1 2 3 4 5 
21. When I’m upset, I feel ashamed with myself for feeling that 
way. 
 
1 2 3 4 5 
22. When I’m upset I know that I can find a way to eventually feel 
better. 
 
1 2 3 4 5 
23. When I’m upset, I feel like I am weak. 
 
1 2 3 4 5 
24. When I’m upset, I feel like I can remain in control of my 
behaviors. 
 
1 2 3 4 5 
25. When I’m upset, I feel guilty for feeling that way. 
 
1 2 3 4 5 
26. When I’m upset, I have difficulty concentrating.  
 
1 2 3 4 5 
27. When I’m upset, I have difficulty controlling my behaviors. 
 
1 2 3 4 5 
28. When I’m upset, I believe that there is nothing I can do to make 
my self feel better. 
 
1 2 3 4 5 
29. When I’m upset, I become irritated with myself for feeling that 
way. 
 
1 2 3 4 5 
30. When I’m upset, I start to feel very bad about myself. 
 
1 2 3 4 5 
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31. When I’m upset, I believe that wallowing in it is all I can do. 
 
1 2 3 4 5 
32. When I’m upset, I lose control over my behaviors. 
 
1 2 3 4 5 
33.  
 
When I’m upset, I have difficulty thinking about anything else. 
 
1 2 3 4 5 
34. When I’m upset, I take time to figure out what I’m really 
feeling. 
 
1 2 3 4 5 
35. When I’m upset, it takes me a long time to feel better. 
 
1 2 3 4 5 
36. When I’m upset, my emotions feel overwhelming. 
 
1 2 3 4 5 
 
 
 
               
           Appendix J 
PHLMS 
Instructions: Please circle how often you experienced each of the following statements  
within the past week.  
 
1.  I am aware of what thoughts are passing through my mind.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
2. I try to distract myself when I feel unpleasant emotions.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
3.  When talking with other people, I am aware of their facial and body expressions.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
 
4.  There are aspects of myself I don’t want to think about.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
5.  When I shower, I am aware of how the water is running over my body.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
6.  I try to stay busy to keep thoughts or feelings from coming to mind.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
7.  When I am startled, I notice what is going on inside my body. 
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
8.  I wish I could control my emotions more easily.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
9.  When I walk outside, I am aware of smells or how the air feels against my face.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
 
 
 
 10.  I tell myself that I shouldn’t have certain thoughts.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
 
11. When someone asks how I am feeling, I can identify my emotions easily. 
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
 
12. There are things I try not to think about.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
13.  I am aware of thoughts I’m having when my mood changes.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
14.  I tell myself that I shouldn’t feel sad.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
15.    I notice changes inside my body, like my heart beating faster or my muscles getting tense.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
16.    If there is something I don’t want to think about, I’ll try many things to get it out of my mind.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
17. Whenever my emotions change, I am conscious of them immediately.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
18.  I try to put my problems out of mind.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
19.  When talking with other people, I am aware of the emotions I am experiencing.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
 
20.   When I have a bad memory, I try to distract myself to make it go away.  
 
1    2    3    4    5  
  Never             Rarely             Sometimes             Often               Very  Often  
            Appendix K 
 
The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) 
 
Below are a series of statements about cigarette smoking. Please rate your level of 
agreement for each using the following scale:  
 
1  2   3   4   5   6   7  
Not True of            Extremely True  
      Me At All             of Me  
  
1. I enjoy the taste of cigarettes most of the time.  1  2 3  4  5  6  7  
2. Smoking keeps me from gaining weight.   1  2 3  4  5  6  7 
     
3. Smoking makes a good mood better.    1  2 3  4  5  6  7  
4. If I always smoke in a certain place it is hard to be  1  2 3  4  5  6  7 
there and not smoke.  
5. I often smoke without thinking about it.   1  2 3  4  5  6  7 
 
6. Cigarettes control me.     1  2 3  4  5  6  7 
7. Smoking a cigarette improves my mood.   1  2 3  4  5  6  7 
8. Smoking makes me feel content.    1  2 3  4  5  6  7 
9. I usually want to smoke right after I wake up.   1  2 3  4  5  6  7 
10. Very few things give me pleasure each day like  1  2 3  4  5  6  7 
cigarettes.  
 
11. It’s hard to ignore an urge to smoke.   1  2 3  4  5  6  7 
12. The flavor of a cigarette is pleasing.    1  2 3  4  5  6  7 
13. I smoke when I really need to concentrate.   1  2 3  4  5  6  7 
14. I can only go a couple hours between cigarettes.  1  2 3  4  5  6  7 
15. I frequently smoke to keep my mind focussed.  1  2 3  4  5  6  7 
 
16. I rely upon smoking to control my hunger and eating. 1  2 3  4  5  6  7 
17. My life is full of reminders to smoke.    1  2 3  4  5  6  7 
18. Smoking helps me feel better in seconds.   1  2 3  4  5  6  7 
19. I smoke without deciding to.     1  2 3  4  5  6  7 
20. Cigarettes keep me company, like a close friend.  1  2 3  4  5  6  7 
 
21. Few things would be able to replace smoking 1  2 3  4  5  6  7 
 in my life.  
22. I’m around smokers much of the time.   1  2 3  4  5  6  7 
23. There are particular sights and smells that trigger  
strong urges to smoke.     1  2 3  4  5  6  7 
24. Smoking helps me stay focussed.    1  2 3  4  5  6  7 
25. Smoking helps me deal with stress.    1  2 3  4  5  6  7 
 
26. I frequently light cigarettes without thinking about it.  1  2 3  4  5  6  7 
27. Most of my daily cigarettes taste good.   1  2 3  4  5  6  7 
28. Sometimes I feel like cigarettes rule my life.   1  2 3  4  5  6  7 
29. I frequently crave cigarettes.    1  2 3  4  5  6  7 
30. Most of the people I spend time with are smokers.  1  2 3  4  5  6  7 
 
31. Weight control is a major reason that I smoke.  1  2 3  4  5  6  7 
32. I usually feel much better after a cigarette.   1  2 3  4  5  6  7 
33. Some of the cigarettes I smoke taste great.  1  2 3  4  5  6  7 
34. I’m really hooked on cigarettes.    1  2 3  4  5  6  7 
 35. Smoking is the fastest way to reward myself.  1  2 3  4  5  6  7 
 
36. Sometimes I feel like cigarettes are my best friends.  1  2 3  4  5  6  7 
37. My urges to smoke keep getting stronger if I  
don’t smoke.       1  2 3  4  5  6  7 
38. I would continue smoking, even if it meant I could   1  2 3  4  5  6  7 
spend less time on my hobbies and other interests.  
 
39. My concentration is improved after smoking 
 a cigarette.      1  2 3  4  5  6  7 
40. Seeing someone smoke makes me really want 
 a cigarette.      1  2 3  4  5  6  7 
 
41. I find myself reaching for cigarettes without thinking 1  2 3  4  5  6  7 
 about it.  
42. I crave cigarettes at certain times of day.   1  2 3  4  5  6  7 
43. I would feel alone without my cigarettes.   1  2 3  4  5  6  7 
44. A lot of my friends or family smoke.    1  2 3  4  5  6  7 
45. Smoking brings me a lot of pleasure.   1  2 3  4  5  6  7 
 
46. Cigarettes are about the only things that can give 1  2 3  4  5  6  7 
me a lift when I need it.  
47. Other smokers would consider me a heavy smoker.  1  2 3  4  5  6  7 
48. I feel a strong bond with my cigarettes.   1  2 3  4  5  6  7 
49. It would take a pretty serious medical problem to 1  2 3  4  5  6  7 
make me quit smoking.  
50. When I haven’t been able to smoke for a few hours,  
the craving gets intolerable.     1  2 3  4  5  6  7 
 
51. When I do certain things I know I’m going to smoke.  1  2 3  4  5  6  7 
52. Most of my friends and acquaintances smoke.   
53. I love the feel of inhaling the smoke into my mouth.  1  2 3  4  5  6  7 
54. I smoke within the first 30 minutes of awakening in  
the morning.      1  2 3  4  5  6  7 
55. Sometimes I’m not aware that I’m smoking.   1  2 3  4  5  6  7 
 
56. I’m worried that if I quit smoking I’ll gain weight.  1  2 3  4  5  6  7 
57. Smoking helps me think better.    1  2 3  4  5  6  7 
58. Smoking really helps me feel better if I’ve been 
 feeling down.      1  2 3  4  5  6  7 
59. Some things are very hard to do without smoking.  1  2 3  4  5  6  7 
60. Smoking makes me feel good.    1  2 3  4  5  6  7 
 
61. Smoking keeps me from overeating.   1  2 3  4  5  6  7 
62. My smoking is out of control.    1  2 3  4  5  6  7 
63. I consider myself a heavy smoker.    1  2 3  4  5  6  7 
64. Even when I feel good, smoking helps me 
 feel better.       1  2 3  4  5  6  7 
65. I reach for cigarettes when I feel irritable.   1  2 3  4  5  6  7 
 
66. I enjoy the sensations of a long, slow  
exhalation of smoke.     1  2 3  4  5  6  7 
67. Giving up cigarettes would be like losing a 
 good friend.      1  2 3  4  5  6  7 
68. Smoking is the easiest way to give myself a lift.  1  2 3  4  5  6  7 
   Appendix L  
TIMELINE FOLLOWBACK CALENDAR: 
 
We ask that you complete the timeline followback calendar so that we can get an idea of the amount of alcohol 
and/or drugs you have used in the past 72 hours.  The first box defines a standard drink. The second box includes 
common street drugs. Review both boxes before you fill in the calendar below. 
  
 
 
 
 
  
 
One 5 oz glass of 
regular (12%) 
wine
1 ½ oz of hard liquor 
(e.g. rum, vodka, 
whiskey) 
1 mixed or straight 
drink with 1 ½ oz 
hard liquor  
1 Standard Drink is Equal to 
One 12 oz 
can/bottle of 
beer 
STREET DRUG 
 
Sedatives Cannabis Stimulants  Opioids Cocaine Hallucinogens          Other
Quaalude Marijuana    Amphetamine  Heroin  Freebase LSD             Steroid
Seconal  Hashish  Speed   Morphine Crack  Mescaline           “glue”
Valium  THC  Crystal meth  Opium  “Speedball” Peyote              Paint
Xanax    Dexadrine  Methadone   Psilocybin            Inhala
Librium    Ritalin   Darvon    STP      Nitrous O
Barbiturates                                    Ice                                       Codeine                                           Mushrooms                    
Miltown                                                                                        Percodan                                         PCP 
                                                                                                     Demerol                                           Ecstacy (MDMA) 
                                                                                                     Dilaudid 
 
    
 
        
 
 
 
 
 
 
Complete the Following 
Start Date (Today):         End Date (72 hours ago):     
MO  DY        YR     MO  DY        YR  
 
 
This calendar represents the past 72 hours. In the first row, indicate the amount of alcohol that you have drunk for 
each day in the last 72 hours.  In the second row, write the name of the drug that you may have used in the past 72 
hours.  If you did not drink alcohol or use drugs, write “N/A” in each of the boxes. 
  
     
 
Alcohol 
 
 
    
 
Drug 
 
    
     
             
         Appendix M 
 
Please draw a vertical line through the lines indicating your response to the following 
questions: 
 
 
1. How much anxiety do you feel right now? 
 
_______________________________________________ 
             0                        100 
        None                 Extreme 
 
 
 
2. How much irritability do you feel right now? 
 
_______________________________________________ 
             0                        100 
        None                 Extreme 
 
 
 
3. How difficult is it for you to concentrate right now? 
 
_______________________________________________ 
             0                        100 
        None                 Extreme 
 
 
 
4. How much discomfort do you feel right now? 
 
_______________________________________________ 
             0                        100 
        None                 Extreme 
 
 
 
5. How strong is the urge to smoke right now? 
 
_______________________________________________ 
             0                        100 
        None                 Extreme 
 
 
             
         Appendix N 
 
Please draw a vertical line through the lines indicating your response to the following 
questions: 
 
 
6. How valuable was the training to you in handling the tolerance test after the 
training? 
 
_______________________________________________ 
             0                        100 
    Not at all                Very Much 
             
 
7. When you had gone through the training, but before you had done the tolerance 
test, how useful did you think the training would be?  That is, how much did you 
think that it would help you? 
 
 
________________________________________________ 
             0                        100 
    Not at all                 Very Much 
 
 
             
         Appendix O 
 
Perceived efficacy 
 
Please draw a vertical line through the line to indicate how well you think you were 
able to regulate your emotional response to the stressors 
 
____________________________________ 
             0              100 
             Not at all able          very able 
 
             
          Appendix P 
 
Manipulation check 
Now we would like you answer a few questions about things you did during the stressors 
and while waiting for the doctor at the end of the experiment.  Use the scale below for the 
following questions. 
 
0=Very Little       1=A Little        2=Some         3=Much         4=Very Much  
 
1.  During the stress challenges, how much did you attempt to accept 
the discomfortable feelings and emotions without trying to change 
them? 
 
0        1        2        3        4 
2.  During the stress challenges, how much did you practice noticing 
your thoughts and feelings. 
 
0        1        2        3        4 
3.  During the stress challenges, how much did you think that your 
thoughts could not control behavior unless you let them? 
 
0        1        2        3        4 
4.  During the stress challenges, how much did you attempt to control 
or stop your thoughts? 
 
0        1        2        3        4 
5.  During the stress challenges, how much did you try to breath deeply 
to help reduce your discomfort? 
 
0        1        2        3        4 
6.  During the stress challenges, how much did you replace your negativ
thoughts with more positive thoughts, like “I can do this”? 
 
0        1        2        3        4 
7. During the stress challenges, how much did you think about the effect
of stress on your body? 
 
0        1        2        3        4 
8.  During the stress challenges, how much did you think about the healt
consequences of smoking on your body when you were having 
cravings to smoke? 
 
0        1        2        3        4 
9.During the stress challenges, how much did you think about the  
health consequences of smoking that you have already felt? 
 
0        1        2        3        4 
 
 
Appendix Q 
FUNCTIONAL GOALS OF THE INTERVENTIONS 
 
ACT Intervention 
Overall:  encourage ppt to 
become aware of their 
experience and increase 
willingness to experience 
distress w/o controlling or 
avoiding experience 
 
Orient ppt to the presentation 
 
Reinforce 
attention/concentration with 
quiz 
 
Teach ppt to differentiate 
btwn external/internal 
triggers have ppt practice 
 
Introduce concept of 
diffusion and have ppt 
practice with leaves on the 
stream  
 
Understanding difference 
btwn controlling external 
things vs internal, internal 
experiences are human and 
natural 
 
Acceptance as an alternative 
to control, practice through 
surfing the wave 
 
Highlight that there is NOT 
an intrinsic link btwn 
thoughts and behavior, 
serenity prayer 
 
Encourage ppt to practice 
ACT strategies during stress 
challenges. 
 
 
 
 
 
 
 
 
 
 
 
CBT Intervention 
Overall: encourage ppt to 
identify triggers and thoughts 
in order to change them 
through cog restructuring. 
Also to develop relax tech to 
help control urges. 
 
Orient ppt to the presentation 
 
Reinforce 
attention/concentration with 
quiz 
 
Teach ppt to identify triggers 
to smoking 
 
 
Introduce concept of 
automatic thoughts and have 
ppt begin to identify ATs. 
 
 
Challenge ATs through 
eval/questioning, practice 
with own ATs 
 
 
 
Substitute ATs with rational 
response   
 
 
Deep breathing relaxation 
technique a strategy to relax 
and cope with cravings 
 
 
Encourage participants to 
practice CBT strategies 
during stress challenges. 
 
 
 
 
 
 
 
 
 
 
 
 
Health Consequence  
Comparison Intervention 
Overall: to provide ppt with 
facts on the health 
consequences of smoking 
cigarettes and benefits of 
quitting. 
 
Orient ppt to the presentation 
 
Reinforce 
attention/concentration with 
quiz 
 
Educate ppt on role of 
nicotine in addiction 
 
 
Explain the motives of the 
tobacco industry in selling 
tobacco products 
 
 
Highlight health 
consequences of smoking 
cigarettes 
 
 
 
Highlight health 
consequences of second hand 
smoke 
 
Health benefits of quitting 
smoking 
 
 
 
Encourage ppt to think about 
benefits of quitting during the 
stress challenges. 
 
 
      
 
Appendix R 
Script for the Acceptance-Based Brief Intervention 
 
Hi! I am Heather a staff member here at the smoking clinic.  Before I begin, I would like to thank 
you for participating in this study.  I’ll shed some light on what you can expect from this 30-minute 
presentation.  I will begin by talking about alternative ways of thinking about cravings to smoke and stress 
and then will discuss an alternative approach to respond to the cravings or stress.  At times I will ask you to 
practice a few of the things are discussed in the presentation by writing down your responses on the 
worksheets included in your smoking study workbook.     
I ask that you listen to the presentation carefully, particularly because at the end of the 
presentation you will be asked to complete a short quiz.  Correct responses on the quiz will increase the 
likelihood of receiving five-dollars!  Also, if you have any questions of concerns during the course of the 
presentation, please let the staff member know. 
Okay, let’s begin by talking about smoking and more importantly why you smoke.  Why do you 
think you smoke?  (pause)  One reason why people smoke is because they are addicted to a chemical 
compound in the cigarette called nicotine.  In addition to wanting the nicotine, people smoke because it is a 
learned habit.  Think about how many years you have been smoking.  Over the years that you have been 
smoking, you have developed or learned smoking habits.  The urges to smoke don’t just come out of thin 
air; the urges are associated with specific situations, people, thoughts, and feelings and every smoker has a 
unique smoking pattern.  However, we know there are two general groups of situations that cause people to 
smoke, external and internal triggers.   
(Slide 1) External triggers would be triggers in the environment that lead to urges or craving to 
smoke.  Examples of external triggers include being around other smokers or seeing your lighter. Other 
external triggers may be drinking coffee or seeing your pack of cigarettes 
(Slide 2) Internal triggers come from within and include physical sensations, emotions, and 
thoughts.  Physical sensation may include being jittery, having an upset stomach, or feeling tense. Emotions 
may include being bored, stressed, or frustrated. Thoughts may be something like “smoking will make me 
feel better,” or “I really need a cigarette right now!”  (end of slide 2) 
These physical sensations, emotions or thoughts lead to urges to smoke.   External and internal 
triggers both lead to urges to smoke, which usually lead to smoking a cigarette.   
Often times we have external and internal triggers that we are not even aware of… we often do 
things, like light up a cigarette, automatically.  It takes practice to figure out what our external and internal 
triggers are, like I mentioned before, they are different for everyone and probably different for you 
depending on the situation you find yourself in.  I want you to practice identifying your external triggers 
and internal triggers.  Remember, external triggers are in the environment like when you are with other 
smokers or see your pack of cigarettes and internal triggers come from within and include physical 
sensations, emotions and thoughts.  Think about today, what were your triggers to smoke.  (slide 3) You 
have a worksheet in your workbook that looks like the computer screen.  Think about today when you 
smoked.  What were your external and internal triggers?  I know that it may be hard to identify them since 
smoking may be so automatic, but try to figure out what you were doing or thinking right before you lit-up 
your cigarette? Take a few minutes to fill in your external and internal triggers in each line provided. (end 
of slide 3) 
Did you have a hard time figuring out what your triggers were today?(pause)  Are you surprised 
with what came up? (pause) Do you think that your triggers are different today than when you first started 
smoking? 
External triggers and internal triggers are different.  We can actively change our external triggers 
by avoiding them, by substituting them or by altering them.  So for example, if drinking coffee is an 
external trigger you have the option of avoiding drinking coffee, substituting tea for the coffee or altering 
the coffee drinking experience by drinking coffee in a coffee store that doesn’t allow smoking.  By 
avoiding, substituting or altering the trigger to smoke, dealing with the cravings seems easier. On the other 
hand, internal triggers like physical sensations, emotions and thoughts may be harder to avoid, substitute or 
alter!  You can’t permanently avoid or escape your inner states.   
Let’s take a moment now to practice identifying some of your internal sensations, emotions and 
thoughts that you’re experiencing right now.  I am going to ask that you try something that may be different 
  
      
for you.  Try to get settled into your chair and find a comfortable position (pause). Close your eyes and 
imagine a beautiful slow-moving stream.  The water flows over rocks, around trees, descends downhill, and 
travels through a valley.  Once in a while, a big leaf drops into the stream and floats away down the river.  
Imagine you are sitting beside that stream on a warm, sunny day, watching the leaves float by.  Now 
become conscious of your thoughts.  Each time a thought pops into your head, imagine that it is written on 
one of the leaves.  If you think in words, put them on the leaf as words.  If you think in images, put them on 
the leaf as an image.  The goal is to stay beside the stream and allow the leaves on the stream to keep 
flowing by.  Don’t try to make the stream go faster or slower; don’t try to change what shows up on the 
leaves in any way.  If the leaves disappear, or if you mentally go somewhere else, or if you find that you are 
in the stream or on a leaf, just stop and notice that this is happening.  File that knowledge away and then 
once again return to the stream, watch a thought come into your mind, write it on the leaf, and let the leaf 
float away down the stream.  Continue to do this for a couple more minutes until I stop you. (3 minutes) 
Okay, place your last thought or image on a leaf and come back to the research room. Slowly open your 
eyes.  What was that experience like for you? (slide 4) 
You’ll notice that you have a worksheet in your workbook that looks like the slide on the 
computer screen.  I want you to take a few minutes now to think about the floating leaves on a moving 
stream and answer the questions about your experience.  (end slide 4) 3 minutes 
 Can you think of the moments when the stream wouldn’t flow… you can think of these moments 
as moments when you were “fused” with your thoughts.  When I say “fused” I mean that sometimes we get 
stuck, and perceive ourselves or our world from the perspective of our thoughts.  Part of the intent of this 
exercise was to practice what we call “diffusion” which is really a made up word for looking at your 
thoughts rather than from them.  This means that you can separate the thoughts that you are having from 
the person doing the thinking. 
 During the rest of the presentation, I am going to focus on alternative strategies to cope with these 
internal triggers to cravings and stress.  I am going to be discussing acceptance and willingness to 
experience cravings and stress.  By acceptance, I mean taking your experience completely, for what it is in 
the moment, without defense.  Willingness is a synonym for acceptance and they are the opposite of 
effortful control.  The words willingness and acceptance mean to respond actively to your feelings by 
allowing yourself to feel them, literally, much as you might reach out and literally feel the texture of a 
cashmere sweater.  During the rest of the presentation I am going to ask that you practice acceptance and 
willingness when thinking of your cravings or stress as a ocean wave and thinking how the serenity prayer 
might relate to your life and your smoking patterns.  Then after the presentation is completed, I ask that you 
continue to practice acceptance and willingness as you complete the challenges. 
We are human; we all have feelings and thoughts.  Our feelings and thoughts, including cravings, 
are a normal response to life events.  We can’t control whether or not they come up, no matter how hard we 
try.  We are never going to completely get rid of stress, negative feelings, urges or even intense positive 
feelings.  Life takes its course and presents us with situations. Our feelings, thoughts and physiological 
responses to these situations are natural. Imagine if you didn’t have feelings, thoughts or physiological 
responses… you would be a robot.  Accepting these experiences is helpful, deserved, and necessary. You 
really can’t escape your experience, and you deserve to have permission to have it.  We get into problems 
when we don’t allow ourselves to have our own experiences.  Painful experiences are universal-we don’t 
have to add to the suffering and the trauma.  When you get involved in cycles of avoiding you end up 
creating new problems and ultimately exacerbate the avoided feeling. For example I feel bad, so I smoke, 
and I feel temperately better but worse over the long run. 
When we are trying to do something new, we need to first of all be willing to do something 
different than what we automatically do. One thing smokers automatically do is cope with life by smoking; 
adjusting their moods and their inner states with nicotine and the habit of smoking a cigarette.  I want you 
to practice acceptance of these feelings, instead of modifying them by smoking (i.e., smoking to make them 
go away or change them in some way). (slide 5) 
I hope to show you that these feelings will come and go, much like a wave, and that you can learn 
to “surf” the wave rather than try to make it go down on your own. (end of slide 5) 
 For example, stress is something that most of us have felt at one time or another.  Stress is 
generally uncomfortable and there are all sorts of physical sensations that go along with being stressed, like 
your chest tightening up or your mind racing on all the things that have to get done.  In addition to the 
physical sensations, there are emotions and thoughts that go along with stress.  Emotions may include 
feeling overwhelmed or frustrated or hopeless and thoughts may be something like “I can’t handle this” or 
  
      
“there is no easy solution to this”.  I talked about acceptance before, as taking in your experience 
completely, for what it is in the moment, without defense.  This would mean allowing yourself to really feel 
the stress that you are feeling at that moment… what does it feel like in your body and what are the 
thoughts you are having.  By accepting stress, I don’t mean that you have to tolerate or resign yourself to 
the feeling. Instead acceptance means taking the experience for what it is without defense or trying to 
control or alter the experience.  One way to practice acceptance of feelings, particularly urges to smoke, is 
though what I call “urge surfing”.  Acceptance of our inner states without controlling them takes practice.  
Think about your stress or cravings as an ocean wave.  Imagine that you are in an ocean, near the surf.  
Today, there are waves coming in, some are huge and others are much smaller. If you are feeling stress, put 
that feeling of stress on the upcoming wave.  Watch the wave, or stress as it comes towards you.  As you 
are in the ocean, you have several options.  At any moment you can choose to try to beat the stress wave 
and control your experience by digging your feet deep into the ocean floor, hoping that the stress wave 
won’t impact you.  You may be strong enough to fight the stress wave, though you may not be and could 
end up being push towards the beach. You could also choose to allow the stress wave to consume you for a 
moment, even though your feet might leave the bottom of the ocean for a brief moment as the wave passes 
under you. 
Let’s take a few minutes right now to practice urge surfing with other feelings or thoughts that you 
may be having right now. Remember, it is natural to respond to our environment and situations, try to 
become aware of what your internal responses are.  How do you feel physically, are there any changes in 
your breathing, heart rate, or the tension in your muscles? (pause)  What is going through your mind right 
now….  What kind of thoughts are you having?  Take a minute to feel what it is that you are currently 
feeling or experiencing.  Practice allowing yourself to experience whatever it is that you are experiencing 
right now. There is no right or wrong reaction to what you are experiencing here.  .  Try placing a thought 
or feeling on an upcoming wave (pause). Practice allowing the wave to come closer and allowing yourself 
to feel the power of the wave lift you off the ocean floor and pass under you. Allow yourself to feel the 
wave pass by and feel your feet back on the ocean floor.  Put another thought or feeling that you are 
experiencing on an upcoming wave… and again practice inviting yourself to feel whatever it is that you are 
feeling (pause), and placing that on an upcoming wave.  Continue to place your thoughts, feelings and 
physical sensations on waves and practice accepting the experience of the wave, whatever it may be…. 
Continue to do this until I stop you. (several minutes) Put a last thought, feeling or physical sensations on 
an upcoming wave and practice accepting the experience of the wave, whatever it may be.  
What did that feel like for you (pause)? How was this different than what you normally do with 
your thoughts, feelings or physical sensations (pause)?  How was this similar to what you normally do?  
During the rest of your time here today, continue to practice surfing the wave.  Your response to 
different situations is natural and the experiences that you may have are yours.  Try to let yourself 
experience whatever it is that you may be feeling, whether it is stress or pain or cravings. Practice allowing 
yourself to experience these feelings, thoughts or physiological responses as if it were a wave that you are 
riding.  Try to allow yourself to feel the wave under you without trying to struggle to beat it.   
Let’s shift gears a little bit. Are you familiar with the serenity prayer? (slide 6)… 
“Grant me the serenity to accept the things that I cannot change, the courage to change the things that I can, 
and the wisdom to know the difference”. (end of slide 6) 
(slide 7)What does this mean to you? How do you think the serenity prayer could relate to your 
cravings? Take a few minutes to answer these questions in your workbook. (few minutes) (end of slide 7) 
We may have less control over feelings and thoughts, though we do have control over our 
behavior.  And it is importance to recognize that feelings do not necessarily lead to action. For example, 
parents may want to lock their kids in a closet, but rarely do—everyone has thoughts/feelings etc. that they 
do not choose to act on.  When we realize that the link between feelings and actions are not necessary, we 
can accept them.  Importantly, we can let go of needing to avoid these thoughts and feelings.  It is kind of 
paradoxical: by accepting our inner experiences, we get back our power: not power over our feeling, but 
power over our behavior. 
While you are here today, you will be asked to complete three tasks. During the tasks you may 
have feelings of frustration, discomfort or cravings to smoke. We encourage you to use the strategies that 
we discussed in this presentation when you are completing the tasks and when you have cravings to smoke 
and are asked not to.  So, for example you will be asked to hold your breath for as long as you can. I am 
sure that you can already imagine the discomfort that you may feel…. You may have all sorts of reactions 
to the experience of holding your breath. All of these experiences are natural responses… and you can’t 
  
      
really control whether or not feelings or thoughts will come up. It’s not that simple.  So today, while you 
are holding your breath, try something new. Instead of trying to alter the situation by taking a breath, try 
accepting the feelings and thoughts that are there.  Practice allowing yourself to experience these feelings 
without trying to control them… allow yourself to really feel what it is like to hold your breath.  Think of 
the discomfort that you are feeling as a wave that you can surf…. Remember, we can’t control our inner 
states or emotional experiences but we do have control over our behavior.  
Another task that you’ll be asked to complete is on the computer. You will be asked to trace a star 
that is on the computer screen using the computer mouse. The task may elicit all sorts of feelings, some of 
which may be frustration or annoyance.  Your reaction, whatever it may be, is a natural response. Whatever 
internal experience you may have during the task, practice sitting with the feelings, thoughts or even 
physiological changes that may come up.  Allow yourself to have these things, whatever they are… You 
may want to even invite the feelings of distress to be high, really allow yourself to feel your feelings 100 
percent just the way they are.  Practice feeling the discomfort and despite having the discomfort or cravings 
to smoke practice behaving in a way that is consistent with what you want. Try allowing yourself to having 
the cravings or stress and still doing or not doing what you want… like continuing to trace the star even 
though you are frustrated or allowing yourself to have cravings and to not smoke.  
 Like I mentioned before, we can’t control our internal experiences like cravings or frustration but 
we do have control over our actions or behaviors. 
We encourage you to use the strategies that we discussed in the presentation while you are 
completing the three tasks today.  In addition to using them during the tasks, practice using the strategies 
when you find yourself in situations where you are not allowed to smoke or when you don’t want to smoke.  
Practice thinking about your cravings as an ocean wave that you can surf. Or think about the serenity prayer 
and how it applies to your life and your smoking habit.   
Before you begin the challenges, we want you to complete a short quiz that is the last page in your 
workbook. Read each item carefully and fill in your answers.  Let the staff member know when you are 
done with the quiz. 
 
  
      
Appendix S 
Script for Control-Based Brief Intervention 
 
Hi! I am Heather a staff member here at the smoking clinic.  Before I begin, I would like to thank 
you for participating in this study.  I’ll shed some light on what you can expect from this 30-minute 
presentation.  I will begin by talking about ways of thinking about cravings or stress and then will discuss 
approaches that have been helpful for people when they are having cravings or stress.  At times I will ask 
you to practice a few of the things are discussed in the presentation by writing down your responses on the 
worksheets included in your smoking study workbook.     
I ask that you listen to the presentation carefully, particularly because at the end of the 
presentation you will be asked to complete a short quiz.  Correct responses on the quiz will increase the 
likelihood of receiving five-dollars!  Also, if you have any questions of concerns during the course of the 
presentation, please let the staff member know. 
Okay, let’s begin by talking about smoking and more importantly why you smoke.  Why do you 
think you smoke?  (pause).  One reason why people smoke is because they are addicted to a chemical 
compound in the cigarette called nicotine.  When a cigarette is smoked, 4,000 byproducts of the cigarette, 
including nicotine, enters the body and is absorbed into the bloodstream.  The nicotine reaches the brain 
within 10 seconds and causes the brain to release special chemicals that create a “buzz” feeling.  When a 
person hasn’t had a cigarette in a while the nicotine levels in the body decrease and the person may start to 
feel withdrawal symptoms including feeling tired, having a hard time concentrating, and on edge.  These 
feelings, in part, are what cause a smoker to light up again and this cycle leads to addiction. 
The nicotine addiction explains part of the reason why people smoke.  Smoking is also a learned 
habit.  Cigarette smoking is a behavioral pattern that is overlearned through years of repetition.  (Slide 1) 
There is a relationship between triggers, urges to smoke and smoking behaviors. A trigger is defined as a 
situation, event, or behavior that is commonly associated with smoking a cigarette, so that being in the 
situation brings on the urge to smoke.  For example, you may automatically light up a cigarette whenever 
you drive in your car.  The trigger here is “driving in your car”.  We call such situations “triggers to 
smoking” because driving in your car leads to an urge to smoke which leads to smoking. Other examples of 
triggers are finishing a meal or seeing a pack of cigarettes. We want to you think about what a few of your 
triggers are.  (end of slide 1)  
Think about different times or situations in which you usually smoke.  These situations may 
trigger your smoking in different ways.  We want you to think about your triggers.  It may be helpful to 
think about earlier today.  When you smoked, what situations were you in? (slide 2)  
 As you think about this, complete the following worksheet that looks like the worksheet shown on 
the computer.  Think about different situations, events or behaviors in which you have urges to smoke. 
Think about today. When you smoked what were your triggers. Again, triggers are situations, events or 
behaviors that led to the urge to smoke. An example is driving in your car. What are your triggers. Take a 
few minutes to write them down in your workbook. (end of slide 2) 
 One strategy to help smokers that are in situations where they can’t smoke or they don’t want to is 
to change the trigger.  After you identify your triggers, you can try to avoid them. 
(slide 3) For instance, if your trigger is coffee, when you avoid coffee you will be less likely to 
have the craving.  When you find yourself in a trigger situation and you don’t want to smoke using a 
substitute for the cigarette can be helpful.  For instance, if driving in a car is a trigger but your neighbor is 
in the car and you don’t want to smoke, substituting the cigarette with a piece of gum or a hard candy can 
help reduce the craving.  Another strategy that works for people that don’t want to smoke when they have a 
craving is to alter the trigger situation.  For example, if you usually have a cigarette right after finishing a 
meal, alter your meals so that you wash the dishes right away instead of having a cigarette. (end of slide 3) 
 Unfortunately, we can’t always get rid of the trigger completely. Or the trigger is unexpected so it 
is hard to find a substitute for the cigarette or alter the trigger. When that happens, a strategy that has 
helped smokers is to identify the thoughts they are having in the situation and think of more helpful 
thoughts.  For example, if you are in a non-smoker’s car getting a ride to the airport and you hit a traffic 
jam, you may be having the thought “I am going to miss my flight”, or “this is just my luck, only bad things 
happen to me”. We call these thoughts “automatic thoughts” because they go through our mind 
automatically.  We often don’t think twice about these thoughts and usually accept them as fact.  Automatic 
thoughts can be positive in nature or negative.  Positive thoughts are thoughts that have a good effect on 
your mood and reflect the positive point of view.  So for the example of riding in your non-smoking 
  
      
friend’s car, a positive thought may be “Even though there is a traffic jam, I tried my best to get to the 
airport on time” or “things will work out”. On the other hand, we often have negative thoughts which are 
thoughts that have a negative effect on our mood and usually the thoughts revolve around bad points or 
negative feelings about the world or the future.  Examples of negative thoughts in the situation described 
above would be “the only luck I ever have is bad luck” or “why do I even bother flying anywhere, it never 
works out”.  Like I said before, our automatic thoughts occur without us necessarily being aware of them.  
Sometimes they are positive or negative thoughts and often times we believe them without questioning 
them.  Sometimes the thoughts are helpful in coping with events, though many times the thoughts are 
unhelpful and even unrealistic.   
The reason I am talking about automatic thoughts is because we often have triggers in life that we 
can’t avoid like hitting a traffic jam, being in an accident, or having to do things that we really don’t want 
to do.  Since we can’t change many life situations that act as triggers to smoke, we can try a different 
strategy.  Try identifying your automatic thoughts.  What are they right now, what thoughts are going 
through your mind? (pause) It may seem unusual to think about thinking…. We encourage you to identify 
your thinking because people often have patterns of thinking that may be unhelpful.  The only way you’ll 
know if your thinking is unhelpful is by identifying your thinking patterns in the first place.  I want you to 
practice identifying your automatic thoughts.  Try to recall a time today when you had a cigarette. (slide 4) 
On your worksheet that looks like the worksheet that is on your screen, identify one situation 
where you smoked today and write it in where it says “situation”.  Pick a trigger (situation, event or 
behavior) which led to smoking today and put the situation in the “triggers to smoke” column. So for 
example being stuck in traffic. Practice identifying your automatic thoughts in that situation. For this 
example the automatic thought may have been “I am so stress out, I need a cigarette”. Remember, 
automatic thoughts are thoughts that went through your mind right before you smoked. Sometimes thoughts 
are so automatic it is hard to identify them. Try your best to remember the kinds of thoughts you were 
having right before you lit a cigarette today. That is, what were you saying to yourself right before you lit 
up? Take a few minutes to think about this and write in your thoughts on your worksheet provided in your 
worksheet. Several minutes (end of slide 4) 
Now that you have identified your thoughts, let’s see if your thoughts are helpful or even realistic.  
I’ll use an example trigger situation of a disagreement with a family member, in particular a family member 
is telling you that you need to do something that you don’t want to do and don’t think that you need to do 
it.   
Your automatic thoughts in the situation maybe something along the lines of “he is so bossy, he 
always has to have things his way”, “no one respects me” “why can’t she do it, she is so lazy”.  Automatic 
thoughts may lead to more thoughts, particularly about smoking “I am going to do what I want, I am going 
to have a cigarette”, “I need a cigarette break to get away from this”, or “I need a cigarette to help me 
relax”. Okay, so do you think that these thoughts are generally positive or negative? (pause).  You would 
probably agree that these are not positive thoughts. A positive thought in this situation may be more like “I 
know that I love my family member and disagreeing on something is not going to change that”, or 
“disagreeing is part of any kind of relationship”. 
I’ll use the thought “I need a cigarette break to get away from this” as an example thought.  I 
would say that this thought is pretty negative. This thought implies that the person has to have a cigarette 
and that having a cigarette is the only way to get away from the situation or to cope with the situation.  If 
we begin to question the automatic thought “I need a cigarette break to get away from this” we can 
determine if it is a realistic thought.  This slide includes a few questions you can ask yourself to help 
determine if your automatic thought is realistic or helpful: (slide 5) 
What are the other possible outcomes? Do you really need a cigarette to cope with the situation; 
are there other ways of handling family stress? 
What evidence do you have that smoking will help you cope with the situation? Will smoking a 
cigarette really change your stress level or the disagreement with your family member? 
Does smoking have to equal or lead to having a break? Are there other ways you can take a break 
or reduce the stress? 
What has happened in the past? Are there any exceptions? Have you ever had a disagreement with 
a family member or anyone else for that matter and NOT smoked? 
What is the evidence to suggest the consequences will be disastrous? If you don’t smoke, will the 
outcome be all that bad? Have you ever managed stress and not had a cigarette? (end of slide 5) 
The answer to the questions will help you determine if the automatic thought “I need a cigarette break 
  
      
to get away from this” is helpful and realistic.  The answers to the questions may help you come up with a 
more helpful thought that you can replace the automatic thought with.  For instance the answer to the 
question “will a cigarette really change my stress levels or change the disagreement that I had?”  If the 
answer is no… a more helpful thought in this situation could be “I am stressed and having a cigarette isn’t 
going to change my family member or my stress.  I can handle this because I have handled it before without 
a cigarette break.”  Would you agree that this is a more positive thought and still realistic? (pause).   
Okay, now it is your turn.  Think about that cigarette that you had today. You already identified an 
automatic thought that you had today right before lighting up a cigarette, now try questioning that thought.  
(slide 6) 
These answers to your questions will help you come up with a more helpful, positive thought that you 
can replace the original thought with. Write in your helpful response on the worksheet that looks like the 
worksheet on the computer screen.  Repeating the more helpful thought to yourself may be a useful way for 
you to cope with trigger situations that you can’t avoid.  Take a few minutes now to complete this 
worksheet. (end of slide 6). 
We talked about replacing your automatic thoughts with more helpful thoughts when you find yourself 
in a trigger situation for a cigarette.  This strategy has been helpful for many people who have cravings for 
cigarettes and don’t want to smoke.  We encourage you to give this strategy a try, particularly when you 
have cravings and you are in a place where you can’t smoke.  Try identifying your thoughts, evaluating 
them and coming up with a more helpful thought to replace the unhelpful thought.   
Another strategy that can help smokers cope with cravings is to relax!  The deep breathing 
relaxation exercise that we will discuss may help reduce your overall stress, which may make coping with 
cravings somewhat easier. It is also useful for in-the-moment stressful trigger situations to cope with that 
situation and avoid the urge to smoke.  This deep breathing exercise is one of the simplest relaxation 
methods.  It is based upon a meditative, deep breathing technique.  I am going to ask that you practice the 
deep breathing exercise and follow my cues. (slide 7)  
Before you begin, choose a word or phrase to repeat, either silently or aloud.  This will help you 
keep your mind from wandering.  The words “one” or “calm” are often recommended, but any simple, 
pleasing word will do.  Try to develop a passive “let it happen” attitude while practicing.  Don’t worry 
about how well you are performing or about distracting thoughts.  Okay, let’s begin practicing.  Take a 
minute to get settled in your chair as comfortably as you can.  Close your eyes if you want.  Relax your 
muscles as fully and deeply as possible.  Breathe easily and naturally through your nose.  Become aware of 
your breathing.  As you breath out, say “one” or your special word either silently to yourself or out loud.  
For example; breath in…then out, “one” in ….. out’ “one” etc. Follow my prompts and continue with the 
deep breathing until I tell you to stop. (5 minutes)  
Take a few more breaths, breath in….. and then out , “one”, breath in and the out “one”, take one more 
breath in and then out “one”. Now open your eyes and reorient yourself. It may be helpful to shake out your 
muscles. (end of slide 7) 
Okay, let’s shift gears a little bit and talk about a few thing that you will be doing while you are 
here today. You will be asked to complete three tasks. During the tasks you may have feelings of 
frustration, discomfort or cravings to smoke. We encourage you to use the strategies that we discussed in 
this presentation when you are completing the tasks and when you have cravings to smoke and are asked 
not to.  So, for example you will be asked to hold your breath for as long as you can. I am sure that you can 
already imagine the discomfort that you may feel…. Just imagine what kinds of thoughts may run through 
your mind. You may have an automatic thought like “I can’t take this any longer; I have to breath”. Try 
questioning that thought when you have it while you are completing the tasks. For instance, you can ask 
yourself “can I hold my breath for just a few more seconds” or “is it really that bad?” If your responses to 
your questions are something like this “I have been through worse, this is nothing I can’t handle”, “I am 
tough, I can do this”… try thinking about these responses when you are in the situation to help cope with 
the discomfort. If it helps say to yourself over and over “I can do this, I can do this, I can do this, I can do 
this” or “I have been through much worse, this isn’t that bad, I have been through much worse, this isn’t 
that bad, I have been through much worse, this isn’t that bad”. 
Another task that you’ll be asked to complete is on the computer. You will be asked to trace a star 
that is on the computer screen using the computer mouse. The task may elicit feelings of frustration or 
annoyance and you may have automatic thoughts like “this is so frustrating, I will just give up”, or “I want 
to make this end, I’ll have to give up”.  During the task, practice questioning your automatic thoughts…. 
Questions like “do I have to give up when things are frustrating?” or “is this so bad that I have to give up”, 
  
      
“have there been times when I have been even more frustrated than this and I haven’t given up?” the 
answers to your questions may help you get through the tasks. If your response is something like “I can be 
frustrated and still complete tasks” or “I can do this, even if it is frustrating” or “I am going to try my 
best”…. Saying your response over and over to yourself like “I am going to try my best, I am going to try 
my best, I am going to try my best” may help you keep going on the task despite the discomfort that you 
may be feeling. 
In addition to using the strategies discussed in the presentation when you are completing the four 
tasks today, we encourage you to try practicing this strategy when you find yourself in situations where you 
are unable to smoke or when you find yourself in situation when you don’t want to smoke.  Practice 
identifying your thoughts…. The thoughts that are running thru your mind. Try to question them, and to 
determine if the thoughts are helpful or realistic.  If you find that the thoughts aren’t so helpful in the 
situation where you don’t want to smoke, try coming up with another thought that is helpful even if it is as 
simple as “I can do this without smoking” and try repeating that thought over and over so that it really sinks 
in.  
When you find yourself in situations where you are really trying to concentrate and you want to 
use all your thinking power on the task, remembering to breathe can be a helpful strategy to reduce the 
stress and help you cope with the situation.  Taking a deep breath in and allowing yourself to fully exhale 
can help you relax… and when you are in a situation where you don’t want to smoke or even that you are 
feeling frustrated or angry try the deep breathing relaxation exercises that was discussed in the presentation. 
You breath all the time, so the deep breathing relaxation exercise can be done anywhere, your car, at home, 
at work when you are in a very long line or even here today. 
Before you begin the challenges, we want you to complete a short quiz. Read each item carefully 
and fill in your answers.  Let the staff member know when you are done with the quiz. 
  
      
Appendix T 
Script for Health Consequence Comparison Condition Brief Intervention 
 
 Hi! I am Heather, a staff member here at the smoking clinic. Before I begin, I would like to thank 
you for participating in this study. I’ll shed some light on what you can expect from this 30-minute 
presentation. I’ll begin by talking about reasons why people smoke and then discuss the health 
consequences of smoking. More importantly, I’ll highlight the health benefits of quitting smoking. 
 I ask that you listen to the presentation carefully, particularly because at the end of the 
presentation you will be asked to complete a short quiz. Correct responses on the quiz will increase the 
likelihood of receiving five-dollars. Also, if you have any questions or concerns, please let a staff member 
know. 
 Okay, let’s begin by discussing what really happens when you take a puff of your cigarette, the 
smoke that you inhale is absorbed by your body, mostly your lungs. From there, thousands of the chemicals 
agents in the cigarette including nicotine, are absorbed into your bloodstream and within 10 seconds 
reaches your brain. The nicotine causes the brain to release special chemicals that create a feeling of a 
“buzz”. This reaction is similar to that seen with other drugs of abuse- such as cocaine and heroin. Not only 
is the nicotine quickly absorbed, but it is also quickly eliminated. Within 30 minutes, the levels of nicotine 
is reduced, leaving the smoker feeling tired, unable to concentrate, and on edge. These feelings which result 
from not smoking are referred to as withdrawal. These withdrawal feelings, in part, cause smokers to light 
up again. This cycle of smoking leads to addiction. The body builds tolerance to the nicotine, so the smoker 
has to smoke more and more just to get the same high. Think about your smoking habit, when you first 
started smoking were you smoking as much as you are today? Does smoking one cigarette have the same 
effect that it did when you first started? Probably not, you have probably built a tolerance to the nicotine…. 
And if you did smoke a pack when you first started smoking you would have probably felt sick! 
 So the majority of smokers have built a tolerance to the nicotine and when they don’t smoke for a 
period of time the person will feel the withdrawal symptoms mentioned earlier. 
 Once you understand the addictive properties of nicotine, it makes sense that so many people 
continue to smoke. Right now, 48 million Americans smoke cigarettes, which is just about one in every 
four Americans. 
 The tobacco industry is making a huge profit on people who continue to use their product. In 
particular, the tobacco industry is making a bundle of money from the American population that smokes 
and the industry wants to continue to reap the profits of selling tobacco products. From a business 
prospective, the tobacco industry wants to make their products most desirable and has done just that. In 
fact, the tobacco industry has added compounds to their products, including cigarettes, to enhance the 
effects of nicotine. Three of the most widely known chemicals are nicotine, tar, and carbon monoxide. 
Nicotine is a strong poisonous drug, and is the main ingredient in insecticides or bug sprays. In its pure 
form, just one drop on nicotine on a person’s tongue would kill him or her. 
 Tar is the oily material which remains after tobacco passes through the filter. When a smoker 
inhales, a lot of the tar sticks to and blackens the lungs. Tar is a material used to make roads. Smoking a 
pack of cigarettes per day for one year will put about 8 ounces, which is a full cup, of tar into your lungs. 
(Slide 1) 
 Open your workbook and look for the worksheet that looks like the computer screen. Take a 
minute now to calculate how many years you have been smoking cigarettes. Now calculate how many 
years you have been smoking cigarettes. Now calculate how many cigarettes on average you smoke per 
day. If you smoke a pack a day, multiple 8 oz by the number of years you have smoked. If you smoke two 
packs everyday, multiply 16 oz by the number of years you have smoked. If you smoke three packs a day, 
multiply 24 oz by the number of years you have smoked. If you smoke half a pack a day, multiply 4 oz by 
the number of years you have smoked. If you want to get a better idea of the amount of tar that equals, 
multiply the number of oz by .062. Your final number is the number of gallons of tar that has accumulated 
over the years. That is a lot of tar that has been in your body at one point or another (end slide 1). 
 (Slide 2) This slide shows some of the familiar chemicals that are in cigarettes. Another chemical 
in cigarettes is the poisonous gas, carbon monoxide. A smoker inhales this gas which is also found in the 
exhaust of a car. This gas interferes with our respiratory and circulatory systems. When we breathe in air 
through our nose and mouth, the airs passes down the windpipe and bronchial tubes into the lungs. The 
cilia that are made up of small hairs and mucous help to clean this air as it moves down and into the lungs. 
The cilia remove small pieces of dirt, dust and germs. When a person smokes cigarettes, the cilia get coated 
  
      
with tar and can’t do their job in removing dirt, dust and germs. 
 In addition to the nicotine, tar, and carbon monoxide other chemicals are found in cigarettes and in 
most cases added to the products. As you can see on the slide, arsenic which is found in rat poison is in 
cigarettes along with other chemicals found in cleaning products, gas chamber poison, nail polish remover, 
lighter fluid, insecticides, car batteries, and pesticides (end of slide 2). 
 Ammonia compounds, which are found in cleaning products, have been used as a cigarette 
additive to increase the speed of nicotine absorption and to provide an “impact booster”. In addition to the 
tobacco industry adding compounds to cigarettes to enhance the desirability or enhance the level of 
addiction, the tobacco companies spend a lot of money marketing their products and recruiting new 
smokers. Cigarettes are one of the most heavily marketed consumer products in America. In 2002, tobacco 
companies spent more than 34 million dollars PER DAY to promote and advertise their products! A 
product that is the only legal product that causes death and disability when used as intended.  
 The tobacco industry understands that smokers have health concerns regarding continuous use of 
their products and has thus marketed “light cigarettes” targeting these smokers that have worries about their 
health. Light cigarettes are a marketing strategy the tobacco industry has created. In truth, light and ultra 
light cigarettes may have less tar and nicotine but the tobacco industry fails to reveal that ALL tar levels 
produce similar health risks. Smoking low tar and low nicotine cigarettes does NOT significantly reduce 
health risks. 
 Tobacco use is the leading preventable cause of death in the United States and accounts for one in 
five deaths (slide 3). This slide illustrates the seven leading causes of death in the U.S. Alcohol abuse, drug 
abuse, AIDS, motor vehicle accidents, homicide, and suicide are the six of the seven leading causes of 
death. All six of these causes combined account for only half as many deaths each year as does cigarette 
smoking (end of slide 3). 
 Smoking cigarettes has a profound impact on your health. The amount of life expectancy lost for 
each pack of cigarettes smoked is 28 minutes, and the years of life expectancy a typical smoker loses is 25 
years. Smoking cigarettes impacts the entire body. Because the 4,000 toxic byproducts of cigarettes are 
absorbed into the bloodstream, every cell in the body is affected by cigarette smoking (slide 4).  
 Let’s take a break for a minute now to calculate the number of cigarettes that you smoke each day. 
Turn to the worksheet that looks like your computer screen. Think about how many cigarettes you smoke 
per day. How many packs per week do you typically smoke? Since the amount of your life expectancy lost 
for each pack of cigarettes you smoke is about 28 minutes, multiply the number of packs you smoke per 
week by 28. The number you get is the amount of time you will lose in your life just from smoking this 
week. Now take that number and multiply it by 4, this number will indicate how many minutes of your life 
you will lose from smoking just this month. To figure out how much time you’ll lose from smoking this 
year, multiply the previous number by 12. How many years have you been smoking? Take the previous 
number and multiply it by the number of years that you have been smoking. This number indicates the 
number of minutes you’ll have already lost in your life from smoking cigarettes (end slide 4). 
 The amount of life expectancy lost for each pack of cigarettes smoked is related to the toxins in 
cigarettes that impacts the entire body. To break it down even more, smoking has been linked to at least 1/3 
of all cancer related deaths in the United States. Cigarette smoking ahs been linked to 90% of all lung 
cancer cases. Lung cancer is killing more women than breast cancer. The overall rates of death from cancer 
are twice as high among smokers as non-smokers, with heavy smokers having rates that are four times 
greater than those of nonsmokers. Smoking is also associated with cancers of the mouth, pharynx, larynx, 
esophagus, stomach, pancreas, cervix, kidney, ureter, and bladder.  The respiratory system is the first 
system in the body to attempt to filter the toxins inhaled from cigarettes; it is not surprising that smokers 
have greatly increased risk of emphysema, chronic bronchitis, and chronic obstructive pulmonary disease. 
In addition to causing and exacerbating lung disease and cancer, smokers’ ability to withstand various 
infectious diseases and asthma is compromised, and diseases are generally more severe and more persistent 
in smokers. 
 While smoking has well-known risks for developing cancer and heart disease, smoking also 
affects other areas of the body since the 4,000 toxic byproducts of cigarettes are absorbed into the 
bloodstream, which is delivered to every cell in the body. For instance, smokers are four times more likely 
to have gray hair and increased hair loss. Smoking affects bones and muscles and smokers not only fare 
worse after certain surgical procedures, they are more likely to see them fail. Also, medical reports indicate 
that colds, flu, and laryngitis last much longer for those who smoke.  
 Also, smoking reduces the body’s ability to circulate oxygen rich blood, which has impacts on 
  
      
your body’s ability to function and it also speeds up the aging process. For instance the skin of smoker’s 
forms wrinkles earlier in life since smoking reduces the body’s ability to form collagen, the main structural 
component of skin, reduces oxygen supplies to the skin, and interferes with the skin’s ability to protect 
itself from other environmental toxins. Smokers also tend to have tobacco-stained hands and yellowish, 
brownish tobacco stained teeth. Smoking doubles a person’s risk of losing teeth. Smoking cigarettes also 
impacts your sex life and health. Overall, smoking increases the risk of impotency by about 50% for men in 
their 30s and 40s. For women, smoking can cause reduced fertility. It is estimated that smoking women 
were only 72% as fertile as non-smokers. 
 Smoking during pregnancy has enormous long-term health consequences on the child’s life. Only 
about 30% of women who smoke stop smoking when they find out that they are pregnant. Smoking in 
pregnancy accounts for an estimated 20 to 30 percent of low-birth weight babies, up to 14% of preterm 
deliveries, and 10% of all infant deaths. Even apparently healthy, full-term babies of smokers have been 
found to be born with narrowed airways and curtailed lung functioning. 
 Take a minute now to think about the health consequences from smoking that you have noticed in 
yourself. How has smoking impacted your health? In your workbook, jot down a few health problems that 
you are already experiencing which you believe is a result of your smoking habits (slide 5). 
 Evidence supporting the dose-response of tobacco exposure and health problems can be seen in 
populations that are not actively smoking cigarettes but are exposed to second-hand smoke. Individuals 
exposed to second hand smoke have health risks similar to those of light smokers. Research suggests that 
even low levels of smoke exposure increase the risk of developing lung cancer, which suggests that there is 
no minimum threshold for tobacco carcinogenesis. Second hand smoke is a mixture of chemicals generated 
during the burning of the cigarettes that can be emitted from the smoldering cigarette or exhaled smoke. 
Second hand smoke is the third leading cause of preventable death in the US. Second hand smoke accounts 
for approximately 3,000 lung cancer deaths per year in the U.S. For every eight smokers the tobacco 
industry kills, it takes one nonsmoker with them. 
 Children are significantly impacted by second hand smoke. Because children’s bodies are still 
developing, exposure to the poisons in the second hand smoke puts them at risk for respiratory diseases, 
infection and cognitive problems like reading deficits and math and visuospatial reasoning. Also, second 
hand smoke is a known cause of low birth weight and Sudden Infant Death Syndrome (SIDS). The level of 
second hand smoke that a child is exposed to is directly proportional to the likelihood of the child 
becoming a smoker as an adolescent or an adult. 
 For most smokers, quitting smoking is the single most important thing that can be done to improve 
their health! It is never too late to quit smoking. Quitting has immediate as well as long term benefits, both 
by reducing the risk for disease caused by smoking and improving the health of smokers in general (Slide 
6). 
 As this slide illustrates, after just 20 minutes of quitting the heart rate drops. After only 12 hours, 
the carbon monoxide levels and the oxygen levels in the blood return to normal. In 24 hours of not 
smoking, the chances of heart attack decreases. After 48 hours, nerve endings start regrowing and the 
ability to smell and taste is enhanced. In 2 weeks to 3 months, circulation improves and lung functioning 
increase up to 30%, and walking becomes easier. Between one and nine months, coughing, sinus 
congestion, fatigue, and shortness of breath decreases. The cilia in your lungs regrow, increasing the ability 
to handle mucus, clean the lungs and reduce infection. Plus the body’s overall energy increases. After about 
one year, the excess risk of coronary heart disease is half that of a smokers’. Lung cancer death rates for 
average smoker are cut in half after quitting smoking for 5 years. Also, the risk of stroke is reduced to that 
of a nonsmoker. The risk of cancer of the mouth, throat and esophagus is half that of a smoker’s. After ten 
years, the lung cancer death rate is similar to that of a nonsmoker and precancerous cells are replaced. 
 As I mentioned before, it is never too late to quit smoking because when you quit smoking your 
body begins to recover and repair some of the damages caused by smoking. 
 Earlier I asked you to calculate the number of minutes of your life that has been lost by smoking 
cigarettes. Now I want you to take a minute to think about the time in your life that you could save by 
quitting smoking. 
 (Slide 7) Remember I said that the amount of life expectancy lost for each pack of cigarettes is 28 
minutes. You calculated the number of packs that you smoke per week. Multiply the number of packs that 
you smoke per week. Multiply the number of packs of cigarettes that you smoke each week by 28. This will 
tell you the number of minutes in your life that you can save by quitting smoking for just one week. 
Multiply that number by 52. The number that you calculate indicates the number of minutes in your life 
  
      
that you could save by not smoking this year. How old are you? How old are you planning on living? The 
national average for life expectancy for men is 74.8 years and for women 80.1 years. If you are a male, 
subtract your current age from 74.8. If you are women, subtract your current age from 80.1. Now take that 
number of years that you likely will live and multiply that by the number from question 3 (the number of 
minutes you’ll save per year). This calculation gives you the number of minutes of your life that you could 
save, on average, by not smoking another cigarette. To calculate the number of days you’ll save, divide you 
last calculation by 1440. How many days in your life will you save? Think of all the things you could do 
with that time.   
 While you are here today, you will be asked to complete three tasks. During the tasks you may 
have feelings of frustration, discomfort or cravings to smoke. We encourage you to think about the health 
consequences and benefits of quitting that we discussed in this presentation when you are completing the 
tasks and when you have cravings to smoke and are asked not to. So for example, you will be asked to hold 
your breath for as long as you can. I am sure that you can already imagine the discomfort that you may feel. 
During this task, think of the negative consequences that smoking a cigarette that moment would have. 
Think about the toxins that you would be inhaling, like the tar, carbon monoxide, nicotine, arsenic and 
ammonia just to name a few. Think of these chemicals traveling to every cell in your body, taking the place 
of oxygen rich blood. When you are holding your breath, think about the benefits of holding your breath as 
appose to breathing in the smoke from a cigarette.  
 Another task that you’ll be asked to complete is on the computer. You will be asked to trace a star 
that is on the computer screen using the computer mouse. The task may elicit all sorts of feelings, some of 
which may be frustrating or annoying. You may be use to smoking a cigarette when you are frustrated or 
annoyed. During the task, instead of thinking about the cigarette, think about the benefits of not smoking 
the cigarette. So for instance, by the time you are working on the computer task you would not have 
smoked for about two hours…. In just that amount of time your heart rate has dropped down and the carbon 
monoxide levels and oxygen levels in your blood are starting to return to normal. If you continue not to 
smoke, by tomorrow at this time your chance of having a heart attack decreases! 
 In addition to using the strategies discussed in the presentation when you are completing the three 
tasks today, we encourage you to try and practice this strategy when you find yourself in situations where 
you are unable to smoke or when you find yourself in situations when you don’t want to smoke. Practice 
thinking about health consequences of continuing to smoke, think about your chances of developing cancer 
increasing every time you take a puff, or your ability to breath… decreasing because of the tar sticking to 
the lining of your lungs. Think about the amount of life that you’ll be losing for each cigarette that you 
smoke and the 28 minutes of your life that you’ll lose by smoking that next pack of cigarettes. Like I 
mentioned before, it may be helpful to think of the benefits of not smoking when you have urges and you 
don’t want to smoke. It is never too late to quit smoking because when you quit smoking your body begins 
to recover and repair the damages caused by smoking. 
 Before you begin the challenges, we want you to complete a short quiz that you can find in your 
workbook. Read each item carefully and fill in your answers. Let the staff member know when you are 
done with the quiz. 
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